<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:dcterms="http://purl.org/dc/terms/"
 xmlns:cc="http://web.resource.org/cc/"
 xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/"
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns:admin="http://webns.net/mvcb/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/">
    <channel rdf:about="https://www.mdpi.com/rss/journal/molbank">
		<title>Molbank</title>
		<description>Latest open access articles published in Molbank at https://www.mdpi.com/journal/molbank</description>
		<link>https://www.mdpi.com/journal/molbank</link>
		<admin:generatorAgent rdf:resource="https://www.mdpi.com/journal/molbank"/>
		<admin:errorReportsTo rdf:resource="mailto:support@mdpi.com"/>
		<dc:publisher>MDPI</dc:publisher>
		<dc:language>en</dc:language>
		<dc:rights>Creative Commons Attribution (CC-BY)</dc:rights>
						<prism:copyright>MDPI</prism:copyright>
		<prism:rightsAgent>support@mdpi.com</prism:rightsAgent>
		<image rdf:resource="https://pub.mdpi-res.com/img/design/mdpi-pub-logo.png?13cf3b5bd783e021?1778040678"/>
				<items>
			<rdf:Seq>
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2170" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2169" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2168" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2167" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2166" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2165" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2164" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2163" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2162" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2161" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2160" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2159" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2158" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2157" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2156" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2155" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2154" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2153" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2152" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2151" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2150" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2149" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2148" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2147" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2146" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2145" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2144" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2143" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2142" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2141" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2140" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2139" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2138" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2137" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2136" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2135" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2134" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2133" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2132" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2131" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2130" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2129" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2128" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2127" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2126" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2125" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2124" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2123" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2122" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2121" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2120" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2119" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2118" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2117" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2116" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2115" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2114" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2113" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2112" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2111" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2110" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2109" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2108" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2107" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2106" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2105" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2104" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2103" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2102" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2101" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2100" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2099" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2098" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2097" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2096" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2095" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2094" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2093" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2092" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2091" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2090" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2089" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2088" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2087" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2086" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2085" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2083" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2084" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2082" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2081" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2080" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2079" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2078" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2077" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2076" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2075" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2074" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2073" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2072" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2025/4/M2071" />
                    	</rdf:Seq>
		</items>
				<cc:license rdf:resource="https://creativecommons.org/licenses/by/4.0/" />
	</channel>

        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2170">

	<title>Molbank, Vol. 2026, Article M2170: Synthesis of Three Bent Bis(imido-ferrocidiphenols)</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2170</link>
	<description>The ferrocidiphenol family brings together anticancer molecules featuring a [ferrocene-alkene-(p-phenol)2] motif that can form upon oxidation a quinone methide metabolite targeting cellular proteins. Adding an imide group (imido-ferrocidiphenol) dramatically enhanced the anticancer activity of ferrocidiphenol. We aimed to explore whether molecules with two ferrociphenol motifs connected by bisimide moieties could provide even more effective compounds. Using amino-ferrocidiphenol and commercial bisanhydrides at reflux, for the first time, three symmetrical and bent bis(imido-ferrocidiphenols) were synthesized, with moderate yields, and characterized. However, these compounds were insoluble in most common organic solvents and unstable. This likely explains why their anticancer activity was nil.</description>
	<pubDate>2026-05-06</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2170: Synthesis of Three Bent Bis(imido-ferrocidiphenols)</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2170">doi: 10.3390/M2170</a></p>
	<p>Authors:
		Pascal Pigeon
		</p>
	<p>The ferrocidiphenol family brings together anticancer molecules featuring a [ferrocene-alkene-(p-phenol)2] motif that can form upon oxidation a quinone methide metabolite targeting cellular proteins. Adding an imide group (imido-ferrocidiphenol) dramatically enhanced the anticancer activity of ferrocidiphenol. We aimed to explore whether molecules with two ferrociphenol motifs connected by bisimide moieties could provide even more effective compounds. Using amino-ferrocidiphenol and commercial bisanhydrides at reflux, for the first time, three symmetrical and bent bis(imido-ferrocidiphenols) were synthesized, with moderate yields, and characterized. However, these compounds were insoluble in most common organic solvents and unstable. This likely explains why their anticancer activity was nil.</p>
	]]></content:encoded>

	<dc:title>Synthesis of Three Bent Bis(imido-ferrocidiphenols)</dc:title>
			<dc:creator>Pascal Pigeon</dc:creator>
		<dc:identifier>doi: 10.3390/M2170</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-05-06</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-05-06</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2170</prism:startingPage>
		<prism:doi>10.3390/M2170</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2170</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2169">

	<title>Molbank, Vol. 2026, Article M2169: New Pyridinium Salt Bioconjugates of Cholesterol and Methylpyridine Derivatives: Synthesis and Characterization</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2169</link>
	<description>The synthesis of three novel, valuable bioconjugates obtained by coupling cholesterol bromoacetate with pyridine derivatives via an SN2 reaction was successfully carried out. Each of the products was fully characterized by magnetic nuclear resonance (1H, 13C, APT, 1H&amp;amp;minus;1H COSY, 1H&amp;amp;ndash;13C HMBC, 1H&amp;amp;ndash;13C HSQC), infrared spectroscopy (IR), and high-resolution mass spectrometry (HRMS).</description>
	<pubDate>2026-05-02</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2169: New Pyridinium Salt Bioconjugates of Cholesterol and Methylpyridine Derivatives: Synthesis and Characterization</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2169">doi: 10.3390/M2169</a></p>
	<p>Authors:
		José María Peña-Martínez
		Jesús Alberto Rojas Morales
		Luis Ramiro Caso-Vargas
		Elizabeth Bautista-Rodríguez
		Joel L. Terán
		Alan Carrasco-Carballo
		</p>
	<p>The synthesis of three novel, valuable bioconjugates obtained by coupling cholesterol bromoacetate with pyridine derivatives via an SN2 reaction was successfully carried out. Each of the products was fully characterized by magnetic nuclear resonance (1H, 13C, APT, 1H&amp;amp;minus;1H COSY, 1H&amp;amp;ndash;13C HMBC, 1H&amp;amp;ndash;13C HSQC), infrared spectroscopy (IR), and high-resolution mass spectrometry (HRMS).</p>
	]]></content:encoded>

	<dc:title>New Pyridinium Salt Bioconjugates of Cholesterol and Methylpyridine Derivatives: Synthesis and Characterization</dc:title>
			<dc:creator>José María Peña-Martínez</dc:creator>
			<dc:creator>Jesús Alberto Rojas Morales</dc:creator>
			<dc:creator>Luis Ramiro Caso-Vargas</dc:creator>
			<dc:creator>Elizabeth Bautista-Rodríguez</dc:creator>
			<dc:creator>Joel L. Terán</dc:creator>
			<dc:creator>Alan Carrasco-Carballo</dc:creator>
		<dc:identifier>doi: 10.3390/M2169</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-05-02</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-05-02</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2169</prism:startingPage>
		<prism:doi>10.3390/M2169</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2169</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2168">

	<title>Molbank, Vol. 2026, Article M2168: Synthesis of 2-(2-Methoxyphenyl)-4-methyl-6-nitroquinoline and 2-(2-Methoxyphenyl)-4-methylquinolin-6-amine</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2168</link>
	<description>A new compound, 2-(2-methoxyphenyl)-4-methyl-6-nitroquinoline, was obtained via Suzuki reaction. An unexpected side product, 2-(2-methoxyphenyl)-4-methylquinolin-6-amine, was isolated. The structures of the novel compounds were confirmed by 1H, 13C and 2D-NMR. Their optical properties were also studied.</description>
	<pubDate>2026-04-30</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2168: Synthesis of 2-(2-Methoxyphenyl)-4-methyl-6-nitroquinoline and 2-(2-Methoxyphenyl)-4-methylquinolin-6-amine</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2168">doi: 10.3390/M2168</a></p>
	<p>Authors:
		Rumen Lyapchev
		Maria Ivanova
		Iskra Z. Koleva
		Dimitar Shandurkov
		</p>
	<p>A new compound, 2-(2-methoxyphenyl)-4-methyl-6-nitroquinoline, was obtained via Suzuki reaction. An unexpected side product, 2-(2-methoxyphenyl)-4-methylquinolin-6-amine, was isolated. The structures of the novel compounds were confirmed by 1H, 13C and 2D-NMR. Their optical properties were also studied.</p>
	]]></content:encoded>

	<dc:title>Synthesis of 2-(2-Methoxyphenyl)-4-methyl-6-nitroquinoline and 2-(2-Methoxyphenyl)-4-methylquinolin-6-amine</dc:title>
			<dc:creator>Rumen Lyapchev</dc:creator>
			<dc:creator>Maria Ivanova</dc:creator>
			<dc:creator>Iskra Z. Koleva</dc:creator>
			<dc:creator>Dimitar Shandurkov</dc:creator>
		<dc:identifier>doi: 10.3390/M2168</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-30</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-30</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2168</prism:startingPage>
		<prism:doi>10.3390/M2168</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2168</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2167">

	<title>Molbank, Vol. 2026, Article M2167: Synthesis of (R)-(+)-3-(1-Hydroxyethylidene)-1-(1-phenylethyl)piperidine-2,4-dione, a Novel Tetramic Acid Analog</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2167</link>
	<description>Herein, starting from (R)-(+)-&amp;amp;alpha;-methylbenzylamine, we report an efficient synthesis and full characterization of a new (R)-3-(1-hydroxyethylidene)-1-(1-phenylethyl)piperidine-2,4-dione, a new tetramic acid analog. The key steps involved a non-classical Corey&amp;amp;ndash;Chaykovsky intramolecular cyclization reaction to access the corresponding zwitterion, followed by a sequential desulfurization/reduction and condensation procedure. The titled product was obtained in five steps, and the desired product 7 with an overall 58% yield.</description>
	<pubDate>2026-04-27</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2167: Synthesis of (R)-(+)-3-(1-Hydroxyethylidene)-1-(1-phenylethyl)piperidine-2,4-dione, a Novel Tetramic Acid Analog</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2167">doi: 10.3390/M2167</a></p>
	<p>Authors:
		Alan Aguilar-Aguilar
		Ángel Palillero-Cisneros
		Félix May-Moreno
		Jorge R. Juarez-Posadas
		Joel L. Terán
		David M. Aparicio
		</p>
	<p>Herein, starting from (R)-(+)-&amp;amp;alpha;-methylbenzylamine, we report an efficient synthesis and full characterization of a new (R)-3-(1-hydroxyethylidene)-1-(1-phenylethyl)piperidine-2,4-dione, a new tetramic acid analog. The key steps involved a non-classical Corey&amp;amp;ndash;Chaykovsky intramolecular cyclization reaction to access the corresponding zwitterion, followed by a sequential desulfurization/reduction and condensation procedure. The titled product was obtained in five steps, and the desired product 7 with an overall 58% yield.</p>
	]]></content:encoded>

	<dc:title>Synthesis of (R)-(+)-3-(1-Hydroxyethylidene)-1-(1-phenylethyl)piperidine-2,4-dione, a Novel Tetramic Acid Analog</dc:title>
			<dc:creator>Alan Aguilar-Aguilar</dc:creator>
			<dc:creator>Ángel Palillero-Cisneros</dc:creator>
			<dc:creator>Félix May-Moreno</dc:creator>
			<dc:creator>Jorge R. Juarez-Posadas</dc:creator>
			<dc:creator>Joel L. Terán</dc:creator>
			<dc:creator>David M. Aparicio</dc:creator>
		<dc:identifier>doi: 10.3390/M2167</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-27</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-27</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2167</prism:startingPage>
		<prism:doi>10.3390/M2167</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2167</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2166">

	<title>Molbank, Vol. 2026, Article M2166: Synthesis of (S)-4-Benzyl-3-butyl-1-(2-cycloheptylethyl)imidazolidine</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2166</link>
	<description>LiAlH4 reduction of tert-butyl (S)-butyl(1-((2-cycloheptylethyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate (1) gave imidazolidine 2, while treatment with lithium diisopropylamide furnished the &amp;amp;beta;-elimination product, cinnamamide 3. Both products were fully characterized. Reductive cyclization of N-alkylated-N-Boc-protected amino acid amides with LiAlH4 may be a viable synthetic method for trisubstituted chiral imidazolidines.</description>
	<pubDate>2026-04-16</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2166: Synthesis of (S)-4-Benzyl-3-butyl-1-(2-cycloheptylethyl)imidazolidine</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2166">doi: 10.3390/M2166</a></p>
	<p>Authors:
		Matevž Schweiger
		Luka Ciber
		Nejc Petek
		Franc Požgan
		Jurij Svete
		Bogdan Štefane
		Uroš Grošelj
		</p>
	<p>LiAlH4 reduction of tert-butyl (S)-butyl(1-((2-cycloheptylethyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate (1) gave imidazolidine 2, while treatment with lithium diisopropylamide furnished the &amp;amp;beta;-elimination product, cinnamamide 3. Both products were fully characterized. Reductive cyclization of N-alkylated-N-Boc-protected amino acid amides with LiAlH4 may be a viable synthetic method for trisubstituted chiral imidazolidines.</p>
	]]></content:encoded>

	<dc:title>Synthesis of (S)-4-Benzyl-3-butyl-1-(2-cycloheptylethyl)imidazolidine</dc:title>
			<dc:creator>Matevž Schweiger</dc:creator>
			<dc:creator>Luka Ciber</dc:creator>
			<dc:creator>Nejc Petek</dc:creator>
			<dc:creator>Franc Požgan</dc:creator>
			<dc:creator>Jurij Svete</dc:creator>
			<dc:creator>Bogdan Štefane</dc:creator>
			<dc:creator>Uroš Grošelj</dc:creator>
		<dc:identifier>doi: 10.3390/M2166</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-16</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-16</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2166</prism:startingPage>
		<prism:doi>10.3390/M2166</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2166</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2165">

	<title>Molbank, Vol. 2026, Article M2165: Synthesis of 2-Aminonicotinonitriles via Photodecarboxylation of Azirine-2-Carboxylic Acids</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2165</link>
	<description>2-Aminonicotinonitriles represent an important class of heterocycles with diverse biological activities. Herein, we report an unexpected photochemical transformation of azirine-2-carboxylic acids leading to the formation of 2-aminonicotinonitrile derivatives. Optimization of the reaction conditions enabled the synthesis of the target products in moderate yields. The structure of the obtained product was confirmed by NMR spectroscopy, HRMS, and single-crystal X-ray diffraction analysis.</description>
	<pubDate>2026-04-14</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2165: Synthesis of 2-Aminonicotinonitriles via Photodecarboxylation of Azirine-2-Carboxylic Acids</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2165">doi: 10.3390/M2165</a></p>
	<p>Authors:
		Julia I. Pavlenko
		Mikhail S. Novikov
		Anastasiya V. Agafonova
		</p>
	<p>2-Aminonicotinonitriles represent an important class of heterocycles with diverse biological activities. Herein, we report an unexpected photochemical transformation of azirine-2-carboxylic acids leading to the formation of 2-aminonicotinonitrile derivatives. Optimization of the reaction conditions enabled the synthesis of the target products in moderate yields. The structure of the obtained product was confirmed by NMR spectroscopy, HRMS, and single-crystal X-ray diffraction analysis.</p>
	]]></content:encoded>

	<dc:title>Synthesis of 2-Aminonicotinonitriles via Photodecarboxylation of Azirine-2-Carboxylic Acids</dc:title>
			<dc:creator>Julia I. Pavlenko</dc:creator>
			<dc:creator>Mikhail S. Novikov</dc:creator>
			<dc:creator>Anastasiya V. Agafonova</dc:creator>
		<dc:identifier>doi: 10.3390/M2165</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-14</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-14</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2165</prism:startingPage>
		<prism:doi>10.3390/M2165</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2165</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2164">

	<title>Molbank, Vol. 2026, Article M2164: A Bulky Aryl&amp;ndash;Substituted Acridinium Salt: 10-(3,5-Di-tert-butylphenyl)-9-mesitylacridinium Tetrafluoroborate</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2164</link>
	<description>9-Mesitylacridinium salts are widely recognized as efficient organic photoredox catalysts owing to their strong excited-state oxidizing power and stability under visible-light irradiation. In this study, a new mesityl acridinium derivative bearing a di-tert-butylphenyl substituent on the nitrogen atom was synthesized. The introduction of tert-butyl groups on the N-aryl moiety was primarily aimed at improving solubility and chemical stability of the acridinium salt. Starting from a 9(10H)-acridinone precursor, the target compound was obtained in high overall yield through a concise synthetic sequence. The synthesis consists of a copper-catalyzed C&amp;amp;ndash;N coupling reaction to install the aryl substituent on the nitrogen atom, followed by a Grignard reaction and subsequent acid treatment to afford the corresponding acridinium salt. All transformations proceeded smoothly, providing efficient access to the desired novel acridinium derivative. This work presents a practical example of the structural modification of mesitylacridinium derivatives directed toward enhanced solubility and stability, and provides a useful synthetic platform for the preparation of structurally diverse acridinium salts.</description>
	<pubDate>2026-04-14</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2164: A Bulky Aryl&amp;ndash;Substituted Acridinium Salt: 10-(3,5-Di-tert-butylphenyl)-9-mesitylacridinium Tetrafluoroborate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2164">doi: 10.3390/M2164</a></p>
	<p>Authors:
		Yuki Itabashi
		Kei Ohkubo
		</p>
	<p>9-Mesitylacridinium salts are widely recognized as efficient organic photoredox catalysts owing to their strong excited-state oxidizing power and stability under visible-light irradiation. In this study, a new mesityl acridinium derivative bearing a di-tert-butylphenyl substituent on the nitrogen atom was synthesized. The introduction of tert-butyl groups on the N-aryl moiety was primarily aimed at improving solubility and chemical stability of the acridinium salt. Starting from a 9(10H)-acridinone precursor, the target compound was obtained in high overall yield through a concise synthetic sequence. The synthesis consists of a copper-catalyzed C&amp;amp;ndash;N coupling reaction to install the aryl substituent on the nitrogen atom, followed by a Grignard reaction and subsequent acid treatment to afford the corresponding acridinium salt. All transformations proceeded smoothly, providing efficient access to the desired novel acridinium derivative. This work presents a practical example of the structural modification of mesitylacridinium derivatives directed toward enhanced solubility and stability, and provides a useful synthetic platform for the preparation of structurally diverse acridinium salts.</p>
	]]></content:encoded>

	<dc:title>A Bulky Aryl&amp;amp;ndash;Substituted Acridinium Salt: 10-(3,5-Di-tert-butylphenyl)-9-mesitylacridinium Tetrafluoroborate</dc:title>
			<dc:creator>Yuki Itabashi</dc:creator>
			<dc:creator>Kei Ohkubo</dc:creator>
		<dc:identifier>doi: 10.3390/M2164</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-14</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-14</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2164</prism:startingPage>
		<prism:doi>10.3390/M2164</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2164</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2163">

	<title>Molbank, Vol. 2026, Article M2163: Synthesis of 2-Methylcamalexin</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2163</link>
	<description>2-methylcamalexin, a novel derivative of the phytoalexin Camalexin, was synthesized for the first time, using a convenient two-step approach. The approach realizes coupling of two aromatic heterocyclic moieties (2-methylindole and thiazole) by sequential &amp;amp;alpha;-amidoalkylation/oxidative re-aromatization. The target product was obtained in a cost-effective manner, with 88% yield over two steps. The structure of the synthesized product was unequivocally determined on the basis of NMR, HRMS and FTIR spectral measurments.</description>
	<pubDate>2026-04-13</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2163: Synthesis of 2-Methylcamalexin</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2163">doi: 10.3390/M2163</a></p>
	<p>Authors:
		Yordan Stremski
		Maria Bachvarova
		Stela Statkova-Abeghe
		Plamen Angelov
		</p>
	<p>2-methylcamalexin, a novel derivative of the phytoalexin Camalexin, was synthesized for the first time, using a convenient two-step approach. The approach realizes coupling of two aromatic heterocyclic moieties (2-methylindole and thiazole) by sequential &amp;amp;alpha;-amidoalkylation/oxidative re-aromatization. The target product was obtained in a cost-effective manner, with 88% yield over two steps. The structure of the synthesized product was unequivocally determined on the basis of NMR, HRMS and FTIR spectral measurments.</p>
	]]></content:encoded>

	<dc:title>Synthesis of 2-Methylcamalexin</dc:title>
			<dc:creator>Yordan Stremski</dc:creator>
			<dc:creator>Maria Bachvarova</dc:creator>
			<dc:creator>Stela Statkova-Abeghe</dc:creator>
			<dc:creator>Plamen Angelov</dc:creator>
		<dc:identifier>doi: 10.3390/M2163</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-13</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-13</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2163</prism:startingPage>
		<prism:doi>10.3390/M2163</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2163</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2162">

	<title>Molbank, Vol. 2026, Article M2162: [2-{(5&amp;prime;-Amino-2&amp;prime;-fluoroacetophenone)-5-nitro}]acetophenone</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2162</link>
	<description>Herein we reported on a one-pot nitro reduction/nucleophilic aromatic substitution on 1-(2-fluoro-5-nitrophenyl)ethan-1-one using a mixture of acetic acid and iron powder in ethanol. The resultant target compound, a nitrated N bis-acetophenone, has many reactive handles; as such, it is a novel intermediate that can be deployed for the syntheses of a vast array of compounds not reported before. This compound is fully characterized using 1H and 13C NMR spectroscopy, and HRMS.</description>
	<pubDate>2026-04-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2162: [2-{(5&amp;prime;-Amino-2&amp;prime;-fluoroacetophenone)-5-nitro}]acetophenone</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2162">doi: 10.3390/M2162</a></p>
	<p>Authors:
		Richard M. Beteck
		Lesetja J. Legoabe
		</p>
	<p>Herein we reported on a one-pot nitro reduction/nucleophilic aromatic substitution on 1-(2-fluoro-5-nitrophenyl)ethan-1-one using a mixture of acetic acid and iron powder in ethanol. The resultant target compound, a nitrated N bis-acetophenone, has many reactive handles; as such, it is a novel intermediate that can be deployed for the syntheses of a vast array of compounds not reported before. This compound is fully characterized using 1H and 13C NMR spectroscopy, and HRMS.</p>
	]]></content:encoded>

	<dc:title>[2-{(5&amp;amp;prime;-Amino-2&amp;amp;prime;-fluoroacetophenone)-5-nitro}]acetophenone</dc:title>
			<dc:creator>Richard M. Beteck</dc:creator>
			<dc:creator>Lesetja J. Legoabe</dc:creator>
		<dc:identifier>doi: 10.3390/M2162</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-10</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-10</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2162</prism:startingPage>
		<prism:doi>10.3390/M2162</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2162</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2161">

	<title>Molbank, Vol. 2026, Article M2161: Racemic-Benzimidazolyl Pentafluorobenzyl Sulfoxide</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2161</link>
	<description>As a part of our research on the presence of conglomerates among the aryl benzyl sulfoxides, racemic-benzimidazolyl pentafluorobenzyl sulfoxide was synthesised, and its crystal structure was determined by a single crystal X-ray diffraction experiment. The main interactions building up the crystal structure were recognised and compared with those of similar compounds. Since the crystal structures of racemic and enantiopure benzimidazolyl pentafluorobenzyl sulfoxides are different, the presence of a conglomerate is excluded in the present case.</description>
	<pubDate>2026-04-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2161: Racemic-Benzimidazolyl Pentafluorobenzyl Sulfoxide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2161">doi: 10.3390/M2161</a></p>
	<p>Authors:
		Maria Annunziata M. Capozzi
		Cosimo Cardellicchio
		</p>
	<p>As a part of our research on the presence of conglomerates among the aryl benzyl sulfoxides, racemic-benzimidazolyl pentafluorobenzyl sulfoxide was synthesised, and its crystal structure was determined by a single crystal X-ray diffraction experiment. The main interactions building up the crystal structure were recognised and compared with those of similar compounds. Since the crystal structures of racemic and enantiopure benzimidazolyl pentafluorobenzyl sulfoxides are different, the presence of a conglomerate is excluded in the present case.</p>
	]]></content:encoded>

	<dc:title>Racemic-Benzimidazolyl Pentafluorobenzyl Sulfoxide</dc:title>
			<dc:creator>Maria Annunziata M. Capozzi</dc:creator>
			<dc:creator>Cosimo Cardellicchio</dc:creator>
		<dc:identifier>doi: 10.3390/M2161</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-10</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-10</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2161</prism:startingPage>
		<prism:doi>10.3390/M2161</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2161</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2160">

	<title>Molbank, Vol. 2026, Article M2160: 1-Phenyl-4-p-tolyl-[1,2,3]triazole</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2160</link>
	<description>1-Phenyl-4-p-tolyl-[1,2,3]triazole was obtained via a CuAAC reaction involving phenyl azide and 1-ethynyl-4-methylbenzene. The NMR spectra of the compound are discussed, and its crystal structure was studied by X-ray analysis. According to the latter analysis and a Hirshfeld surface analysis, the predominant intermolecular C-H&amp;amp;sdot;&amp;amp;sdot;&amp;amp;sdot;N and C-H&amp;amp;sdot;&amp;amp;sdot;&amp;amp;sdot;&amp;amp;pi; interactions in this molecule are responsible for crystal packing.</description>
	<pubDate>2026-04-08</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2160: 1-Phenyl-4-p-tolyl-[1,2,3]triazole</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2160">doi: 10.3390/M2160</a></p>
	<p>Authors:
		Eder Y. Nolasco-Terrón
		David Gómez-Colín
		Nelly González-Rivas
		Diego Martínez-Otero
		Erick Cuevas-Yañez
		</p>
	<p>1-Phenyl-4-p-tolyl-[1,2,3]triazole was obtained via a CuAAC reaction involving phenyl azide and 1-ethynyl-4-methylbenzene. The NMR spectra of the compound are discussed, and its crystal structure was studied by X-ray analysis. According to the latter analysis and a Hirshfeld surface analysis, the predominant intermolecular C-H&amp;amp;sdot;&amp;amp;sdot;&amp;amp;sdot;N and C-H&amp;amp;sdot;&amp;amp;sdot;&amp;amp;sdot;&amp;amp;pi; interactions in this molecule are responsible for crystal packing.</p>
	]]></content:encoded>

	<dc:title>1-Phenyl-4-p-tolyl-[1,2,3]triazole</dc:title>
			<dc:creator>Eder Y. Nolasco-Terrón</dc:creator>
			<dc:creator>David Gómez-Colín</dc:creator>
			<dc:creator>Nelly González-Rivas</dc:creator>
			<dc:creator>Diego Martínez-Otero</dc:creator>
			<dc:creator>Erick Cuevas-Yañez</dc:creator>
		<dc:identifier>doi: 10.3390/M2160</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-08</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-08</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2160</prism:startingPage>
		<prism:doi>10.3390/M2160</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2160</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2159">

	<title>Molbank, Vol. 2026, Article M2159: Synthesis of a Calix[4]semitube with a Selectively Dinitrated Face</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2159</link>
	<description>This paper describes the synthesis and characterisation of the calix semitube 5. The calix[4]semitube consists of two calix[4]arenes connected through their lower rim from two phenol groups in distal positions. One calix[4]arene is unsubstituted on its upper rim, while the upper rim of the other calix[4]arene has two nitro groups in the 1,3- position and two tert-butyl groups in the remaining ones. The synthesis procedure yielded an amorphous structure, which did not provide a single crystal. The final compound was comprehensively characterised by infrared spectroscopy, mass spectrometry, and 1H and 13C NMR spectroscopy. The results of the 1H NMR spectroscopy confirmed that the calix[4]arene units adopted a cone conformation. This was confirmed by COSY and 1H-13C HMBC. The results obtained confirm that the compound was successfully synthesised. The IUPAC name of 5 is 2,34-di-tert-butyl-39,49-dinitro-6,7,8,9,27,28,29,30-octahydro-15H,21H,36H,42H-4,32:11,25-bis(methano [1,3]benzenomethano)-16,20:37,41-di(metheno)tetrabenzo[g,g1,p,x][1,6,18,23] tetraoxacyclotetratriacontine-43,46,54,60-tetraol.</description>
	<pubDate>2026-04-07</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2159: Synthesis of a Calix[4]semitube with a Selectively Dinitrated Face</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2159">doi: 10.3390/M2159</a></p>
	<p>Authors:
		Roderick Abdilla
		Stefano Volpi
		Alessandro Casnati
		Maria A. Cardona
		Ruben Gatt
		</p>
	<p>This paper describes the synthesis and characterisation of the calix semitube 5. The calix[4]semitube consists of two calix[4]arenes connected through their lower rim from two phenol groups in distal positions. One calix[4]arene is unsubstituted on its upper rim, while the upper rim of the other calix[4]arene has two nitro groups in the 1,3- position and two tert-butyl groups in the remaining ones. The synthesis procedure yielded an amorphous structure, which did not provide a single crystal. The final compound was comprehensively characterised by infrared spectroscopy, mass spectrometry, and 1H and 13C NMR spectroscopy. The results of the 1H NMR spectroscopy confirmed that the calix[4]arene units adopted a cone conformation. This was confirmed by COSY and 1H-13C HMBC. The results obtained confirm that the compound was successfully synthesised. The IUPAC name of 5 is 2,34-di-tert-butyl-39,49-dinitro-6,7,8,9,27,28,29,30-octahydro-15H,21H,36H,42H-4,32:11,25-bis(methano [1,3]benzenomethano)-16,20:37,41-di(metheno)tetrabenzo[g,g1,p,x][1,6,18,23] tetraoxacyclotetratriacontine-43,46,54,60-tetraol.</p>
	]]></content:encoded>

	<dc:title>Synthesis of a Calix[4]semitube with a Selectively Dinitrated Face</dc:title>
			<dc:creator>Roderick Abdilla</dc:creator>
			<dc:creator>Stefano Volpi</dc:creator>
			<dc:creator>Alessandro Casnati</dc:creator>
			<dc:creator>Maria A. Cardona</dc:creator>
			<dc:creator>Ruben Gatt</dc:creator>
		<dc:identifier>doi: 10.3390/M2159</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-07</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-07</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2159</prism:startingPage>
		<prism:doi>10.3390/M2159</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2159</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2158">

	<title>Molbank, Vol. 2026, Article M2158: (1S,2R,3aR,6S,8aS)-1-Isopropyl-3a,6-Dimethyldecahydroazulene-1,2,6-Triol from Trichoderma virens</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2158</link>
	<description>A novel derivative from carotene-type sesquiterpene, (1S,2R,3aR,6S,8aS)-1-isopropyl-3a,6-dimethyldecahydroazulene-1,2,6-triol (1), was successfully isolated from filamentous fungus Trichoderma virens NBRC 31959. The structure and molecular formula of 1 were determined by interpretation of 1D and 2D NMR and HRMS data. The absolute configuration was established unambiguously by single-crystal X-ray diffraction, with the Flack parameter supporting the assignment. This study adds to the chemical diversity of sesquiterpene-type CAF603 derivatives of Trichoderma virens.</description>
	<pubDate>2026-04-02</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2158: (1S,2R,3aR,6S,8aS)-1-Isopropyl-3a,6-Dimethyldecahydroazulene-1,2,6-Triol from Trichoderma virens</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2158">doi: 10.3390/M2158</a></p>
	<p>Authors:
		Desita Triana Aziz
		Resky Nugraha
		Marwah Wirda Ningsih
		Zetryana Puteri Tachrim
		Yuta Murai
		Makoto Hashimoto
		</p>
	<p>A novel derivative from carotene-type sesquiterpene, (1S,2R,3aR,6S,8aS)-1-isopropyl-3a,6-dimethyldecahydroazulene-1,2,6-triol (1), was successfully isolated from filamentous fungus Trichoderma virens NBRC 31959. The structure and molecular formula of 1 were determined by interpretation of 1D and 2D NMR and HRMS data. The absolute configuration was established unambiguously by single-crystal X-ray diffraction, with the Flack parameter supporting the assignment. This study adds to the chemical diversity of sesquiterpene-type CAF603 derivatives of Trichoderma virens.</p>
	]]></content:encoded>

	<dc:title>(1S,2R,3aR,6S,8aS)-1-Isopropyl-3a,6-Dimethyldecahydroazulene-1,2,6-Triol from Trichoderma virens</dc:title>
			<dc:creator>Desita Triana Aziz</dc:creator>
			<dc:creator>Resky Nugraha</dc:creator>
			<dc:creator>Marwah Wirda Ningsih</dc:creator>
			<dc:creator>Zetryana Puteri Tachrim</dc:creator>
			<dc:creator>Yuta Murai</dc:creator>
			<dc:creator>Makoto Hashimoto</dc:creator>
		<dc:identifier>doi: 10.3390/M2158</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-02</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-02</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2158</prism:startingPage>
		<prism:doi>10.3390/M2158</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2158</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2157">

	<title>Molbank, Vol. 2026, Article M2157: (+)-(3S)-8-(3-Methylbut-2-en-1-yl)-7-Methoxy-6,2&amp;prime;,4&amp;prime;-Trihydroxyisoflavan</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2157</link>
	<description>Phytochemical investigation of Millettia racemosa Benth. led to the identification of an undescribed isoflavan, (+)-(3S)-8-(3-methylbut-2-en-1-yl)-7-methoxy-6,2&amp;amp;prime;,4&amp;amp;prime;-trihydroxyisoflavan, namely milletiaisoflavan (1). The structure of the isolate was elucidated by spectroscopic evidence (one- and two-dimensional nuclear magnetic resonance, ultraviolet, mass spectrometry, and circular dichroism spectra).</description>
	<pubDate>2026-04-02</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2157: (+)-(3S)-8-(3-Methylbut-2-en-1-yl)-7-Methoxy-6,2&amp;prime;,4&amp;prime;-Trihydroxyisoflavan</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2157">doi: 10.3390/M2157</a></p>
	<p>Authors:
		Hye Jin Kim
		Kye Jung Shin
		Khin Myo Htwe
		Kee Dong Yoon
		</p>
	<p>Phytochemical investigation of Millettia racemosa Benth. led to the identification of an undescribed isoflavan, (+)-(3S)-8-(3-methylbut-2-en-1-yl)-7-methoxy-6,2&amp;amp;prime;,4&amp;amp;prime;-trihydroxyisoflavan, namely milletiaisoflavan (1). The structure of the isolate was elucidated by spectroscopic evidence (one- and two-dimensional nuclear magnetic resonance, ultraviolet, mass spectrometry, and circular dichroism spectra).</p>
	]]></content:encoded>

	<dc:title>(+)-(3S)-8-(3-Methylbut-2-en-1-yl)-7-Methoxy-6,2&amp;amp;prime;,4&amp;amp;prime;-Trihydroxyisoflavan</dc:title>
			<dc:creator>Hye Jin Kim</dc:creator>
			<dc:creator>Kye Jung Shin</dc:creator>
			<dc:creator>Khin Myo Htwe</dc:creator>
			<dc:creator>Kee Dong Yoon</dc:creator>
		<dc:identifier>doi: 10.3390/M2157</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-02</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-02</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2157</prism:startingPage>
		<prism:doi>10.3390/M2157</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2157</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2156">

	<title>Molbank, Vol. 2026, Article M2156: (E)-3-(3,4-Di-(2,3,4,6-tetra-O-acetyl-&amp;beta;-d-glucopyranosyloxy)phenyl) Acrylic Acid</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2156</link>
	<description>Phenolic acids are widely known for their antioxidant and biological properties, which make them attractive scaffolds for structural modification. In this short note, we report the synthesis of a new 3,4-di-glucosylated caffeic acid analogue. The (E)-3-(3,4-di-(2,3,4,6-tetra-O-acetyl-&amp;amp;beta;-d-glucopyranosyloxy)phenyl) acrylic acid was obtained through a two-step synthesis, starting with a phase-transfer-catalyzed glycosylation of 3,4-dihydroxybenzaldehyde with 2,3,4,6-tetra-O-acetyl-&amp;amp;alpha;-d-glucopyranosyl bromide followed by a Dobner-modified Knoevenagel condensation. Consistent with the 2-O-acetyl neighbouring participation and the resulting Walden-type inversion at the anomeric centre, both glucopyranosyl units were assigned the &amp;amp;beta;-configuration.</description>
	<pubDate>2026-04-01</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2156: (E)-3-(3,4-Di-(2,3,4,6-tetra-O-acetyl-&amp;beta;-d-glucopyranosyloxy)phenyl) Acrylic Acid</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2156">doi: 10.3390/M2156</a></p>
	<p>Authors:
		Sara Ghazi
		Mohamed Touaibia
		</p>
	<p>Phenolic acids are widely known for their antioxidant and biological properties, which make them attractive scaffolds for structural modification. In this short note, we report the synthesis of a new 3,4-di-glucosylated caffeic acid analogue. The (E)-3-(3,4-di-(2,3,4,6-tetra-O-acetyl-&amp;amp;beta;-d-glucopyranosyloxy)phenyl) acrylic acid was obtained through a two-step synthesis, starting with a phase-transfer-catalyzed glycosylation of 3,4-dihydroxybenzaldehyde with 2,3,4,6-tetra-O-acetyl-&amp;amp;alpha;-d-glucopyranosyl bromide followed by a Dobner-modified Knoevenagel condensation. Consistent with the 2-O-acetyl neighbouring participation and the resulting Walden-type inversion at the anomeric centre, both glucopyranosyl units were assigned the &amp;amp;beta;-configuration.</p>
	]]></content:encoded>

	<dc:title>(E)-3-(3,4-Di-(2,3,4,6-tetra-O-acetyl-&amp;amp;beta;-d-glucopyranosyloxy)phenyl) Acrylic Acid</dc:title>
			<dc:creator>Sara Ghazi</dc:creator>
			<dc:creator>Mohamed Touaibia</dc:creator>
		<dc:identifier>doi: 10.3390/M2156</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-01</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-01</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2156</prism:startingPage>
		<prism:doi>10.3390/M2156</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2156</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2155">

	<title>Molbank, Vol. 2026, Article M2155: 1-(2-Aminophenyl)-3-(4-pyridyl)-3-hydroxy-1-propanone</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2155</link>
	<description>This work reports the isolation and structural characterization of 1-(2-aminophenyl)-3-(4-pyridyl)-3-hydroxy-1-propanone (1), a &amp;amp;beta;-hydroxyketone intermediate that crystallized unexpectedly during the base-catalyzed aldol condensation of 2-aminoacetophenone with pyridine-4-carbaldehyde, a reaction intended to afford the corresponding pyridyl chalcone (2). The formation of (1) highlights the sensitivity of Claisen&amp;amp;ndash;Schmidt reactions to the electronic and steric features of the substrates and to the applied reaction conditions. Single-crystal X-ray diffraction unambiguously confirmed the molecular structure of (1), revealing a hydrogen-bonding network involving the amino, carbonyl, and &amp;amp;beta;-hydroxyl functionalities. These interactions contribute to the solid-state stabilization of the &amp;amp;beta;-hydroxyketone and hinder its dehydration to chalcone (2). The present results provide experimental insight into the mechanistic landscape of aldol condensations and emphasize the relevance of isolable intermediates as structurally defined precursors for further synthetic transformations.</description>
	<pubDate>2026-03-25</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2155: 1-(2-Aminophenyl)-3-(4-pyridyl)-3-hydroxy-1-propanone</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2155">doi: 10.3390/M2155</a></p>
	<p>Authors:
		Yahaira Cuenú Ibargüen
		Fernando Cuenú-Cabezas
		Jovanny A. Gómez Castaño
		</p>
	<p>This work reports the isolation and structural characterization of 1-(2-aminophenyl)-3-(4-pyridyl)-3-hydroxy-1-propanone (1), a &amp;amp;beta;-hydroxyketone intermediate that crystallized unexpectedly during the base-catalyzed aldol condensation of 2-aminoacetophenone with pyridine-4-carbaldehyde, a reaction intended to afford the corresponding pyridyl chalcone (2). The formation of (1) highlights the sensitivity of Claisen&amp;amp;ndash;Schmidt reactions to the electronic and steric features of the substrates and to the applied reaction conditions. Single-crystal X-ray diffraction unambiguously confirmed the molecular structure of (1), revealing a hydrogen-bonding network involving the amino, carbonyl, and &amp;amp;beta;-hydroxyl functionalities. These interactions contribute to the solid-state stabilization of the &amp;amp;beta;-hydroxyketone and hinder its dehydration to chalcone (2). The present results provide experimental insight into the mechanistic landscape of aldol condensations and emphasize the relevance of isolable intermediates as structurally defined precursors for further synthetic transformations.</p>
	]]></content:encoded>

	<dc:title>1-(2-Aminophenyl)-3-(4-pyridyl)-3-hydroxy-1-propanone</dc:title>
			<dc:creator>Yahaira Cuenú Ibargüen</dc:creator>
			<dc:creator>Fernando Cuenú-Cabezas</dc:creator>
			<dc:creator>Jovanny A. Gómez Castaño</dc:creator>
		<dc:identifier>doi: 10.3390/M2155</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-25</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-25</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2155</prism:startingPage>
		<prism:doi>10.3390/M2155</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2155</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2154">

	<title>Molbank, Vol. 2026, Article M2154: 3a-Phenylhexahydropentalene-1,6-dione</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2154</link>
	<description>Bicyclo[3.3.0]skeleton is a common structural motif present in many natural products and pharmaceutical agents. Here we have synthesized a rigid 3a-arylhexahydropentalene-1,6-dione from cyclopent-2-en-1-one which is an easy and readily available starting material.</description>
	<pubDate>2026-03-18</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2154: 3a-Phenylhexahydropentalene-1,6-dione</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2154">doi: 10.3390/M2154</a></p>
	<p>Authors:
		Yongyao Li
		Hongtao Kong
		Xiaoying Huang
		Maxwell Ampomah-Wireko
		Cedric Dzidzor Kodjo Amengor
		En Zhang
		Yihong Zhao
		</p>
	<p>Bicyclo[3.3.0]skeleton is a common structural motif present in many natural products and pharmaceutical agents. Here we have synthesized a rigid 3a-arylhexahydropentalene-1,6-dione from cyclopent-2-en-1-one which is an easy and readily available starting material.</p>
	]]></content:encoded>

	<dc:title>3a-Phenylhexahydropentalene-1,6-dione</dc:title>
			<dc:creator>Yongyao Li</dc:creator>
			<dc:creator>Hongtao Kong</dc:creator>
			<dc:creator>Xiaoying Huang</dc:creator>
			<dc:creator>Maxwell Ampomah-Wireko</dc:creator>
			<dc:creator>Cedric Dzidzor Kodjo Amengor</dc:creator>
			<dc:creator>En Zhang</dc:creator>
			<dc:creator>Yihong Zhao</dc:creator>
		<dc:identifier>doi: 10.3390/M2154</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-18</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-18</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2154</prism:startingPage>
		<prism:doi>10.3390/M2154</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2154</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2153">

	<title>Molbank, Vol. 2026, Article M2153: Naphthalene-Based Schiff Base Compounds</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2153</link>
	<description>The synthesis of a salen-type ligand functionalized with naphthalene moieties, as well as its precursor, are reported. The compounds were characterized by 1H and 13C NMR, ESI-MS spectrometry and single crystal X-ray diffraction.</description>
	<pubDate>2026-03-17</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2153: Naphthalene-Based Schiff Base Compounds</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2153">doi: 10.3390/M2153</a></p>
	<p>Authors:
		Jocelyn Pradegan
		Aurélien Crochet
		Katharina M. Fromm
		</p>
	<p>The synthesis of a salen-type ligand functionalized with naphthalene moieties, as well as its precursor, are reported. The compounds were characterized by 1H and 13C NMR, ESI-MS spectrometry and single crystal X-ray diffraction.</p>
	]]></content:encoded>

	<dc:title>Naphthalene-Based Schiff Base Compounds</dc:title>
			<dc:creator>Jocelyn Pradegan</dc:creator>
			<dc:creator>Aurélien Crochet</dc:creator>
			<dc:creator>Katharina M. Fromm</dc:creator>
		<dc:identifier>doi: 10.3390/M2153</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-17</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-17</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2153</prism:startingPage>
		<prism:doi>10.3390/M2153</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2153</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2152">

	<title>Molbank, Vol. 2026, Article M2152: N-(3,4-Dimethoxyphenethyl)-2-propylpentanamide</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2152</link>
	<description>In this Short Note type article, we report the synthesis of a new hybrid molecule, N-(3,4-dimethoxyphenethyl)-2-propylpentanamide, using a solvent-minimized mechanochemical method that provides a simple and efficient synthetic approach. The process achieved high yield. The compound was confirmed by melting-point analysis, 1H and 13C NMR, IR spectroscopy, and mass spectrometry.</description>
	<pubDate>2026-03-13</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2152: N-(3,4-Dimethoxyphenethyl)-2-propylpentanamide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2152">doi: 10.3390/M2152</a></p>
	<p>Authors:
		Diyana Dimitrova
		Nikol Dimova
		Dimitrina Velikova
		Iliyan Ivanov
		Dimitar Bojilov
		Stanimir Manolov
		</p>
	<p>In this Short Note type article, we report the synthesis of a new hybrid molecule, N-(3,4-dimethoxyphenethyl)-2-propylpentanamide, using a solvent-minimized mechanochemical method that provides a simple and efficient synthetic approach. The process achieved high yield. The compound was confirmed by melting-point analysis, 1H and 13C NMR, IR spectroscopy, and mass spectrometry.</p>
	]]></content:encoded>

	<dc:title>N-(3,4-Dimethoxyphenethyl)-2-propylpentanamide</dc:title>
			<dc:creator>Diyana Dimitrova</dc:creator>
			<dc:creator>Nikol Dimova</dc:creator>
			<dc:creator>Dimitrina Velikova</dc:creator>
			<dc:creator>Iliyan Ivanov</dc:creator>
			<dc:creator>Dimitar Bojilov</dc:creator>
			<dc:creator>Stanimir Manolov</dc:creator>
		<dc:identifier>doi: 10.3390/M2152</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-13</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-13</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2152</prism:startingPage>
		<prism:doi>10.3390/M2152</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2152</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2151">

	<title>Molbank, Vol. 2026, Article M2151: Synthesis, Structural Characterization, and SHG Behavior of a Lanthanum/&amp;beta;-d-Fructose-Based Metal&amp;ndash;Organic Framework</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2151</link>
	<description>Interest in non-centrosymmetric crystalline materials exhibiting second harmonic generation (SHG) has increased due to their potential applications in optical sensing and biosensing. Saccharide-based metal complexes are particularly attractive systems, as chiral sugars can promote non-centrosymmetric crystal packing. In this work, a new lanthanum&amp;amp;ndash;&amp;amp;beta;-d-fructose compound, [La(C6H12O6)(H2O)5]Cl3 (LaFRUCl), was synthesized using a simple and low-cost method and characterized by single-crystal X-ray diffraction. The compound crystallizes in the orthorhombic space group P212121 and consists of infinite (La3+&amp;amp;ndash;fructose)n chains extending along the [001] direction, forming a one-dimensional Metal&amp;amp;ndash;Organic Framework. The nonlinear optical response was evaluated using the Kurtz&amp;amp;ndash;Perry powder technique with a Nd:YAG laser (1064 nm) and compared to a sucrose reference. The measured SHG efficiency is comparable to that of previously reported alkaline earth metal&amp;amp;ndash;sugar analogs. While the compound&amp;amp;rsquo;s SHG emission is significant, evaluation of its structural stability under aqueous or physiological conditions is be required before considering biological applications.</description>
	<pubDate>2026-03-13</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2151: Synthesis, Structural Characterization, and SHG Behavior of a Lanthanum/&amp;beta;-d-Fructose-Based Metal&amp;ndash;Organic Framework</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2151">doi: 10.3390/M2151</a></p>
	<p>Authors:
		Domenica Marabello
		Paola Benzi
		</p>
	<p>Interest in non-centrosymmetric crystalline materials exhibiting second harmonic generation (SHG) has increased due to their potential applications in optical sensing and biosensing. Saccharide-based metal complexes are particularly attractive systems, as chiral sugars can promote non-centrosymmetric crystal packing. In this work, a new lanthanum&amp;amp;ndash;&amp;amp;beta;-d-fructose compound, [La(C6H12O6)(H2O)5]Cl3 (LaFRUCl), was synthesized using a simple and low-cost method and characterized by single-crystal X-ray diffraction. The compound crystallizes in the orthorhombic space group P212121 and consists of infinite (La3+&amp;amp;ndash;fructose)n chains extending along the [001] direction, forming a one-dimensional Metal&amp;amp;ndash;Organic Framework. The nonlinear optical response was evaluated using the Kurtz&amp;amp;ndash;Perry powder technique with a Nd:YAG laser (1064 nm) and compared to a sucrose reference. The measured SHG efficiency is comparable to that of previously reported alkaline earth metal&amp;amp;ndash;sugar analogs. While the compound&amp;amp;rsquo;s SHG emission is significant, evaluation of its structural stability under aqueous or physiological conditions is be required before considering biological applications.</p>
	]]></content:encoded>

	<dc:title>Synthesis, Structural Characterization, and SHG Behavior of a Lanthanum/&amp;amp;beta;-d-Fructose-Based Metal&amp;amp;ndash;Organic Framework</dc:title>
			<dc:creator>Domenica Marabello</dc:creator>
			<dc:creator>Paola Benzi</dc:creator>
		<dc:identifier>doi: 10.3390/M2151</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-13</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-13</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2151</prism:startingPage>
		<prism:doi>10.3390/M2151</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2151</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2150">

	<title>Molbank, Vol. 2026, Article M2150: Synthesis of 3-[(2-Ethylhexyl)amino]-5-phenyl-4H-1,2,6-thiadiazin-4-one and 3-[(2-Ethylhexyl)amino]-5-[(4-oxo-5-phenyl-4H-1,2,6-thiadiazin-3-yl)amino]-4H-1,2,6-thiadiazin-4-one</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2150</link>
	<description>Suzuki&amp;amp;ndash;Miyaura coupling of 3-chloro-5-[(2-ethylhexyl)amino]-4H-1,2,6-thiadiazin-4-one with phenylboronic acid, at ca. 100 &amp;amp;deg;C, gave 3-[(2-ethylhexyl)amino]-5-phenyl-4H-1,2,6-thiadiazin-4-one in 69% yield. Another nucleophilic substitution reaction of 3-chloro-5-[(4-oxo-5-phenyl-4H-1,2,6-thiadiazin-3-yl)amino]-4H-1,2,6-thiadiazin-4-one with 2-ethylhexan-1-amine at ca. 100 &amp;amp;deg;C gave 3-[(2-ethylhexyl)amino]-5-[(4-oxo-5-phenyl-4H-1,2,6-thiadiazin-3-yl)amino]-4H-1,2,6-thiadiazin-4-one in 93% yield.</description>
	<pubDate>2026-03-11</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2150: Synthesis of 3-[(2-Ethylhexyl)amino]-5-phenyl-4H-1,2,6-thiadiazin-4-one and 3-[(2-Ethylhexyl)amino]-5-[(4-oxo-5-phenyl-4H-1,2,6-thiadiazin-3-yl)amino]-4H-1,2,6-thiadiazin-4-one</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2150">doi: 10.3390/M2150</a></p>
	<p>Authors:
		Andreas S. Kalogirou
		Panayiotis A. Koutentis
		</p>
	<p>Suzuki&amp;amp;ndash;Miyaura coupling of 3-chloro-5-[(2-ethylhexyl)amino]-4H-1,2,6-thiadiazin-4-one with phenylboronic acid, at ca. 100 &amp;amp;deg;C, gave 3-[(2-ethylhexyl)amino]-5-phenyl-4H-1,2,6-thiadiazin-4-one in 69% yield. Another nucleophilic substitution reaction of 3-chloro-5-[(4-oxo-5-phenyl-4H-1,2,6-thiadiazin-3-yl)amino]-4H-1,2,6-thiadiazin-4-one with 2-ethylhexan-1-amine at ca. 100 &amp;amp;deg;C gave 3-[(2-ethylhexyl)amino]-5-[(4-oxo-5-phenyl-4H-1,2,6-thiadiazin-3-yl)amino]-4H-1,2,6-thiadiazin-4-one in 93% yield.</p>
	]]></content:encoded>

	<dc:title>Synthesis of 3-[(2-Ethylhexyl)amino]-5-phenyl-4H-1,2,6-thiadiazin-4-one and 3-[(2-Ethylhexyl)amino]-5-[(4-oxo-5-phenyl-4H-1,2,6-thiadiazin-3-yl)amino]-4H-1,2,6-thiadiazin-4-one</dc:title>
			<dc:creator>Andreas S. Kalogirou</dc:creator>
			<dc:creator>Panayiotis A. Koutentis</dc:creator>
		<dc:identifier>doi: 10.3390/M2150</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-11</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-11</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2150</prism:startingPage>
		<prism:doi>10.3390/M2150</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2150</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2149">

	<title>Molbank, Vol. 2026, Article M2149: HAT-Initiated Fragmentation of 4-(Dimethylamino)-1-((3-methylbut-2-en-1-yl)oxy)-3-phenylbut-3-en-2-one</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2149</link>
	<description>An alkene-tethered enaminone 7 was synthesized in four steps from bromoacetic acid and 3,3-dimethylallyl alcohol. The enaminone was fully characterized, including UV-Vis spectra. TBADT-catalyzed HAT of the alkene-tethered enaminone initiated a fragmentation that yielded the literature-known phenylacetone-derived enaminone.</description>
	<pubDate>2026-03-11</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2149: HAT-Initiated Fragmentation of 4-(Dimethylamino)-1-((3-methylbut-2-en-1-yl)oxy)-3-phenylbut-3-en-2-one</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2149">doi: 10.3390/M2149</a></p>
	<p>Authors:
		Andrej Bogataj
		Luka Ciber
		Nejc Petek
		Franc Požgan
		Jurij Svete
		Bogdan Štefane
		Uroš Grošelj
		</p>
	<p>An alkene-tethered enaminone 7 was synthesized in four steps from bromoacetic acid and 3,3-dimethylallyl alcohol. The enaminone was fully characterized, including UV-Vis spectra. TBADT-catalyzed HAT of the alkene-tethered enaminone initiated a fragmentation that yielded the literature-known phenylacetone-derived enaminone.</p>
	]]></content:encoded>

	<dc:title>HAT-Initiated Fragmentation of 4-(Dimethylamino)-1-((3-methylbut-2-en-1-yl)oxy)-3-phenylbut-3-en-2-one</dc:title>
			<dc:creator>Andrej Bogataj</dc:creator>
			<dc:creator>Luka Ciber</dc:creator>
			<dc:creator>Nejc Petek</dc:creator>
			<dc:creator>Franc Požgan</dc:creator>
			<dc:creator>Jurij Svete</dc:creator>
			<dc:creator>Bogdan Štefane</dc:creator>
			<dc:creator>Uroš Grošelj</dc:creator>
		<dc:identifier>doi: 10.3390/M2149</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-11</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-11</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2149</prism:startingPage>
		<prism:doi>10.3390/M2149</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2149</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2148">

	<title>Molbank, Vol. 2026, Article M2148: Two-Stage Synthesis of 3-(4-Hydroxyphenyl)-1&amp;prime;,3&amp;prime;,6-trimethyl-2&amp;prime;H,3H,4H-spiro[furo[3,2-c]pyran-2,5&amp;prime;-pyrimidine]-2&amp;prime;,4,4&amp;prime;,6&amp;prime;(1&amp;prime;H,3&amp;prime;H)-tetraone</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2148</link>
	<description>Spirocyclic compounds are experiencing a research surge due to their unique 3D structure, offering enhanced pharmacological, industrial, and material applications. They are increasingly used in medicinal chemistry to improve drug-like properties, such as solubility and target binding, and are also being utilized for advanced material applications, including electronics and photonics. In this communication, 3-(4-hydroxyphenyl)-1&amp;amp;prime;,3&amp;amp;prime;,6-trimethyl-2&amp;amp;prime;H,3H,4H-spiro[furo[3,2-c]pyran-2,5&amp;amp;prime;-pyrimidine]-2&amp;amp;prime;,4,4&amp;amp;prime;,6&amp;amp;prime;(1&amp;amp;prime;H,3&amp;amp;prime;H)-tetraone was prepared via a two-stage transformation including a tandem Knoevenagel&amp;amp;ndash;Michael reaction and NBS-induced cyclization. At the first stage, a previously unknown ionic scaffold, morpholin-4-ium 5-((4-hydroxy-6-methyl-2-oxo-2H-pyran-3-yl)(4-hydroxyphenyl)methyl)-1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-olate was also isolated. Structures of the newly synthesized compounds were established by 1H and 13C NMR, IR spectroscopy, high-resolution mass spectrometry, and elemental analysis.</description>
	<pubDate>2026-03-11</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2148: Two-Stage Synthesis of 3-(4-Hydroxyphenyl)-1&amp;prime;,3&amp;prime;,6-trimethyl-2&amp;prime;H,3H,4H-spiro[furo[3,2-c]pyran-2,5&amp;prime;-pyrimidine]-2&amp;prime;,4,4&amp;prime;,6&amp;prime;(1&amp;prime;H,3&amp;prime;H)-tetraone</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2148">doi: 10.3390/M2148</a></p>
	<p>Authors:
		Michail N. Elinson
		Varvara M. Kalashnikova
		Yuliya E. Ryzhkova
		Oleg A. Rakitin
		</p>
	<p>Spirocyclic compounds are experiencing a research surge due to their unique 3D structure, offering enhanced pharmacological, industrial, and material applications. They are increasingly used in medicinal chemistry to improve drug-like properties, such as solubility and target binding, and are also being utilized for advanced material applications, including electronics and photonics. In this communication, 3-(4-hydroxyphenyl)-1&amp;amp;prime;,3&amp;amp;prime;,6-trimethyl-2&amp;amp;prime;H,3H,4H-spiro[furo[3,2-c]pyran-2,5&amp;amp;prime;-pyrimidine]-2&amp;amp;prime;,4,4&amp;amp;prime;,6&amp;amp;prime;(1&amp;amp;prime;H,3&amp;amp;prime;H)-tetraone was prepared via a two-stage transformation including a tandem Knoevenagel&amp;amp;ndash;Michael reaction and NBS-induced cyclization. At the first stage, a previously unknown ionic scaffold, morpholin-4-ium 5-((4-hydroxy-6-methyl-2-oxo-2H-pyran-3-yl)(4-hydroxyphenyl)methyl)-1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-olate was also isolated. Structures of the newly synthesized compounds were established by 1H and 13C NMR, IR spectroscopy, high-resolution mass spectrometry, and elemental analysis.</p>
	]]></content:encoded>

	<dc:title>Two-Stage Synthesis of 3-(4-Hydroxyphenyl)-1&amp;amp;prime;,3&amp;amp;prime;,6-trimethyl-2&amp;amp;prime;H,3H,4H-spiro[furo[3,2-c]pyran-2,5&amp;amp;prime;-pyrimidine]-2&amp;amp;prime;,4,4&amp;amp;prime;,6&amp;amp;prime;(1&amp;amp;prime;H,3&amp;amp;prime;H)-tetraone</dc:title>
			<dc:creator>Michail N. Elinson</dc:creator>
			<dc:creator>Varvara M. Kalashnikova</dc:creator>
			<dc:creator>Yuliya E. Ryzhkova</dc:creator>
			<dc:creator>Oleg A. Rakitin</dc:creator>
		<dc:identifier>doi: 10.3390/M2148</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-11</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-11</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2148</prism:startingPage>
		<prism:doi>10.3390/M2148</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2148</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2147">

	<title>Molbank, Vol. 2026, Article M2147: N-(3,6-Dimethoxy-2-nitrophenyl)acetamide</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2147</link>
	<description>1,4-Dimethoxy-2,3-dinitrobenzene (1) reduction using sodium hydrosulfite resulted in 3,6-dimethoxybenzene-1,2-diamine (2) and 3,6-dimethoxy-2-nitroaniline (3) in 24% and 59% yields, respectively. Nitroaniline 3 was acetylated with acetyl chloride to give N-(3,6-dimethoxy-2-nitrophenyl)acetamide (4) in a 65% yield and with acetic anhydride to give N-acetyl-N-(3,6-dimethoxy-2-nitrophenyl)acetamide (5) in 78% yield. Novel compounds 4 and 5 were characterized by FT-IR, 1H and 13C-NMR, and HRMS. The X-ray crystal structure of acetamide 4 is also presented.</description>
	<pubDate>2026-03-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2147: N-(3,6-Dimethoxy-2-nitrophenyl)acetamide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2147">doi: 10.3390/M2147</a></p>
	<p>Authors:
		Lina A. Al-Dulaimi
		Joseph C. Bear
		Jeremy K. Cockcroft
		Giuseppe Trigiante
		Fawaz Aldabbagh
		</p>
	<p>1,4-Dimethoxy-2,3-dinitrobenzene (1) reduction using sodium hydrosulfite resulted in 3,6-dimethoxybenzene-1,2-diamine (2) and 3,6-dimethoxy-2-nitroaniline (3) in 24% and 59% yields, respectively. Nitroaniline 3 was acetylated with acetyl chloride to give N-(3,6-dimethoxy-2-nitrophenyl)acetamide (4) in a 65% yield and with acetic anhydride to give N-acetyl-N-(3,6-dimethoxy-2-nitrophenyl)acetamide (5) in 78% yield. Novel compounds 4 and 5 were characterized by FT-IR, 1H and 13C-NMR, and HRMS. The X-ray crystal structure of acetamide 4 is also presented.</p>
	]]></content:encoded>

	<dc:title>N-(3,6-Dimethoxy-2-nitrophenyl)acetamide</dc:title>
			<dc:creator>Lina A. Al-Dulaimi</dc:creator>
			<dc:creator>Joseph C. Bear</dc:creator>
			<dc:creator>Jeremy K. Cockcroft</dc:creator>
			<dc:creator>Giuseppe Trigiante</dc:creator>
			<dc:creator>Fawaz Aldabbagh</dc:creator>
		<dc:identifier>doi: 10.3390/M2147</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-10</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-10</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2147</prism:startingPage>
		<prism:doi>10.3390/M2147</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2147</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2146">

	<title>Molbank, Vol. 2026, Article M2146: Synthesis of 6,7-Dihydro-5H-pyrrolo[3,4-b]pyridin-5-one Derivatives</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2146</link>
	<description>Owing to their distinctive physicochemical features, their structural analogues of benzene ring bioisosteres, and their strong affinity for biomacromolecules, pyridine derivatives function both as core structural scaffolds in pharmacologically active compounds and as versatile elements for optimizing key drug-like properties, such as water solubility, membrane permeability, and metabolic stability. In this study, we synthesized five pyridine-fused heterocyclic compounds using common synthetic intermediates as precursors.</description>
	<pubDate>2026-03-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2146: Synthesis of 6,7-Dihydro-5H-pyrrolo[3,4-b]pyridin-5-one Derivatives</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2146">doi: 10.3390/M2146</a></p>
	<p>Authors:
		Yong-Yao Li
		Zhi-Hao Li
		Xiao-Ying Huang
		Maxwell Ampomah-Wireko
		Cedric Dzidzor Kodjo Amengor
		En Zhang
		Yi-Hong Zhao
		</p>
	<p>Owing to their distinctive physicochemical features, their structural analogues of benzene ring bioisosteres, and their strong affinity for biomacromolecules, pyridine derivatives function both as core structural scaffolds in pharmacologically active compounds and as versatile elements for optimizing key drug-like properties, such as water solubility, membrane permeability, and metabolic stability. In this study, we synthesized five pyridine-fused heterocyclic compounds using common synthetic intermediates as precursors.</p>
	]]></content:encoded>

	<dc:title>Synthesis of 6,7-Dihydro-5H-pyrrolo[3,4-b]pyridin-5-one Derivatives</dc:title>
			<dc:creator>Yong-Yao Li</dc:creator>
			<dc:creator>Zhi-Hao Li</dc:creator>
			<dc:creator>Xiao-Ying Huang</dc:creator>
			<dc:creator>Maxwell Ampomah-Wireko</dc:creator>
			<dc:creator>Cedric Dzidzor Kodjo Amengor</dc:creator>
			<dc:creator>En Zhang</dc:creator>
			<dc:creator>Yi-Hong Zhao</dc:creator>
		<dc:identifier>doi: 10.3390/M2146</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-10</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-10</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2146</prism:startingPage>
		<prism:doi>10.3390/M2146</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2146</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2145">

	<title>Molbank, Vol. 2026, Article M2145: Synthesis, Crystal Structure, and Properties of a Dinuclear Zinc(II) Complex Featuring a Bromo-Functionalized Semicarbazone Schiff Base Ligand</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2145</link>
	<description>This study investigates the rational design of a dinuclear zinc(II) coordination polymer, (C36H34Br2N8O4S2Zn2), to explore how halogen substitution and ligand choice modulate structural architecture, contributing to the development of functional coordination polymers with tailored properties. The complex was synthesized from a bromo-substituted semicarbazone Schiff base ligand (L1) and a rigid bipyridine linker (L2) under solvothermal conditions, and its structure was elucidated using single-crystal X-ray diffraction (SCXRD), complemented by characterization via powder X-ray diffraction (PXRD), thermogravimetric analysis (TGA), and infrared (IR) spectroscopy. Crystallographic analysis reveals that the complex crystallizes in the triclinic space group P-1, forming discrete dinuclear units where each Zn(II) center adopts a distorted square&amp;amp;ndash;pyramidal geometry; these units are extended into one-dimensional chains by bridging L2 ligands and further assembled into a three-dimensional supramolecular network through hydrogen-bonding interactions. PXRD confirms the high phase purity of the bulk material, TGA indicates notable thermal stability up to 130 &amp;amp;deg;C, and IR spectroscopy validates the coordination modes and hydrogen-bonding network. This work elucidates the critical role of the bromo substituent and rigid ancillary ligands in modulating the solid-state structure of the zinc(II) complex. The revealed structure-directing principles provide a valuable reference for the rational design of functional coordination polymers.</description>
	<pubDate>2026-03-05</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2145: Synthesis, Crystal Structure, and Properties of a Dinuclear Zinc(II) Complex Featuring a Bromo-Functionalized Semicarbazone Schiff Base Ligand</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2145">doi: 10.3390/M2145</a></p>
	<p>Authors:
		Cuicui Wang
		Jinhua Wang
		Yunkai Zhang
		Azura A. Rashid
		Siew Kooi Ong
		</p>
	<p>This study investigates the rational design of a dinuclear zinc(II) coordination polymer, (C36H34Br2N8O4S2Zn2), to explore how halogen substitution and ligand choice modulate structural architecture, contributing to the development of functional coordination polymers with tailored properties. The complex was synthesized from a bromo-substituted semicarbazone Schiff base ligand (L1) and a rigid bipyridine linker (L2) under solvothermal conditions, and its structure was elucidated using single-crystal X-ray diffraction (SCXRD), complemented by characterization via powder X-ray diffraction (PXRD), thermogravimetric analysis (TGA), and infrared (IR) spectroscopy. Crystallographic analysis reveals that the complex crystallizes in the triclinic space group P-1, forming discrete dinuclear units where each Zn(II) center adopts a distorted square&amp;amp;ndash;pyramidal geometry; these units are extended into one-dimensional chains by bridging L2 ligands and further assembled into a three-dimensional supramolecular network through hydrogen-bonding interactions. PXRD confirms the high phase purity of the bulk material, TGA indicates notable thermal stability up to 130 &amp;amp;deg;C, and IR spectroscopy validates the coordination modes and hydrogen-bonding network. This work elucidates the critical role of the bromo substituent and rigid ancillary ligands in modulating the solid-state structure of the zinc(II) complex. The revealed structure-directing principles provide a valuable reference for the rational design of functional coordination polymers.</p>
	]]></content:encoded>

	<dc:title>Synthesis, Crystal Structure, and Properties of a Dinuclear Zinc(II) Complex Featuring a Bromo-Functionalized Semicarbazone Schiff Base Ligand</dc:title>
			<dc:creator>Cuicui Wang</dc:creator>
			<dc:creator>Jinhua Wang</dc:creator>
			<dc:creator>Yunkai Zhang</dc:creator>
			<dc:creator>Azura A. Rashid</dc:creator>
			<dc:creator>Siew Kooi Ong</dc:creator>
		<dc:identifier>doi: 10.3390/M2145</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-05</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-05</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2145</prism:startingPage>
		<prism:doi>10.3390/M2145</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2145</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2144">

	<title>Molbank, Vol. 2026, Article M2144: Synthesis of Ethyl 2-Amino-6-hydroxy-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate and Ethyl 6-(Acetyloxy)-2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2144</link>
	<description>An effective one-step synthetic procedure for preparation of hydroxylated analogues of ethyl 2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate as novel promising multifunctional building blocks for drug discovery based on the Gewald procedure was developed.</description>
	<pubDate>2026-03-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2144: Synthesis of Ethyl 2-Amino-6-hydroxy-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate and Ethyl 6-(Acetyloxy)-2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2144">doi: 10.3390/M2144</a></p>
	<p>Authors:
		Andrii Yu. Myshastyi
		Sergiy V. Vlasov
		Hanna I. Severina
		Georgiy G. Yakovenko
		Andrii R. Khairulin
		</p>
	<p>An effective one-step synthetic procedure for preparation of hydroxylated analogues of ethyl 2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate as novel promising multifunctional building blocks for drug discovery based on the Gewald procedure was developed.</p>
	]]></content:encoded>

	<dc:title>Synthesis of Ethyl 2-Amino-6-hydroxy-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate and Ethyl 6-(Acetyloxy)-2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate</dc:title>
			<dc:creator>Andrii Yu. Myshastyi</dc:creator>
			<dc:creator>Sergiy V. Vlasov</dc:creator>
			<dc:creator>Hanna I. Severina</dc:creator>
			<dc:creator>Georgiy G. Yakovenko</dc:creator>
			<dc:creator>Andrii R. Khairulin</dc:creator>
		<dc:identifier>doi: 10.3390/M2144</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-04</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-04</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2144</prism:startingPage>
		<prism:doi>10.3390/M2144</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2144</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2143">

	<title>Molbank, Vol. 2026, Article M2143: (4S*,10aS*,11S*)-4-Hydroxy-2,7,7-trimethyl-11-(4-methylbenzoyl)-7,8-dihydro-10H-4,10a-methano[1,4]oxazino[3,4-d][1,3,5]thiadiazepine-5,10(4H)-dione</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2143</link>
	<description>The reaction of 4,4-dimethyl-8-(4-methylbenzoyl)-3,4-dihydro-1H-pyrrolo[2,1-c][1,4]oxazine-1,6,7-trione with thioacetamide in a 1:1 ratio when refluxed in dichloromethane gives (4S*,10aS*,11S*)-4-hydroxy-2,7,7-trimethyl-11-(4-methylbenzoyl)-7,8-dihydro-10H-4,10a-methano[1,4]oxazino[3,4-d][1,3,5]thiadiazepine-5,10(4H)-dione with a good yield. This compound was fully characterized.</description>
	<pubDate>2026-03-03</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2143: (4S*,10aS*,11S*)-4-Hydroxy-2,7,7-trimethyl-11-(4-methylbenzoyl)-7,8-dihydro-10H-4,10a-methano[1,4]oxazino[3,4-d][1,3,5]thiadiazepine-5,10(4H)-dione</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2143">doi: 10.3390/M2143</a></p>
	<p>Authors:
		Nikita A. Tretyakov
		Andrey N. Maslivets
		</p>
	<p>The reaction of 4,4-dimethyl-8-(4-methylbenzoyl)-3,4-dihydro-1H-pyrrolo[2,1-c][1,4]oxazine-1,6,7-trione with thioacetamide in a 1:1 ratio when refluxed in dichloromethane gives (4S*,10aS*,11S*)-4-hydroxy-2,7,7-trimethyl-11-(4-methylbenzoyl)-7,8-dihydro-10H-4,10a-methano[1,4]oxazino[3,4-d][1,3,5]thiadiazepine-5,10(4H)-dione with a good yield. This compound was fully characterized.</p>
	]]></content:encoded>

	<dc:title>(4S*,10aS*,11S*)-4-Hydroxy-2,7,7-trimethyl-11-(4-methylbenzoyl)-7,8-dihydro-10H-4,10a-methano[1,4]oxazino[3,4-d][1,3,5]thiadiazepine-5,10(4H)-dione</dc:title>
			<dc:creator>Nikita A. Tretyakov</dc:creator>
			<dc:creator>Andrey N. Maslivets</dc:creator>
		<dc:identifier>doi: 10.3390/M2143</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-03</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-03</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2143</prism:startingPage>
		<prism:doi>10.3390/M2143</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2143</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2142">

	<title>Molbank, Vol. 2026, Article M2142: 8-Phenyl-13a-(trifluoromethyl)-13aH-benzo[4,5]imidazo[1,2-a]chromeno[3,2-e]pyridine-6-carbonitrile</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2142</link>
	<description>A DABCO-catalyzed one-pot synthesis of a novel pentacyclic heterocycle featuring an unprecedented benzo[4,5]imidazo[1,2-a]chromeno[3,2-e]pyridine scaffold from 2-(cyanomethyl)benzimidazole and 3-trifluoroacetyl-4-phenyl-4H-chromene has been developed. This hybrid architecture merges three privileged pharmacophores&amp;amp;mdash;benzimidazole, chromene, and pyridine&amp;amp;mdash;into a rigid, nearly planar &amp;amp;pi;-extended system decorated with trifluoromethyl and nitrile groups. The structure of 8-phenyl-13a-(trifluoromethyl)-13aH-benzo[4,5]imidazo[1,2-a]chromeno[3,2-e]pyridine-6-carbonitrile was unambiguously confirmed through NMR spectroscopy and X-ray diffraction analysis. A plausible mechanism involves Michael addition, hemiaminal formation, ring opening, recyclization, and oxidation.</description>
	<pubDate>2026-02-23</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2142: 8-Phenyl-13a-(trifluoromethyl)-13aH-benzo[4,5]imidazo[1,2-a]chromeno[3,2-e]pyridine-6-carbonitrile</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2142">doi: 10.3390/M2142</a></p>
	<p>Authors:
		Dmitry V. Osipov
		Pavel E. Krasnikov
		Vitaly A. Osyanin
		</p>
	<p>A DABCO-catalyzed one-pot synthesis of a novel pentacyclic heterocycle featuring an unprecedented benzo[4,5]imidazo[1,2-a]chromeno[3,2-e]pyridine scaffold from 2-(cyanomethyl)benzimidazole and 3-trifluoroacetyl-4-phenyl-4H-chromene has been developed. This hybrid architecture merges three privileged pharmacophores&amp;amp;mdash;benzimidazole, chromene, and pyridine&amp;amp;mdash;into a rigid, nearly planar &amp;amp;pi;-extended system decorated with trifluoromethyl and nitrile groups. The structure of 8-phenyl-13a-(trifluoromethyl)-13aH-benzo[4,5]imidazo[1,2-a]chromeno[3,2-e]pyridine-6-carbonitrile was unambiguously confirmed through NMR spectroscopy and X-ray diffraction analysis. A plausible mechanism involves Michael addition, hemiaminal formation, ring opening, recyclization, and oxidation.</p>
	]]></content:encoded>

	<dc:title>8-Phenyl-13a-(trifluoromethyl)-13aH-benzo[4,5]imidazo[1,2-a]chromeno[3,2-e]pyridine-6-carbonitrile</dc:title>
			<dc:creator>Dmitry V. Osipov</dc:creator>
			<dc:creator>Pavel E. Krasnikov</dc:creator>
			<dc:creator>Vitaly A. Osyanin</dc:creator>
		<dc:identifier>doi: 10.3390/M2142</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-23</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-23</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2142</prism:startingPage>
		<prism:doi>10.3390/M2142</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2142</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2141">

	<title>Molbank, Vol. 2026, Article M2141: (E)-Methyl 3-(2-amino-4-chloro-6-morpholinopyrimidin-5-yl)acrylate</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2141</link>
	<description>The synthesis of methyl (E)-3-(2-amino-4-chloro-6-morpholinopyrimidin-5-yl)acrylate 3 was accomplished using a Schlosser-modified Wittig reaction. Complete 1H and 13C NMR signal assignments confirm the formation of E-alkene.</description>
	<pubDate>2026-02-16</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2141: (E)-Methyl 3-(2-amino-4-chloro-6-morpholinopyrimidin-5-yl)acrylate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2141">doi: 10.3390/M2141</a></p>
	<p>Authors:
		Jorge Trilleras
		Efraín Polo-Cuadrado
		Jairo Quiroga
		</p>
	<p>The synthesis of methyl (E)-3-(2-amino-4-chloro-6-morpholinopyrimidin-5-yl)acrylate 3 was accomplished using a Schlosser-modified Wittig reaction. Complete 1H and 13C NMR signal assignments confirm the formation of E-alkene.</p>
	]]></content:encoded>

	<dc:title>(E)-Methyl 3-(2-amino-4-chloro-6-morpholinopyrimidin-5-yl)acrylate</dc:title>
			<dc:creator>Jorge Trilleras</dc:creator>
			<dc:creator>Efraín Polo-Cuadrado</dc:creator>
			<dc:creator>Jairo Quiroga</dc:creator>
		<dc:identifier>doi: 10.3390/M2141</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-16</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-16</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2141</prism:startingPage>
		<prism:doi>10.3390/M2141</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2141</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2140">

	<title>Molbank, Vol. 2026, Article M2140: (5R,5aR,8aR,9S)-9-(2-Bromo-3,4,5-trimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3&amp;prime;,4&amp;prime;:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 3,4,5-trimethoxybenzoate</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2140</link>
	<description>In this report, we describe the synthesis and full spectroscopic characterization of a previously unreported podophyllotoxin (PTOX) analogue bearing a second 3,4,5-trimethoxyphenyl (TMP) unit at the C-4 position through an ester linkage. This dual-TMP PTOX derivative is obtained from a brominated PTOX intermediate. In this precursor, the bromine atom is located on the TMP aromatic ring at the 2&amp;amp;prime;-position. The new compound was fully characterized by proton (1H), carbon-13 (13C), heteronuclear single-quantum coherence (HSQC), and distortionless enhancement by polarization transfer (DEPT) NMR spectroscopy. Ultraviolet&amp;amp;ndash;visible (UV-Vis) spectroscopy, Fourier-transform infrared (FTIR) spectroscopy, mass spectrometry and elemental analysis were also performed to confirm the structure and purity of the synthesized ester derivative.</description>
	<pubDate>2026-02-13</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2140: (5R,5aR,8aR,9S)-9-(2-Bromo-3,4,5-trimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3&amp;prime;,4&amp;prime;:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 3,4,5-trimethoxybenzoate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2140">doi: 10.3390/M2140</a></p>
	<p>Authors:
		Yuhan Xie
		Alessandra Gianoncelli
		Imran Khan
		Giovanni Ribaudo
		Paolo Coghi
		</p>
	<p>In this report, we describe the synthesis and full spectroscopic characterization of a previously unreported podophyllotoxin (PTOX) analogue bearing a second 3,4,5-trimethoxyphenyl (TMP) unit at the C-4 position through an ester linkage. This dual-TMP PTOX derivative is obtained from a brominated PTOX intermediate. In this precursor, the bromine atom is located on the TMP aromatic ring at the 2&amp;amp;prime;-position. The new compound was fully characterized by proton (1H), carbon-13 (13C), heteronuclear single-quantum coherence (HSQC), and distortionless enhancement by polarization transfer (DEPT) NMR spectroscopy. Ultraviolet&amp;amp;ndash;visible (UV-Vis) spectroscopy, Fourier-transform infrared (FTIR) spectroscopy, mass spectrometry and elemental analysis were also performed to confirm the structure and purity of the synthesized ester derivative.</p>
	]]></content:encoded>

	<dc:title>(5R,5aR,8aR,9S)-9-(2-Bromo-3,4,5-trimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3&amp;amp;prime;,4&amp;amp;prime;:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 3,4,5-trimethoxybenzoate</dc:title>
			<dc:creator>Yuhan Xie</dc:creator>
			<dc:creator>Alessandra Gianoncelli</dc:creator>
			<dc:creator>Imran Khan</dc:creator>
			<dc:creator>Giovanni Ribaudo</dc:creator>
			<dc:creator>Paolo Coghi</dc:creator>
		<dc:identifier>doi: 10.3390/M2140</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-13</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-13</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2140</prism:startingPage>
		<prism:doi>10.3390/M2140</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2140</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2139">

	<title>Molbank, Vol. 2026, Article M2139: Diisopropyl(6-(phenyl(phenylthio)arsaneyl)-1,2-dihydroacenaphthylen-5-yl)phosphane</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2139</link>
	<description>Peri-substituted bis(tertiary) phosphine-arsine Acenap(PiPr2)(As(SPh)Ph) (4, Acenap = acenaphthene-5,6-diyl) was synthesized by the reaction of the chloroarsine (PiPr2)(AsPhCl) with PhSLi. The X-ray crystal structure of this compound reveals an intramolecular P&amp;amp;#8729;&amp;amp;#8729;&amp;amp;#8729;As&amp;amp;ndash;Cl pnictogen bond, with the phosphorus lone pair donating into the As&amp;amp;ndash;S &amp;amp;sigma;* orbital.</description>
	<pubDate>2026-02-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2139: Diisopropyl(6-(phenyl(phenylthio)arsaneyl)-1,2-dihydroacenaphthylen-5-yl)phosphane</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2139">doi: 10.3390/M2139</a></p>
	<p>Authors:
		Laurence J. Taylor
		Philip Pickett
		David B. Cordes
		Petr Kilian
		</p>
	<p>Peri-substituted bis(tertiary) phosphine-arsine Acenap(PiPr2)(As(SPh)Ph) (4, Acenap = acenaphthene-5,6-diyl) was synthesized by the reaction of the chloroarsine (PiPr2)(AsPhCl) with PhSLi. The X-ray crystal structure of this compound reveals an intramolecular P&amp;amp;#8729;&amp;amp;#8729;&amp;amp;#8729;As&amp;amp;ndash;Cl pnictogen bond, with the phosphorus lone pair donating into the As&amp;amp;ndash;S &amp;amp;sigma;* orbital.</p>
	]]></content:encoded>

	<dc:title>Diisopropyl(6-(phenyl(phenylthio)arsaneyl)-1,2-dihydroacenaphthylen-5-yl)phosphane</dc:title>
			<dc:creator>Laurence J. Taylor</dc:creator>
			<dc:creator>Philip Pickett</dc:creator>
			<dc:creator>David B. Cordes</dc:creator>
			<dc:creator>Petr Kilian</dc:creator>
		<dc:identifier>doi: 10.3390/M2139</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-10</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-10</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2139</prism:startingPage>
		<prism:doi>10.3390/M2139</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2139</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2138">

	<title>Molbank, Vol. 2026, Article M2138: Crystal Structure of [1046127-79-0], 3,3&amp;prime;-(n-Hexane-1,6-diyl)bis(1-vinylimidazolium) Bromide</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2138</link>
	<description>Vinylimidazolium salts constitute a highly relevant class of polymerizable heterocycles, especially in the field of so-called polymer ionic liquids (PILs), and they are frequently used as components of polyelectrolytes. Therefore, crystallographic characterizations, in particular studies of charge distribution and conformational features, can provide fundamental insights concerning ion&amp;amp;ndash;ion and ion&amp;amp;ndash;dipole interactions. The structure of the title compound [1046127-79-0] has the space group symmetry P21/c. Its asymmetric unit contains one formula unit, consisting of two bromide anions and the halves of two cation moieties. The cation units possess inversion symmetry, and their C6H12 chains adopt an all-trans conformation.</description>
	<pubDate>2026-02-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2138: Crystal Structure of [1046127-79-0], 3,3&amp;prime;-(n-Hexane-1,6-diyl)bis(1-vinylimidazolium) Bromide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2138">doi: 10.3390/M2138</a></p>
	<p>Authors:
		Thomas Gelbrich
		Johanna Freilinger
		Gabriel Partl
		Herwig Schottenberger
		Volker Kahlenberg
		Jan Back
		Sven Nerdinger
		</p>
	<p>Vinylimidazolium salts constitute a highly relevant class of polymerizable heterocycles, especially in the field of so-called polymer ionic liquids (PILs), and they are frequently used as components of polyelectrolytes. Therefore, crystallographic characterizations, in particular studies of charge distribution and conformational features, can provide fundamental insights concerning ion&amp;amp;ndash;ion and ion&amp;amp;ndash;dipole interactions. The structure of the title compound [1046127-79-0] has the space group symmetry P21/c. Its asymmetric unit contains one formula unit, consisting of two bromide anions and the halves of two cation moieties. The cation units possess inversion symmetry, and their C6H12 chains adopt an all-trans conformation.</p>
	]]></content:encoded>

	<dc:title>Crystal Structure of [1046127-79-0], 3,3&amp;amp;prime;-(n-Hexane-1,6-diyl)bis(1-vinylimidazolium) Bromide</dc:title>
			<dc:creator>Thomas Gelbrich</dc:creator>
			<dc:creator>Johanna Freilinger</dc:creator>
			<dc:creator>Gabriel Partl</dc:creator>
			<dc:creator>Herwig Schottenberger</dc:creator>
			<dc:creator>Volker Kahlenberg</dc:creator>
			<dc:creator>Jan Back</dc:creator>
			<dc:creator>Sven Nerdinger</dc:creator>
		<dc:identifier>doi: 10.3390/M2138</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-10</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-10</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2138</prism:startingPage>
		<prism:doi>10.3390/M2138</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2138</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2137">

	<title>Molbank, Vol. 2026, Article M2137: (2R,3R,5R,6S)-5-Bromo-2-{[(2R,3R,5R)-3-bromo-5-(propa-1,2-dien-1-yl)tetrahydro-furan-2-yl]methyl}-6-ethyltetrahydro-2H-pyran-3-ol</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2137</link>
	<description>As a part of an SAR study aimed at testing the antitumor activity of some C15 acetogenins related to mycalin A, we report here the synthesis of the C-1 debromo-derivative of laurenciallene, a substance recently isolated from the red alga Laurencia obtusa. This new substance has been obtained by the selective, reductive debromination of the terminal bromoallene moiety of laurenciallene with Zn/AcOH. Its structure has been fully characterized by spectral methods, including 2D-NMR spectra.</description>
	<pubDate>2026-02-09</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2137: (2R,3R,5R,6S)-5-Bromo-2-{[(2R,3R,5R)-3-bromo-5-(propa-1,2-dien-1-yl)tetrahydro-furan-2-yl]methyl}-6-ethyltetrahydro-2H-pyran-3-ol</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2137">doi: 10.3390/M2137</a></p>
	<p>Authors:
		Vincenzo Piccialli
		Nicola Borbone
		Monica Terracciano
		</p>
	<p>As a part of an SAR study aimed at testing the antitumor activity of some C15 acetogenins related to mycalin A, we report here the synthesis of the C-1 debromo-derivative of laurenciallene, a substance recently isolated from the red alga Laurencia obtusa. This new substance has been obtained by the selective, reductive debromination of the terminal bromoallene moiety of laurenciallene with Zn/AcOH. Its structure has been fully characterized by spectral methods, including 2D-NMR spectra.</p>
	]]></content:encoded>

	<dc:title>(2R,3R,5R,6S)-5-Bromo-2-{[(2R,3R,5R)-3-bromo-5-(propa-1,2-dien-1-yl)tetrahydro-furan-2-yl]methyl}-6-ethyltetrahydro-2H-pyran-3-ol</dc:title>
			<dc:creator>Vincenzo Piccialli</dc:creator>
			<dc:creator>Nicola Borbone</dc:creator>
			<dc:creator>Monica Terracciano</dc:creator>
		<dc:identifier>doi: 10.3390/M2137</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-09</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-09</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2137</prism:startingPage>
		<prism:doi>10.3390/M2137</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2137</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2136">

	<title>Molbank, Vol. 2026, Article M2136: 2,3,4,6-Tetra(9H-carbazol-9-yl)benzonitrile</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2136</link>
	<description>Here, we synthesized 2,3,4,6-tetra(9H-carbazol-9-yl)benzonitrile (4CzHPN) via visible-light-driven photocatalytic monodecyanation using the versatile metal-free catalyst 4CzIPN. Characterized by NMR, IR, X-ray diffraction, and DFT calculations, it features a 3.49 eV HOMO-LUMO gap and shows blue-shifted absorption/emission, emerging as a promising advanced metal-free photoredox catalyst.</description>
	<pubDate>2026-02-06</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2136: 2,3,4,6-Tetra(9H-carbazol-9-yl)benzonitrile</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2136">doi: 10.3390/M2136</a></p>
	<p>Authors:
		Qing-Qing Wan
		Zhi-Cheng Fu
		</p>
	<p>Here, we synthesized 2,3,4,6-tetra(9H-carbazol-9-yl)benzonitrile (4CzHPN) via visible-light-driven photocatalytic monodecyanation using the versatile metal-free catalyst 4CzIPN. Characterized by NMR, IR, X-ray diffraction, and DFT calculations, it features a 3.49 eV HOMO-LUMO gap and shows blue-shifted absorption/emission, emerging as a promising advanced metal-free photoredox catalyst.</p>
	]]></content:encoded>

	<dc:title>2,3,4,6-Tetra(9H-carbazol-9-yl)benzonitrile</dc:title>
			<dc:creator>Qing-Qing Wan</dc:creator>
			<dc:creator>Zhi-Cheng Fu</dc:creator>
		<dc:identifier>doi: 10.3390/M2136</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-06</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-06</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2136</prism:startingPage>
		<prism:doi>10.3390/M2136</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2136</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2135">

	<title>Molbank, Vol. 2026, Article M2135: 2-Iodopyridin-3-yl acetate</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2135</link>
	<description>The title compound 2-iodopyridin-3-yl acetate was obtained by acetylation of the OH group of 2-iodo-3-hydroxypyridine. Knowing that the hydroxyl group, as a strong H-bond donor in halogenated hydroxypyridines, usually directs supramolecular packing and might enforce possible halogen&amp;amp;ndash;halogen contacts, we crystallized 2-iodo-3-acetoxypyridine with the aim of disrupting the most important H-bond donor and assessing the propensity of the iodine for halogen bond formation. Indeed, in the compound 2-iodopyridin-3-yl acetate, the crystal packing is characterized by infinite 3D chains bonded through I&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;O=C and C-H&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;I contacts between adjacent molecules. These chains are interconnected by weak C-H&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;O contacts, implying the presence of oxygen in the ester. The I&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;H contact with the C-H axis perpendicular to the electron belt of the iodine atom can enhance the &amp;amp;sigma;-hole of the iodine and act cooperatively in crystal cohesion. No halogen&amp;amp;ndash;halogen contacts were present.</description>
	<pubDate>2026-02-06</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2135: 2-Iodopyridin-3-yl acetate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2135">doi: 10.3390/M2135</a></p>
	<p>Authors:
		Mihaela Cristea
		Sergiu Shova
		Marcel Mirel Popa
		Florea Dumitrascu
		</p>
	<p>The title compound 2-iodopyridin-3-yl acetate was obtained by acetylation of the OH group of 2-iodo-3-hydroxypyridine. Knowing that the hydroxyl group, as a strong H-bond donor in halogenated hydroxypyridines, usually directs supramolecular packing and might enforce possible halogen&amp;amp;ndash;halogen contacts, we crystallized 2-iodo-3-acetoxypyridine with the aim of disrupting the most important H-bond donor and assessing the propensity of the iodine for halogen bond formation. Indeed, in the compound 2-iodopyridin-3-yl acetate, the crystal packing is characterized by infinite 3D chains bonded through I&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;O=C and C-H&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;I contacts between adjacent molecules. These chains are interconnected by weak C-H&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;O contacts, implying the presence of oxygen in the ester. The I&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;H contact with the C-H axis perpendicular to the electron belt of the iodine atom can enhance the &amp;amp;sigma;-hole of the iodine and act cooperatively in crystal cohesion. No halogen&amp;amp;ndash;halogen contacts were present.</p>
	]]></content:encoded>

	<dc:title>2-Iodopyridin-3-yl acetate</dc:title>
			<dc:creator>Mihaela Cristea</dc:creator>
			<dc:creator>Sergiu Shova</dc:creator>
			<dc:creator>Marcel Mirel Popa</dc:creator>
			<dc:creator>Florea Dumitrascu</dc:creator>
		<dc:identifier>doi: 10.3390/M2135</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-06</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-06</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2135</prism:startingPage>
		<prism:doi>10.3390/M2135</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2135</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2134">

	<title>Molbank, Vol. 2026, Article M2134: Synthesis and Characteristics of New 3-(Dichloromethyl)-2-nitro-6,7-dihydro-1-benzofuran-4(5H)-ones</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2134</link>
	<description>The previously unknown compounds&amp;amp;mdash;3-(dichloromethyl)-2-nitro-6,7-dihydro-1-benzofuran-4(5H)-ones&amp;amp;mdash;have been synthesized and structurally characterized via single-crystal X-ray diffraction, 1H, 13C&amp;amp;ndash;{1H}, 1H&amp;amp;ndash;13C HMQC and 1H&amp;amp;ndash;13C HMBC NMR spectroscopy, IR, and UV spectroscopy.</description>
	<pubDate>2026-02-06</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2134: Synthesis and Characteristics of New 3-(Dichloromethyl)-2-nitro-6,7-dihydro-1-benzofuran-4(5H)-ones</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2134">doi: 10.3390/M2134</a></p>
	<p>Authors:
		Ilia A. Pilipenko
		Olga Yu. Ozerova
		Oleg P. Demidov
		Ruslan I. Baichurin
		Oussama A. Mammeri
		Sergey V. Makarenko
		</p>
	<p>The previously unknown compounds&amp;amp;mdash;3-(dichloromethyl)-2-nitro-6,7-dihydro-1-benzofuran-4(5H)-ones&amp;amp;mdash;have been synthesized and structurally characterized via single-crystal X-ray diffraction, 1H, 13C&amp;amp;ndash;{1H}, 1H&amp;amp;ndash;13C HMQC and 1H&amp;amp;ndash;13C HMBC NMR spectroscopy, IR, and UV spectroscopy.</p>
	]]></content:encoded>

	<dc:title>Synthesis and Characteristics of New 3-(Dichloromethyl)-2-nitro-6,7-dihydro-1-benzofuran-4(5H)-ones</dc:title>
			<dc:creator>Ilia A. Pilipenko</dc:creator>
			<dc:creator>Olga Yu. Ozerova</dc:creator>
			<dc:creator>Oleg P. Demidov</dc:creator>
			<dc:creator>Ruslan I. Baichurin</dc:creator>
			<dc:creator>Oussama A. Mammeri</dc:creator>
			<dc:creator>Sergey V. Makarenko</dc:creator>
		<dc:identifier>doi: 10.3390/M2134</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-06</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-06</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2134</prism:startingPage>
		<prism:doi>10.3390/M2134</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2134</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2133">

	<title>Molbank, Vol. 2026, Article M2133: 2-(3&amp;prime;,5&amp;prime;-Bis((dodecyloxy)carbonyl)-2&amp;prime;,6&amp;prime;-dimethyl-1&amp;prime;,4&amp;prime;-dihydro-[3,4&amp;prime;-bipyridin]-1-ium-1-yl)-1,3-dioxo-2,3-dihydro-1H-inden-2-ide</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2133</link>
	<description>Indane-1,3-dione and 1,4-dihydropyridine (1,4-DHP) scaffolds are of significant interest in medicinal chemistry. Herein, we report the synthesis characterization of a new lipid-like indane-1,3-dione&amp;amp;ndash;1,4-DHP betaine, 2-(3&amp;amp;prime;,5&amp;amp;prime;-bis((dodecyloxy)carbonyl)-2&amp;amp;prime;,6&amp;amp;prime;-dimethyl-1&amp;amp;prime;,4&amp;amp;prime;-dihydro-[3,4&amp;amp;prime;-bipyridin]-1-ium-1-yl)-1,3-dioxo-2,3-dihydro-1H-inden-2-ide (3). Compound 3 was synthesized from 2,2-dicyanomethylideneindan-1,3-dione (1) oxide and a didodecyl-substituted 1,4-DHP derivative 2 and characterized by UV&amp;amp;ndash;Vis spectroscopy, 1H-NMR, 13C-NMR, and HRMS. The obtained results demonstrate a promising strategy for the design of delivery agents, exploiting the lipid-like properties of the synthesized betaine.</description>
	<pubDate>2026-02-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2133: 2-(3&amp;prime;,5&amp;prime;-Bis((dodecyloxy)carbonyl)-2&amp;prime;,6&amp;prime;-dimethyl-1&amp;prime;,4&amp;prime;-dihydro-[3,4&amp;prime;-bipyridin]-1-ium-1-yl)-1,3-dioxo-2,3-dihydro-1H-inden-2-ide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2133">doi: 10.3390/M2133</a></p>
	<p>Authors:
		Mara Plotniece
		Krista Arule
		Karlis Pajuste
		Aiva Plotniece
		Arkadij Sobolev
		</p>
	<p>Indane-1,3-dione and 1,4-dihydropyridine (1,4-DHP) scaffolds are of significant interest in medicinal chemistry. Herein, we report the synthesis characterization of a new lipid-like indane-1,3-dione&amp;amp;ndash;1,4-DHP betaine, 2-(3&amp;amp;prime;,5&amp;amp;prime;-bis((dodecyloxy)carbonyl)-2&amp;amp;prime;,6&amp;amp;prime;-dimethyl-1&amp;amp;prime;,4&amp;amp;prime;-dihydro-[3,4&amp;amp;prime;-bipyridin]-1-ium-1-yl)-1,3-dioxo-2,3-dihydro-1H-inden-2-ide (3). Compound 3 was synthesized from 2,2-dicyanomethylideneindan-1,3-dione (1) oxide and a didodecyl-substituted 1,4-DHP derivative 2 and characterized by UV&amp;amp;ndash;Vis spectroscopy, 1H-NMR, 13C-NMR, and HRMS. The obtained results demonstrate a promising strategy for the design of delivery agents, exploiting the lipid-like properties of the synthesized betaine.</p>
	]]></content:encoded>

	<dc:title>2-(3&amp;amp;prime;,5&amp;amp;prime;-Bis((dodecyloxy)carbonyl)-2&amp;amp;prime;,6&amp;amp;prime;-dimethyl-1&amp;amp;prime;,4&amp;amp;prime;-dihydro-[3,4&amp;amp;prime;-bipyridin]-1-ium-1-yl)-1,3-dioxo-2,3-dihydro-1H-inden-2-ide</dc:title>
			<dc:creator>Mara Plotniece</dc:creator>
			<dc:creator>Krista Arule</dc:creator>
			<dc:creator>Karlis Pajuste</dc:creator>
			<dc:creator>Aiva Plotniece</dc:creator>
			<dc:creator>Arkadij Sobolev</dc:creator>
		<dc:identifier>doi: 10.3390/M2133</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-04</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-04</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2133</prism:startingPage>
		<prism:doi>10.3390/M2133</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2133</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2132">

	<title>Molbank, Vol. 2026, Article M2132: N-(4-Methoxyphenethyl)-2-propylpentanamide</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2132</link>
	<description>Herein, we report the mechanochemical synthesis of a novel hybrid molecule, N-(4-methoxyphenethyl)-2-propylpentanamide. This solvent-minimized synthesis aligns with the principles of Green Chemistry and exemplifies the emerging paradigm of medicinal mechanochemistry, offering an efficient, sustainable route to pharmaceutically relevant amides. The newly synthesized compound was fully characterized by melting point determination, 1H and 13C NMR spectroscopy, infrared (IR) spectroscopy, and mass spectrometry.</description>
	<pubDate>2026-02-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2132: N-(4-Methoxyphenethyl)-2-propylpentanamide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2132">doi: 10.3390/M2132</a></p>
	<p>Authors:
		Diyana Dimitrova
		Tsvetelina Marinova
		Reni Bozhanova
		Iliyan Ivanov
		Dimitar Bojilov
		Gabriel Marc
		Stanimir Manolov
		</p>
	<p>Herein, we report the mechanochemical synthesis of a novel hybrid molecule, N-(4-methoxyphenethyl)-2-propylpentanamide. This solvent-minimized synthesis aligns with the principles of Green Chemistry and exemplifies the emerging paradigm of medicinal mechanochemistry, offering an efficient, sustainable route to pharmaceutically relevant amides. The newly synthesized compound was fully characterized by melting point determination, 1H and 13C NMR spectroscopy, infrared (IR) spectroscopy, and mass spectrometry.</p>
	]]></content:encoded>

	<dc:title>N-(4-Methoxyphenethyl)-2-propylpentanamide</dc:title>
			<dc:creator>Diyana Dimitrova</dc:creator>
			<dc:creator>Tsvetelina Marinova</dc:creator>
			<dc:creator>Reni Bozhanova</dc:creator>
			<dc:creator>Iliyan Ivanov</dc:creator>
			<dc:creator>Dimitar Bojilov</dc:creator>
			<dc:creator>Gabriel Marc</dc:creator>
			<dc:creator>Stanimir Manolov</dc:creator>
		<dc:identifier>doi: 10.3390/M2132</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-04</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-04</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2132</prism:startingPage>
		<prism:doi>10.3390/M2132</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2132</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2131">

	<title>Molbank, Vol. 2026, Article M2131: Molecular Structure of the Monohydrate Hydrochloride Salt of the Antimalarial Drug Chloroquine</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2131</link>
	<description>We report the crystallization and single-crystal X-ray analysis of the monohydrate hydrochloride salt of chloroquine(CQ), abbreviated CQHCl&amp;amp;middot;H2O, an antimalarial drug with the formula C18H26ClN3. The crystal structure reveals a well-defined supramolecular architecture stabilized by an extensive hydrogen-bonding network involving CQH+ cations, chloride anions, and water molecules. Notably, this study provides the first crystallographic characterization of a monoprotonated chloroquine salt. Additionally, our findings demonstrate the feasibility of isolating pseudo-polymorphic forms of a commercially available CQ salt via heterogeneous crystallization.</description>
	<pubDate>2026-02-03</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2131: Molecular Structure of the Monohydrate Hydrochloride Salt of the Antimalarial Drug Chloroquine</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2131">doi: 10.3390/M2131</a></p>
	<p>Authors:
		Silvia Rizzato
		Massimo Moret
		</p>
	<p>We report the crystallization and single-crystal X-ray analysis of the monohydrate hydrochloride salt of chloroquine(CQ), abbreviated CQHCl&amp;amp;middot;H2O, an antimalarial drug with the formula C18H26ClN3. The crystal structure reveals a well-defined supramolecular architecture stabilized by an extensive hydrogen-bonding network involving CQH+ cations, chloride anions, and water molecules. Notably, this study provides the first crystallographic characterization of a monoprotonated chloroquine salt. Additionally, our findings demonstrate the feasibility of isolating pseudo-polymorphic forms of a commercially available CQ salt via heterogeneous crystallization.</p>
	]]></content:encoded>

	<dc:title>Molecular Structure of the Monohydrate Hydrochloride Salt of the Antimalarial Drug Chloroquine</dc:title>
			<dc:creator>Silvia Rizzato</dc:creator>
			<dc:creator>Massimo Moret</dc:creator>
		<dc:identifier>doi: 10.3390/M2131</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-03</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-03</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2131</prism:startingPage>
		<prism:doi>10.3390/M2131</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2131</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2130">

	<title>Molbank, Vol. 2026, Article M2130: (2RS,3aRS,9aRS)-3a-Methyl-2-phenyl-3,3a,9,9a-tetrahydro-1H-benzo[f]indol-4(2H)-one Hydrobromide</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2130</link>
	<description>(2RS,3aRS,9aRS)-3a-methyl-2-phenyl-3,3a,9,9a-tetrahydro-1H-benzo[f]indol-4(2H)-one hydrobromide was first synthesized via a tandem aza-Cope rearrangement and Mannich reaction from (1RS,2SR)-2-amino-1-(prop-1-en-2-yl)-2,3-dihydro-1H-inden-1-ol, which, in turn, was obtained in four steps from commercially available 2,3-dihydro-1H-inden-1-one. The molecular and crystal structure features of the new compounds were characterized using NMR spectroscopy (1H, 13C spectra).</description>
	<pubDate>2026-02-02</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2130: (2RS,3aRS,9aRS)-3a-Methyl-2-phenyl-3,3a,9,9a-tetrahydro-1H-benzo[f]indol-4(2H)-one Hydrobromide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2130">doi: 10.3390/M2130</a></p>
	<p>Authors:
		Denis A. Tiunov
		Victor A. Tafeenko
		Alexander V. Kurkin
		</p>
	<p>(2RS,3aRS,9aRS)-3a-methyl-2-phenyl-3,3a,9,9a-tetrahydro-1H-benzo[f]indol-4(2H)-one hydrobromide was first synthesized via a tandem aza-Cope rearrangement and Mannich reaction from (1RS,2SR)-2-amino-1-(prop-1-en-2-yl)-2,3-dihydro-1H-inden-1-ol, which, in turn, was obtained in four steps from commercially available 2,3-dihydro-1H-inden-1-one. The molecular and crystal structure features of the new compounds were characterized using NMR spectroscopy (1H, 13C spectra).</p>
	]]></content:encoded>

	<dc:title>(2RS,3aRS,9aRS)-3a-Methyl-2-phenyl-3,3a,9,9a-tetrahydro-1H-benzo[f]indol-4(2H)-one Hydrobromide</dc:title>
			<dc:creator>Denis A. Tiunov</dc:creator>
			<dc:creator>Victor A. Tafeenko</dc:creator>
			<dc:creator>Alexander V. Kurkin</dc:creator>
		<dc:identifier>doi: 10.3390/M2130</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-02</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-02</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2130</prism:startingPage>
		<prism:doi>10.3390/M2130</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2130</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2129">

	<title>Molbank, Vol. 2026, Article M2129: Synthesis of 1-(Naphthalen-2-yl)-3-(3-(triethoxysilyl)propyl)urea and Determination of Its Crystal Structure</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2129</link>
	<description>The addition of 3-isocyanatopropyltriethoxysilane and 2-aminonaphthalene in THF affords the title compound 1-(naphthalen-2-yl)-3-(3-(triethoxysilyl)propyl)urea 1. A determination of the crystal structure of this naphthyl urea reveals the occurrence of strong intermolecular N-H&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;O hydrogen bonds, giving rise to a 1D supramolecular ribbon, whose interactions have also been assessed by a Hirshfeld surface analysis. The propensity of 1 to sense halide ions by intramolecular trapping through N-H&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;Hal bonding was also investigated by UV-vis spectroscopy and fluorescence measurements.</description>
	<pubDate>2026-01-28</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2129: Synthesis of 1-(Naphthalen-2-yl)-3-(3-(triethoxysilyl)propyl)urea and Determination of Its Crystal Structure</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2129">doi: 10.3390/M2129</a></p>
	<p>Authors:
		Abderrahim Khatyr
		Isabelle Jourdain
		Michael Knorr
		Carsten Strohmann
		Tobias Schrimpf
		</p>
	<p>The addition of 3-isocyanatopropyltriethoxysilane and 2-aminonaphthalene in THF affords the title compound 1-(naphthalen-2-yl)-3-(3-(triethoxysilyl)propyl)urea 1. A determination of the crystal structure of this naphthyl urea reveals the occurrence of strong intermolecular N-H&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;O hydrogen bonds, giving rise to a 1D supramolecular ribbon, whose interactions have also been assessed by a Hirshfeld surface analysis. The propensity of 1 to sense halide ions by intramolecular trapping through N-H&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;Hal bonding was also investigated by UV-vis spectroscopy and fluorescence measurements.</p>
	]]></content:encoded>

	<dc:title>Synthesis of 1-(Naphthalen-2-yl)-3-(3-(triethoxysilyl)propyl)urea and Determination of Its Crystal Structure</dc:title>
			<dc:creator>Abderrahim Khatyr</dc:creator>
			<dc:creator>Isabelle Jourdain</dc:creator>
			<dc:creator>Michael Knorr</dc:creator>
			<dc:creator>Carsten Strohmann</dc:creator>
			<dc:creator>Tobias Schrimpf</dc:creator>
		<dc:identifier>doi: 10.3390/M2129</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-28</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-28</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2129</prism:startingPage>
		<prism:doi>10.3390/M2129</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2129</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2128">

	<title>Molbank, Vol. 2026, Article M2128: 2-((6,7-Dimethoxy-4-oxo-3-(4-(trifluoromethyl)phenethyl)-3,4-dihydroquinazolin-2-yl)thio)-N-(4-ethylphenyl)butanamide</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2128</link>
	<description>2-({3-[2-(1-cyclohexen-1-yl)ethyl]-6,7-dimethoxy-4-oxo-3,4-dihydro-2-quinazolinyl}sulfanyl)-N-(4-ethylphenyl)butanamide (K284-6111; K284), the representative CHI3L1 inhibitor, has interesting biological activities, including anti-cancer and anti-inflammatory effects on neuroinflammation. Following our hit-to-lead program, we report the most active novel derivative, named CBJL-025, 2-((6,7-dimethoxy-4-oxo-3-(4-(trifluoromethyl)phenethyl)-3,4-dihydroquinazolin-2-yl)thio)-N-(4-ethylphenyl)butanamide. The title compound, CBJL-025, was successfully synthesized by S-alkylation of the p-trifluoromethyl phenethyl group possessing quinazoline and the corresponding bromide. The structure of CBJL-025 was confirmed by 1H and 13C nuclear magnetic resonance (NMR) and high-resolution mass spectrometry (HRMS).</description>
	<pubDate>2026-01-26</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2128: 2-((6,7-Dimethoxy-4-oxo-3-(4-(trifluoromethyl)phenethyl)-3,4-dihydroquinazolin-2-yl)thio)-N-(4-ethylphenyl)butanamide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2128">doi: 10.3390/M2128</a></p>
	<p>Authors:
		Young Hee Lee
		Jae-Kyung Jung
		</p>
	<p>2-({3-[2-(1-cyclohexen-1-yl)ethyl]-6,7-dimethoxy-4-oxo-3,4-dihydro-2-quinazolinyl}sulfanyl)-N-(4-ethylphenyl)butanamide (K284-6111; K284), the representative CHI3L1 inhibitor, has interesting biological activities, including anti-cancer and anti-inflammatory effects on neuroinflammation. Following our hit-to-lead program, we report the most active novel derivative, named CBJL-025, 2-((6,7-dimethoxy-4-oxo-3-(4-(trifluoromethyl)phenethyl)-3,4-dihydroquinazolin-2-yl)thio)-N-(4-ethylphenyl)butanamide. The title compound, CBJL-025, was successfully synthesized by S-alkylation of the p-trifluoromethyl phenethyl group possessing quinazoline and the corresponding bromide. The structure of CBJL-025 was confirmed by 1H and 13C nuclear magnetic resonance (NMR) and high-resolution mass spectrometry (HRMS).</p>
	]]></content:encoded>

	<dc:title>2-((6,7-Dimethoxy-4-oxo-3-(4-(trifluoromethyl)phenethyl)-3,4-dihydroquinazolin-2-yl)thio)-N-(4-ethylphenyl)butanamide</dc:title>
			<dc:creator>Young Hee Lee</dc:creator>
			<dc:creator>Jae-Kyung Jung</dc:creator>
		<dc:identifier>doi: 10.3390/M2128</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-26</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-26</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2128</prism:startingPage>
		<prism:doi>10.3390/M2128</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2128</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2127">

	<title>Molbank, Vol. 2026, Article M2127: Ethyl 2-(2-((6-Methyl-4-oxo-4H-chromen-3-yl)methylene)hydrazineyl)thiazole-4-carboxylate</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2127</link>
	<description>This study presents the synthesis of a new compound, ethyl 2-(2-((6-methyl-4-oxo-4H-chromen-3-yl)methylene)hydrazinyl)thiazole-4-carboxylate, obtained by the Hantzsch heterocyclisation reaction. The compound was analyzed through melting point determination, 1H and 13C NMR spectroscopy, infrared, and UV spectroscopy.</description>
	<pubDate>2026-01-22</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2127: Ethyl 2-(2-((6-Methyl-4-oxo-4H-chromen-3-yl)methylene)hydrazineyl)thiazole-4-carboxylate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2127">doi: 10.3390/M2127</a></p>
	<p>Authors:
		Adriana Grozav
		Cristina Azarov
		Gabriel Marc
		Adrian Pîrnău
		Stanimir Manolov
		Ovidiu Oniga
		Ovidiu Crișan
		</p>
	<p>This study presents the synthesis of a new compound, ethyl 2-(2-((6-methyl-4-oxo-4H-chromen-3-yl)methylene)hydrazinyl)thiazole-4-carboxylate, obtained by the Hantzsch heterocyclisation reaction. The compound was analyzed through melting point determination, 1H and 13C NMR spectroscopy, infrared, and UV spectroscopy.</p>
	]]></content:encoded>

	<dc:title>Ethyl 2-(2-((6-Methyl-4-oxo-4H-chromen-3-yl)methylene)hydrazineyl)thiazole-4-carboxylate</dc:title>
			<dc:creator>Adriana Grozav</dc:creator>
			<dc:creator>Cristina Azarov</dc:creator>
			<dc:creator>Gabriel Marc</dc:creator>
			<dc:creator>Adrian Pîrnău</dc:creator>
			<dc:creator>Stanimir Manolov</dc:creator>
			<dc:creator>Ovidiu Oniga</dc:creator>
			<dc:creator>Ovidiu Crișan</dc:creator>
		<dc:identifier>doi: 10.3390/M2127</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-22</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-22</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2127</prism:startingPage>
		<prism:doi>10.3390/M2127</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2127</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2126">

	<title>Molbank, Vol. 2026, Article M2126: Structural and Electronic Insights into Arylalkanones from Myristica ceylanica</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2126</link>
	<description>A phytochemical investigation of Myristica ceylanica resulted in the identification of seven arylalkanone-derived phenolic compounds, comprising one new naturally occurring arylalkanone (A), two derivatives (A1 and A2) prepared by chemical synthesis, and four known malabaricones (B&amp;amp;ndash;E). Density functional theory (DFT) calculations were conducted to evaluate the geometries, electronic properties, and charge distributions of the newly identified arylalkanone and its derivatives and to compare them with those of malabaricones B&amp;amp;ndash;E. The arylalkanones exhibited geometrical features comparable to those of the malabaricones, whereas frontier molecular orbital analysis revealed similar HOMO&amp;amp;ndash;LUMO energy gaps for the malabaricones but a progressive widening of the gap among the arylalkanone derivatives, indicating enhanced electronic stabilisation. Mulliken population analysis identified oxygen atoms as the principal electron-rich sites in both series, with arylalkanones displaying greater charge polarisation and increased sensitivity to structural substitution.</description>
	<pubDate>2026-01-20</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2126: Structural and Electronic Insights into Arylalkanones from Myristica ceylanica</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2126">doi: 10.3390/M2126</a></p>
	<p>Authors:
		Navaratnarajah Kuganathan
		Tharmarajah Manoranjan
		</p>
	<p>A phytochemical investigation of Myristica ceylanica resulted in the identification of seven arylalkanone-derived phenolic compounds, comprising one new naturally occurring arylalkanone (A), two derivatives (A1 and A2) prepared by chemical synthesis, and four known malabaricones (B&amp;amp;ndash;E). Density functional theory (DFT) calculations were conducted to evaluate the geometries, electronic properties, and charge distributions of the newly identified arylalkanone and its derivatives and to compare them with those of malabaricones B&amp;amp;ndash;E. The arylalkanones exhibited geometrical features comparable to those of the malabaricones, whereas frontier molecular orbital analysis revealed similar HOMO&amp;amp;ndash;LUMO energy gaps for the malabaricones but a progressive widening of the gap among the arylalkanone derivatives, indicating enhanced electronic stabilisation. Mulliken population analysis identified oxygen atoms as the principal electron-rich sites in both series, with arylalkanones displaying greater charge polarisation and increased sensitivity to structural substitution.</p>
	]]></content:encoded>

	<dc:title>Structural and Electronic Insights into Arylalkanones from Myristica ceylanica</dc:title>
			<dc:creator>Navaratnarajah Kuganathan</dc:creator>
			<dc:creator>Tharmarajah Manoranjan</dc:creator>
		<dc:identifier>doi: 10.3390/M2126</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-20</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-20</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2126</prism:startingPage>
		<prism:doi>10.3390/M2126</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2126</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2125">

	<title>Molbank, Vol. 2026, Article M2125: Synthesis of 5&amp;prime;-Chlorospiro(benzo[d][1,3]dioxole-2,4&amp;prime;-[1,2,6]thiadiazin)-3&amp;prime;-amine and 10-Chloro-1,4-dioxa-8-thia-7,9-diazaspiro[4.5]deca-6,9-dien-6-amine</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2125</link>
	<description>Reactions of 3&amp;amp;prime;,5&amp;amp;prime;-dichlorospiro(benzo[d][1,3]dioxole-2,4&amp;amp;prime;-[1,2,6]thiadiazine) or 6,10-dichloro-1,4-dioxa-8-thia-7,9-diazaspiro[4.5]deca-6,9-diene with ammonia in MeCN, at ca. 20 &amp;amp;deg;C, gave 5&amp;amp;prime;-chlorospiro(benzo[d][1,3]dioxole-2,4&amp;amp;prime;-[1,2,6]thiadiazin)-3&amp;amp;prime;-amine and 10-chloro-1,4-dioxa-8-thia-7,9-diazaspiro[4.5]deca-6,9-dien-6-amine, respectively, in near quantitative yields.</description>
	<pubDate>2026-01-16</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2125: Synthesis of 5&amp;prime;-Chlorospiro(benzo[d][1,3]dioxole-2,4&amp;prime;-[1,2,6]thiadiazin)-3&amp;prime;-amine and 10-Chloro-1,4-dioxa-8-thia-7,9-diazaspiro[4.5]deca-6,9-dien-6-amine</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2125">doi: 10.3390/M2125</a></p>
	<p>Authors:
		Andreas S. Kalogirou
		Panayiotis A. Koutentis
		</p>
	<p>Reactions of 3&amp;amp;prime;,5&amp;amp;prime;-dichlorospiro(benzo[d][1,3]dioxole-2,4&amp;amp;prime;-[1,2,6]thiadiazine) or 6,10-dichloro-1,4-dioxa-8-thia-7,9-diazaspiro[4.5]deca-6,9-diene with ammonia in MeCN, at ca. 20 &amp;amp;deg;C, gave 5&amp;amp;prime;-chlorospiro(benzo[d][1,3]dioxole-2,4&amp;amp;prime;-[1,2,6]thiadiazin)-3&amp;amp;prime;-amine and 10-chloro-1,4-dioxa-8-thia-7,9-diazaspiro[4.5]deca-6,9-dien-6-amine, respectively, in near quantitative yields.</p>
	]]></content:encoded>

	<dc:title>Synthesis of 5&amp;amp;prime;-Chlorospiro(benzo[d][1,3]dioxole-2,4&amp;amp;prime;-[1,2,6]thiadiazin)-3&amp;amp;prime;-amine and 10-Chloro-1,4-dioxa-8-thia-7,9-diazaspiro[4.5]deca-6,9-dien-6-amine</dc:title>
			<dc:creator>Andreas S. Kalogirou</dc:creator>
			<dc:creator>Panayiotis A. Koutentis</dc:creator>
		<dc:identifier>doi: 10.3390/M2125</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-16</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-16</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2125</prism:startingPage>
		<prism:doi>10.3390/M2125</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2125</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2124">

	<title>Molbank, Vol. 2026, Article M2124: Methyl 2-(Chloromethoxy-1-carbonyl)-7-oxabicyclo[2.2.1]heptane-3-carboxylate</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2124</link>
	<description>Overexpression of protein phosphatase 5 (PP5) is implicated in tumor cell growth, establishing PP5 as a compelling target for small-molecule anticancer therapy. Building on prior success in achieving selectivity within the PP2A domain through scaffold functionalization that maximizes active-site interactions, we propose a parallel strategy for PP5 inhibition. Norcantharidin, the demethylated cousin of cantharidin, is a potent yet unselective phosphatase inhibitor, making its bicyclic framework an attractive platform for systematic derivatization. The approach reported herein exploits anhydride reactivity to generate a carboxylic acid derivative that is transformed into a chloromethyl ester. Chloromethyl ester functionality serves as a strategically activated intermediate enabling downstream functional-group diversification under mild, neutral conditions while preserving scaffold integrity. This modular synthetic strategy establishes a foundation for the development of PP5-selective norcantharidin derivatives with improved tumor selectivity, potency, and synthetic feasibility.</description>
	<pubDate>2026-01-13</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2124: Methyl 2-(Chloromethoxy-1-carbonyl)-7-oxabicyclo[2.2.1]heptane-3-carboxylate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2124">doi: 10.3390/M2124</a></p>
	<p>Authors:
		Hannah K. Lawley
		Bailey N. Baxter
		Caleb N. Lopansri
		Mary Helene Marmande
		Kathryn N. Mayeaux
		Lucy A. Orr
		David C. Forbes
		</p>
	<p>Overexpression of protein phosphatase 5 (PP5) is implicated in tumor cell growth, establishing PP5 as a compelling target for small-molecule anticancer therapy. Building on prior success in achieving selectivity within the PP2A domain through scaffold functionalization that maximizes active-site interactions, we propose a parallel strategy for PP5 inhibition. Norcantharidin, the demethylated cousin of cantharidin, is a potent yet unselective phosphatase inhibitor, making its bicyclic framework an attractive platform for systematic derivatization. The approach reported herein exploits anhydride reactivity to generate a carboxylic acid derivative that is transformed into a chloromethyl ester. Chloromethyl ester functionality serves as a strategically activated intermediate enabling downstream functional-group diversification under mild, neutral conditions while preserving scaffold integrity. This modular synthetic strategy establishes a foundation for the development of PP5-selective norcantharidin derivatives with improved tumor selectivity, potency, and synthetic feasibility.</p>
	]]></content:encoded>

	<dc:title>Methyl 2-(Chloromethoxy-1-carbonyl)-7-oxabicyclo[2.2.1]heptane-3-carboxylate</dc:title>
			<dc:creator>Hannah K. Lawley</dc:creator>
			<dc:creator>Bailey N. Baxter</dc:creator>
			<dc:creator>Caleb N. Lopansri</dc:creator>
			<dc:creator>Mary Helene Marmande</dc:creator>
			<dc:creator>Kathryn N. Mayeaux</dc:creator>
			<dc:creator>Lucy A. Orr</dc:creator>
			<dc:creator>David C. Forbes</dc:creator>
		<dc:identifier>doi: 10.3390/M2124</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-13</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-13</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2124</prism:startingPage>
		<prism:doi>10.3390/M2124</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2124</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2123">

	<title>Molbank, Vol. 2026, Article M2123: N-(2-(1H-Indol-3-yl)ethyl)-2-propylpentanamide</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2123</link>
	<description>Herein we describe the synthesis of N-(2-(1H-indol-3-yl)ethyl)-2-propylpentanamide. The compound was comprehensively characterized using melting-point analysis, 1H and 13C NMR spectroscopy, infrared spectroscopy, and mass spectrometry. The collective analytical results confirm the successful synthesis and structural integrity of the target molecule.</description>
	<pubDate>2026-01-09</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2123: N-(2-(1H-Indol-3-yl)ethyl)-2-propylpentanamide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2123">doi: 10.3390/M2123</a></p>
	<p>Authors:
		Diyana Dimitrova
		Iliyan Ivanov
		Simona Ilieva
		Ivelina Cherneva
		Dimitar Bojilov
		Stanimir Manolov
		</p>
	<p>Herein we describe the synthesis of N-(2-(1H-indol-3-yl)ethyl)-2-propylpentanamide. The compound was comprehensively characterized using melting-point analysis, 1H and 13C NMR spectroscopy, infrared spectroscopy, and mass spectrometry. The collective analytical results confirm the successful synthesis and structural integrity of the target molecule.</p>
	]]></content:encoded>

	<dc:title>N-(2-(1H-Indol-3-yl)ethyl)-2-propylpentanamide</dc:title>
			<dc:creator>Diyana Dimitrova</dc:creator>
			<dc:creator>Iliyan Ivanov</dc:creator>
			<dc:creator>Simona Ilieva</dc:creator>
			<dc:creator>Ivelina Cherneva</dc:creator>
			<dc:creator>Dimitar Bojilov</dc:creator>
			<dc:creator>Stanimir Manolov</dc:creator>
		<dc:identifier>doi: 10.3390/M2123</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-09</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-09</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2123</prism:startingPage>
		<prism:doi>10.3390/M2123</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2123</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2122">

	<title>Molbank, Vol. 2026, Article M2122: Synthesis and Investigation of a Symmetrical Bis(methoxycarbonyl)-Substituted Rubrene Derivative</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2122</link>
	<description>A symmetrical rubrene derivative, 5,6-bis(4-(methoxycarbonyl)phenyl)-11,12-diphenyltetracene, was synthesized via the thermal dimerization of 1,1-diphenyl-3-[4-(methoxycarbonyl)phenyl]-3-chloroallene. The reaction proceeded with the low selectivity typical of the classical &amp;amp;ldquo;rubrenic synthesis&amp;amp;rdquo; under these conditions, affording the target tetracene and the bis(alkylidene)cyclobutene by-product in nearly equal yields of 25% each. The optical characteristics of this rubrene derivative were investigated, revealing bright orange fluorescence in a CHCl3 solution (&amp;amp;lambda;em = 565 nm, &amp;amp;Phi;F = 0.81, &amp;amp;tau; = 11.41 ns), which is strongly quenched in the solid state (&amp;amp;Phi;F = 0.01) due to aggregation.</description>
	<pubDate>2026-01-06</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2122: Synthesis and Investigation of a Symmetrical Bis(methoxycarbonyl)-Substituted Rubrene Derivative</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2122">doi: 10.3390/M2122</a></p>
	<p>Authors:
		Roman A. Irgashev
		Alexander S. Steparuk
		Gennady L. Rusinov
		Ildar R. Sayarov
		Alexey E. Aleksandrov
		Alexey R. Tameev
		</p>
	<p>A symmetrical rubrene derivative, 5,6-bis(4-(methoxycarbonyl)phenyl)-11,12-diphenyltetracene, was synthesized via the thermal dimerization of 1,1-diphenyl-3-[4-(methoxycarbonyl)phenyl]-3-chloroallene. The reaction proceeded with the low selectivity typical of the classical &amp;amp;ldquo;rubrenic synthesis&amp;amp;rdquo; under these conditions, affording the target tetracene and the bis(alkylidene)cyclobutene by-product in nearly equal yields of 25% each. The optical characteristics of this rubrene derivative were investigated, revealing bright orange fluorescence in a CHCl3 solution (&amp;amp;lambda;em = 565 nm, &amp;amp;Phi;F = 0.81, &amp;amp;tau; = 11.41 ns), which is strongly quenched in the solid state (&amp;amp;Phi;F = 0.01) due to aggregation.</p>
	]]></content:encoded>

	<dc:title>Synthesis and Investigation of a Symmetrical Bis(methoxycarbonyl)-Substituted Rubrene Derivative</dc:title>
			<dc:creator>Roman A. Irgashev</dc:creator>
			<dc:creator>Alexander S. Steparuk</dc:creator>
			<dc:creator>Gennady L. Rusinov</dc:creator>
			<dc:creator>Ildar R. Sayarov</dc:creator>
			<dc:creator>Alexey E. Aleksandrov</dc:creator>
			<dc:creator>Alexey R. Tameev</dc:creator>
		<dc:identifier>doi: 10.3390/M2122</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-06</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-06</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2122</prism:startingPage>
		<prism:doi>10.3390/M2122</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2122</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2121">

	<title>Molbank, Vol. 2026, Article M2121: 6-((2-Oxoindolin-3-ylidene)hydrazineylidene)indolo[2,1-b]quinazolin-12(6H)-one</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2121</link>
	<description>A novel unsymmetrical azine, 6-((2-oxoindolin-3-ylidene)hydrazineylidene)indolo[2,1-b]quinazolin-12(6H)-one, was synthesized through a condensation reaction between tryptanthrin-6-hydrazone and isatin in chloroform under reflux conditions. Structural characterization revealed the compound exists as a mixture of geometric isomers with one predominant form. Density functional theory (DFT) calculations identified the E,E configuration as the most stable isomer. The isomerization barriers for both C=N bonds were calculated at approximately 18.5 kcal/mol via nitrogen inversion. Given the established biological activities of tryptanthrin and isatin derivatives, this hybrid azine represents a promising lead compound for developing bifunctional drug candidates.</description>
	<pubDate>2026-01-06</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2121: 6-((2-Oxoindolin-3-ylidene)hydrazineylidene)indolo[2,1-b]quinazolin-12(6H)-one</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2121">doi: 10.3390/M2121</a></p>
	<p>Authors:
		Elizaveta I. Samorodova
		Anastasia R. Kovrizhina
		Andrei I. Khlebnikov
		</p>
	<p>A novel unsymmetrical azine, 6-((2-oxoindolin-3-ylidene)hydrazineylidene)indolo[2,1-b]quinazolin-12(6H)-one, was synthesized through a condensation reaction between tryptanthrin-6-hydrazone and isatin in chloroform under reflux conditions. Structural characterization revealed the compound exists as a mixture of geometric isomers with one predominant form. Density functional theory (DFT) calculations identified the E,E configuration as the most stable isomer. The isomerization barriers for both C=N bonds were calculated at approximately 18.5 kcal/mol via nitrogen inversion. Given the established biological activities of tryptanthrin and isatin derivatives, this hybrid azine represents a promising lead compound for developing bifunctional drug candidates.</p>
	]]></content:encoded>

	<dc:title>6-((2-Oxoindolin-3-ylidene)hydrazineylidene)indolo[2,1-b]quinazolin-12(6H)-one</dc:title>
			<dc:creator>Elizaveta I. Samorodova</dc:creator>
			<dc:creator>Anastasia R. Kovrizhina</dc:creator>
			<dc:creator>Andrei I. Khlebnikov</dc:creator>
		<dc:identifier>doi: 10.3390/M2121</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-06</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-06</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2121</prism:startingPage>
		<prism:doi>10.3390/M2121</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2121</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2120">

	<title>Molbank, Vol. 2026, Article M2120: (Benzo[h]quinoline-&amp;kappa;2C,N)-[2,2&amp;prime;-bis(diphenylphosphino)-1,1&amp;prime;-binaphthalene-&amp;kappa;2P,P&amp;prime;]-platinum(II) Hexafluorophosphate</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2120</link>
	<description>A cyclometalated platinum(II) complex [Pt(bzq)(BINAP)]PF6 bearing a 2,2&amp;amp;prime;-bis(diphenylphosphino)-1,1&amp;amp;prime;-binaphthalene (BINAP) auxiliary ligand and a cyclometalated benzo[h]quinoline (bzq) ligand have been prepared. Structural characterization was achieved through X-ray crystallography, 1H, 13C and 31P NMR spectroscopy, ESI&amp;amp;minus;MS, and elemental analysis.</description>
	<pubDate>2026-01-05</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2120: (Benzo[h]quinoline-&amp;kappa;2C,N)-[2,2&amp;prime;-bis(diphenylphosphino)-1,1&amp;prime;-binaphthalene-&amp;kappa;2P,P&amp;prime;]-platinum(II) Hexafluorophosphate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2120">doi: 10.3390/M2120</a></p>
	<p>Authors:
		Haoni Wang
		Meiting Zhang
		Jianwei Wu
		Junqi Zhang
		Xianglong Meng
		Yuliang Yang
		</p>
	<p>A cyclometalated platinum(II) complex [Pt(bzq)(BINAP)]PF6 bearing a 2,2&amp;amp;prime;-bis(diphenylphosphino)-1,1&amp;amp;prime;-binaphthalene (BINAP) auxiliary ligand and a cyclometalated benzo[h]quinoline (bzq) ligand have been prepared. Structural characterization was achieved through X-ray crystallography, 1H, 13C and 31P NMR spectroscopy, ESI&amp;amp;minus;MS, and elemental analysis.</p>
	]]></content:encoded>

	<dc:title>(Benzo[h]quinoline-&amp;amp;kappa;2C,N)-[2,2&amp;amp;prime;-bis(diphenylphosphino)-1,1&amp;amp;prime;-binaphthalene-&amp;amp;kappa;2P,P&amp;amp;prime;]-platinum(II) Hexafluorophosphate</dc:title>
			<dc:creator>Haoni Wang</dc:creator>
			<dc:creator>Meiting Zhang</dc:creator>
			<dc:creator>Jianwei Wu</dc:creator>
			<dc:creator>Junqi Zhang</dc:creator>
			<dc:creator>Xianglong Meng</dc:creator>
			<dc:creator>Yuliang Yang</dc:creator>
		<dc:identifier>doi: 10.3390/M2120</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-05</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-05</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2120</prism:startingPage>
		<prism:doi>10.3390/M2120</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2120</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2119">

	<title>Molbank, Vol. 2026, Article M2119: 4-(4-Chlorophenyl)-6-phenyl-2-(prop-2-yn-1-yloxy)nicotinonitrile</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2119</link>
	<description>We report an efficient and transition-metal-free protocol for the propargylation of 4-(4-chlorophenyl)-2-oxo-6-phenyl-1,2-dihydropyridine-3-carbonitrile using propargyl bromide in the presence of cesium carbonate in dimethylsulfoxide under mild conditions. This synthetic transformation proceeds with marked chemoselectivity, furnishing the O-propargylated pyridine and the N-propargylated 2-pyridone in 75% and 8% yields, respectively. Both products were fully characterized by IR and NMR spectroscopy, as well as high-resolution mass spectrometry, confirming their molecular structures.</description>
	<pubDate>2026-01-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2119: 4-(4-Chlorophenyl)-6-phenyl-2-(prop-2-yn-1-yloxy)nicotinonitrile</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2119">doi: 10.3390/M2119</a></p>
	<p>Authors:
		Diana Becerra
		Diana Hurtado-Rodríguez
		Juan-Carlos Castillo
		</p>
	<p>We report an efficient and transition-metal-free protocol for the propargylation of 4-(4-chlorophenyl)-2-oxo-6-phenyl-1,2-dihydropyridine-3-carbonitrile using propargyl bromide in the presence of cesium carbonate in dimethylsulfoxide under mild conditions. This synthetic transformation proceeds with marked chemoselectivity, furnishing the O-propargylated pyridine and the N-propargylated 2-pyridone in 75% and 8% yields, respectively. Both products were fully characterized by IR and NMR spectroscopy, as well as high-resolution mass spectrometry, confirming their molecular structures.</p>
	]]></content:encoded>

	<dc:title>4-(4-Chlorophenyl)-6-phenyl-2-(prop-2-yn-1-yloxy)nicotinonitrile</dc:title>
			<dc:creator>Diana Becerra</dc:creator>
			<dc:creator>Diana Hurtado-Rodríguez</dc:creator>
			<dc:creator>Juan-Carlos Castillo</dc:creator>
		<dc:identifier>doi: 10.3390/M2119</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-04</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-04</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2119</prism:startingPage>
		<prism:doi>10.3390/M2119</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2119</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2118">

	<title>Molbank, Vol. 2026, Article M2118: 4&amp;rsquo;-Ethyl 1,2-dimethyl 1&amp;rsquo;,5-dibenzyl-4,4-dicyano-2&amp;rsquo;-oxo-5&amp;rsquo;-phenyl-1&amp;rsquo;,2&amp;rsquo;,4a,5-tetrahydro-4H-spiro[benzo[4,5]imidazo[1,2-a]pyridine-3,3&amp;rsquo;-pyrrole]-1,2,4&amp;rsquo;-tricarboxylate</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2118</link>
	<description>The 1,4-dipolar cycloaddition of the ylidene derivative of 1H-pyrrole-2,3-dione to a dipole generated in situ from 1-benzylbenzimidazole and dimethyl acetylenedicarboxylate proceeds via the exocyclic multiple bond of the ylidene derivative and affords a mixture of diastereomeric spiro[benzo[4,5]imidazo[1,2-a]pyridine-3,3&amp;amp;rsquo;-pyrroles], which slowly epimerized in a solution.</description>
	<pubDate>2026-01-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2118: 4&amp;rsquo;-Ethyl 1,2-dimethyl 1&amp;rsquo;,5-dibenzyl-4,4-dicyano-2&amp;rsquo;-oxo-5&amp;rsquo;-phenyl-1&amp;rsquo;,2&amp;rsquo;,4a,5-tetrahydro-4H-spiro[benzo[4,5]imidazo[1,2-a]pyridine-3,3&amp;rsquo;-pyrrole]-1,2,4&amp;rsquo;-tricarboxylate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2118">doi: 10.3390/M2118</a></p>
	<p>Authors:
		Anna A. Moroz
		Maksim V. Dmitriev
		Andrey N. Maslivets
		</p>
	<p>The 1,4-dipolar cycloaddition of the ylidene derivative of 1H-pyrrole-2,3-dione to a dipole generated in situ from 1-benzylbenzimidazole and dimethyl acetylenedicarboxylate proceeds via the exocyclic multiple bond of the ylidene derivative and affords a mixture of diastereomeric spiro[benzo[4,5]imidazo[1,2-a]pyridine-3,3&amp;amp;rsquo;-pyrroles], which slowly epimerized in a solution.</p>
	]]></content:encoded>

	<dc:title>4&amp;amp;rsquo;-Ethyl 1,2-dimethyl 1&amp;amp;rsquo;,5-dibenzyl-4,4-dicyano-2&amp;amp;rsquo;-oxo-5&amp;amp;rsquo;-phenyl-1&amp;amp;rsquo;,2&amp;amp;rsquo;,4a,5-tetrahydro-4H-spiro[benzo[4,5]imidazo[1,2-a]pyridine-3,3&amp;amp;rsquo;-pyrrole]-1,2,4&amp;amp;rsquo;-tricarboxylate</dc:title>
			<dc:creator>Anna A. Moroz</dc:creator>
			<dc:creator>Maksim V. Dmitriev</dc:creator>
			<dc:creator>Andrey N. Maslivets</dc:creator>
		<dc:identifier>doi: 10.3390/M2118</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-04</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-04</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2118</prism:startingPage>
		<prism:doi>10.3390/M2118</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2118</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2117">

	<title>Molbank, Vol. 2026, Article M2117: (RS)-6,6,7&amp;prime;,7&amp;prime;-Tetramethyl-2-sulfanylidene-5,6,6&amp;prime;,7&amp;prime;-tetrahydro-2H,2&amp;prime;H,4H,4&amp;prime;H,5&amp;prime;H-spiro[thiopyran-3,3&amp;prime;-thiopyrano [2,3-b]thiopyran]-4,5&amp;prime;-dione</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2117</link>
	<description>The reaction of aliphatic aldehydes with the tautomers 6,6-dimethyl-4-hydroxy-2H-thiopyrane-2-thione and 6,6-dimethyl-2-mercapto-4H-thiopyrane-4-one is reported to yield spiro compounds. However, the spiro compound of the reaction with formaldehyde is postulated, but has not been isolated to date. Due to a change in reaction conditions, we managed to isolate (RS)-6,6,7&amp;amp;prime;,7&amp;amp;prime;-Tetramethyl-2-sulfanylidene-5,6,6&amp;amp;prime;,7&amp;amp;prime;-tetrahydro-2H,2&amp;amp;prime;H,4H,4&amp;amp;prime;H,5&amp;amp;prime;H-spiro[thiopyran-3,3&amp;amp;prime;-thiopyrano [2,3-b]thiopyran]-4,5&amp;amp;prime;-dione for the first time. The structure was proven with the help of a single X-ray crystal analysis. Furthermore, the new compound was fully characterized using one- and two- dimensional NMR techniques such as 1H, 13C, DEPT, COSY, HSQC and HMBC spectra, as well as IR and HRMS measurements.</description>
	<pubDate>2026-01-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2117: (RS)-6,6,7&amp;prime;,7&amp;prime;-Tetramethyl-2-sulfanylidene-5,6,6&amp;prime;,7&amp;prime;-tetrahydro-2H,2&amp;prime;H,4H,4&amp;prime;H,5&amp;prime;H-spiro[thiopyran-3,3&amp;prime;-thiopyrano [2,3-b]thiopyran]-4,5&amp;prime;-dione</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2117">doi: 10.3390/M2117</a></p>
	<p>Authors:
		Werner Seebacher
		Antoine Dupé
		Eva-Maria Pferschy-Wenzig
		Robert Saf
		Theresa Hermann
		Robert Weis
		</p>
	<p>The reaction of aliphatic aldehydes with the tautomers 6,6-dimethyl-4-hydroxy-2H-thiopyrane-2-thione and 6,6-dimethyl-2-mercapto-4H-thiopyrane-4-one is reported to yield spiro compounds. However, the spiro compound of the reaction with formaldehyde is postulated, but has not been isolated to date. Due to a change in reaction conditions, we managed to isolate (RS)-6,6,7&amp;amp;prime;,7&amp;amp;prime;-Tetramethyl-2-sulfanylidene-5,6,6&amp;amp;prime;,7&amp;amp;prime;-tetrahydro-2H,2&amp;amp;prime;H,4H,4&amp;amp;prime;H,5&amp;amp;prime;H-spiro[thiopyran-3,3&amp;amp;prime;-thiopyrano [2,3-b]thiopyran]-4,5&amp;amp;prime;-dione for the first time. The structure was proven with the help of a single X-ray crystal analysis. Furthermore, the new compound was fully characterized using one- and two- dimensional NMR techniques such as 1H, 13C, DEPT, COSY, HSQC and HMBC spectra, as well as IR and HRMS measurements.</p>
	]]></content:encoded>

	<dc:title>(RS)-6,6,7&amp;amp;prime;,7&amp;amp;prime;-Tetramethyl-2-sulfanylidene-5,6,6&amp;amp;prime;,7&amp;amp;prime;-tetrahydro-2H,2&amp;amp;prime;H,4H,4&amp;amp;prime;H,5&amp;amp;prime;H-spiro[thiopyran-3,3&amp;amp;prime;-thiopyrano [2,3-b]thiopyran]-4,5&amp;amp;prime;-dione</dc:title>
			<dc:creator>Werner Seebacher</dc:creator>
			<dc:creator>Antoine Dupé</dc:creator>
			<dc:creator>Eva-Maria Pferschy-Wenzig</dc:creator>
			<dc:creator>Robert Saf</dc:creator>
			<dc:creator>Theresa Hermann</dc:creator>
			<dc:creator>Robert Weis</dc:creator>
		<dc:identifier>doi: 10.3390/M2117</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-04</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-04</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2117</prism:startingPage>
		<prism:doi>10.3390/M2117</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2117</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2116">

	<title>Molbank, Vol. 2026, Article M2116: (Z)-8-Hydroxy-6-(2-hydroxyphenyl)-9-(4-methylbenzoyl)-2-(((E)-2-oxoindolin-3-ylidene)hydrazineylidene)-1-thia-3,6-diazaspiro[4.4]non-8-ene-4,7-dione</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2116</link>
	<description>A novel spiro-pyrrolothiazole derivative bearing a 2-oxindole substituent was synthesized and characterized. The compound was prepared via a catalyst-free reaction under mild conditions and isolated using a straightforward workup procedure. The structure of the synthesized title compound was confirmed with 1H, 13C NMR spectra and X-Ray diffraction data.</description>
	<pubDate>2025-12-29</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2116: (Z)-8-Hydroxy-6-(2-hydroxyphenyl)-9-(4-methylbenzoyl)-2-(((E)-2-oxoindolin-3-ylidene)hydrazineylidene)-1-thia-3,6-diazaspiro[4.4]non-8-ene-4,7-dione</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2116">doi: 10.3390/M2116</a></p>
	<p>Authors:
		Dzhamilia N. Belozerova
		Maksim V. Dmitriev
		Irina V. Mashevskaya
		</p>
	<p>A novel spiro-pyrrolothiazole derivative bearing a 2-oxindole substituent was synthesized and characterized. The compound was prepared via a catalyst-free reaction under mild conditions and isolated using a straightforward workup procedure. The structure of the synthesized title compound was confirmed with 1H, 13C NMR spectra and X-Ray diffraction data.</p>
	]]></content:encoded>

	<dc:title>(Z)-8-Hydroxy-6-(2-hydroxyphenyl)-9-(4-methylbenzoyl)-2-(((E)-2-oxoindolin-3-ylidene)hydrazineylidene)-1-thia-3,6-diazaspiro[4.4]non-8-ene-4,7-dione</dc:title>
			<dc:creator>Dzhamilia N. Belozerova</dc:creator>
			<dc:creator>Maksim V. Dmitriev</dc:creator>
			<dc:creator>Irina V. Mashevskaya</dc:creator>
		<dc:identifier>doi: 10.3390/M2116</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-12-29</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-12-29</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2116</prism:startingPage>
		<prism:doi>10.3390/M2116</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2116</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2115">

	<title>Molbank, Vol. 2026, Article M2115: Stepwise Orthogonal Protection of Calix[4]arene Triamine: A Facile Route to Asymmetric Structures</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2115</link>
	<description>A cone calix[4]arene having one tert-butyl group and three amino groups at the wide rim was bis-N-protected stepwise using sulfonylation with 4-nitrobenzylsulfonyl chloride, followed by acylation with di-tert-butyl dicarbonate. The selective sulfonylation was shown to prefer the amino group located in the proximal calixarene aromatic unit relative to the tert-butylated moiety, resulting in the formation of an inherently chiral calix[4]arene with a wide-rim substitution pattern of AABC type. Further acylation of one of the two remaining amino groups also proceeded selectively. It involved the calixarene aromatic unit adjacent to the sulfonylated moiety, as clearly demonstrated by 2D NMR data for the ABCD-substituted reaction product, which was obtained as a mixture of enantiomers. The mixture was acylated with (R)-mandelic acid succinimide ester, and the resulting diastereomers were separated by conventional column chromatography, thus demonstrating the applicability of the stepwise protection strategy for the further preparation of enantiopure calix[4]arene cores possessing inherent chirality due to four different substituents at their wide rims.</description>
	<pubDate>2025-12-24</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2115: Stepwise Orthogonal Protection of Calix[4]arene Triamine: A Facile Route to Asymmetric Structures</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2115">doi: 10.3390/M2115</a></p>
	<p>Authors:
		Ivan Alekseev
		Dmitry Cheshkov
		Alexander Gorbunov
		Vladimir Kovalev
		Ivan Vatsouro
		</p>
	<p>A cone calix[4]arene having one tert-butyl group and three amino groups at the wide rim was bis-N-protected stepwise using sulfonylation with 4-nitrobenzylsulfonyl chloride, followed by acylation with di-tert-butyl dicarbonate. The selective sulfonylation was shown to prefer the amino group located in the proximal calixarene aromatic unit relative to the tert-butylated moiety, resulting in the formation of an inherently chiral calix[4]arene with a wide-rim substitution pattern of AABC type. Further acylation of one of the two remaining amino groups also proceeded selectively. It involved the calixarene aromatic unit adjacent to the sulfonylated moiety, as clearly demonstrated by 2D NMR data for the ABCD-substituted reaction product, which was obtained as a mixture of enantiomers. The mixture was acylated with (R)-mandelic acid succinimide ester, and the resulting diastereomers were separated by conventional column chromatography, thus demonstrating the applicability of the stepwise protection strategy for the further preparation of enantiopure calix[4]arene cores possessing inherent chirality due to four different substituents at their wide rims.</p>
	]]></content:encoded>

	<dc:title>Stepwise Orthogonal Protection of Calix[4]arene Triamine: A Facile Route to Asymmetric Structures</dc:title>
			<dc:creator>Ivan Alekseev</dc:creator>
			<dc:creator>Dmitry Cheshkov</dc:creator>
			<dc:creator>Alexander Gorbunov</dc:creator>
			<dc:creator>Vladimir Kovalev</dc:creator>
			<dc:creator>Ivan Vatsouro</dc:creator>
		<dc:identifier>doi: 10.3390/M2115</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-12-24</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-12-24</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2115</prism:startingPage>
		<prism:doi>10.3390/M2115</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2115</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2114">

	<title>Molbank, Vol. 2025, Article M2114: N-(3-Methoxyphenethyl)-2-propylpentanamide</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2114</link>
	<description>Herein, we present the synthesis of N-(3-methoxyphenethyl)-2-propylpentanamide, a derivative of valproic acid. The compound has been thoroughly characterized through melting-point determination, 1H and 13C NMR spectroscopy, infrared spectroscopy, and mass spectrometry. The comprehensive analytical data obtained from these techniques confirm the successful preparation and structural integrity of the newly synthesized molecule.</description>
	<pubDate>2025-12-17</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2114: N-(3-Methoxyphenethyl)-2-propylpentanamide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2114">doi: 10.3390/M2114</a></p>
	<p>Authors:
		Diyana Dimitrova
		Yoana Barakova
		Ivaylo Trifonov
		Iliyan Ivanov
		Dimitar Bojilov
		Stanimir Manolov
		</p>
	<p>Herein, we present the synthesis of N-(3-methoxyphenethyl)-2-propylpentanamide, a derivative of valproic acid. The compound has been thoroughly characterized through melting-point determination, 1H and 13C NMR spectroscopy, infrared spectroscopy, and mass spectrometry. The comprehensive analytical data obtained from these techniques confirm the successful preparation and structural integrity of the newly synthesized molecule.</p>
	]]></content:encoded>

	<dc:title>N-(3-Methoxyphenethyl)-2-propylpentanamide</dc:title>
			<dc:creator>Diyana Dimitrova</dc:creator>
			<dc:creator>Yoana Barakova</dc:creator>
			<dc:creator>Ivaylo Trifonov</dc:creator>
			<dc:creator>Iliyan Ivanov</dc:creator>
			<dc:creator>Dimitar Bojilov</dc:creator>
			<dc:creator>Stanimir Manolov</dc:creator>
		<dc:identifier>doi: 10.3390/M2114</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-12-17</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-12-17</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2114</prism:startingPage>
		<prism:doi>10.3390/M2114</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2114</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2113">

	<title>Molbank, Vol. 2025, Article M2113: Benzyl 2,4-dichlorophenyl sulfoxide</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2113</link>
	<description>Benzyl 2,4-dichlorophenyl sulfoxide was synthesized both in racemic and in an enantiopure form. This enantiopure sulfoxide is a further successful confirmation of our straightforward protocol to yield easily chiral aryl benzyl sulfoxides. We solved also the crystal structure of racemic benzyl 2,4-dichlorophenyl sulfoxide with a single crystal X-ray diffraction experiment. The main interactions building up the crystal structure were recognized and compared with other similar sulfoxides.</description>
	<pubDate>2025-12-16</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2113: Benzyl 2,4-dichlorophenyl sulfoxide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2113">doi: 10.3390/M2113</a></p>
	<p>Authors:
		Maria Annunziata M. Capozzi
		Joan F. Piniella Febrer
		Cosimo Cardellicchio
		</p>
	<p>Benzyl 2,4-dichlorophenyl sulfoxide was synthesized both in racemic and in an enantiopure form. This enantiopure sulfoxide is a further successful confirmation of our straightforward protocol to yield easily chiral aryl benzyl sulfoxides. We solved also the crystal structure of racemic benzyl 2,4-dichlorophenyl sulfoxide with a single crystal X-ray diffraction experiment. The main interactions building up the crystal structure were recognized and compared with other similar sulfoxides.</p>
	]]></content:encoded>

	<dc:title>Benzyl 2,4-dichlorophenyl sulfoxide</dc:title>
			<dc:creator>Maria Annunziata M. Capozzi</dc:creator>
			<dc:creator>Joan F. Piniella Febrer</dc:creator>
			<dc:creator>Cosimo Cardellicchio</dc:creator>
		<dc:identifier>doi: 10.3390/M2113</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-12-16</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-12-16</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2113</prism:startingPage>
		<prism:doi>10.3390/M2113</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2113</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2112">

	<title>Molbank, Vol. 2025, Article M2112: Linear Synthesis of 10-Hydroxy-N,N-dimethyl-N-((3-(tosyloxy)pyridin-2-yl)methyl)decan-1-aminium Bromide</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2112</link>
	<description>In 2019, carbamates derived from 3-hydroxypyridine were classified as nerve agents and subsequently included in the Annex on Chemicals by the Conference of the States Parties. Herein, we describe the preparation of a structural simulant of this class of compounds, 10-hydroxy-N,N-dimethyl-N-((3-(tosyloxy)pyridin-2-yl)methyl)decan-1-aminium bromide. The compound was synthesized via tosylation of 2-((N,N-dimethylamino)methyl)pyridin-3-ol with tosyl chloride in the presence of sodium hydride, followed by alkylation of the resulting ((N,N-dimethylamino)methyl)pyridin-3-yl 4-methylbenzenesulfonate with 10-bromodecan-1-ol.</description>
	<pubDate>2025-12-16</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2112: Linear Synthesis of 10-Hydroxy-N,N-dimethyl-N-((3-(tosyloxy)pyridin-2-yl)methyl)decan-1-aminium Bromide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2112">doi: 10.3390/M2112</a></p>
	<p>Authors:
		Václav Hron
		Martin Urban
		Tomáš Tobrman
		</p>
	<p>In 2019, carbamates derived from 3-hydroxypyridine were classified as nerve agents and subsequently included in the Annex on Chemicals by the Conference of the States Parties. Herein, we describe the preparation of a structural simulant of this class of compounds, 10-hydroxy-N,N-dimethyl-N-((3-(tosyloxy)pyridin-2-yl)methyl)decan-1-aminium bromide. The compound was synthesized via tosylation of 2-((N,N-dimethylamino)methyl)pyridin-3-ol with tosyl chloride in the presence of sodium hydride, followed by alkylation of the resulting ((N,N-dimethylamino)methyl)pyridin-3-yl 4-methylbenzenesulfonate with 10-bromodecan-1-ol.</p>
	]]></content:encoded>

	<dc:title>Linear Synthesis of 10-Hydroxy-N,N-dimethyl-N-((3-(tosyloxy)pyridin-2-yl)methyl)decan-1-aminium Bromide</dc:title>
			<dc:creator>Václav Hron</dc:creator>
			<dc:creator>Martin Urban</dc:creator>
			<dc:creator>Tomáš Tobrman</dc:creator>
		<dc:identifier>doi: 10.3390/M2112</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-12-16</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-12-16</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2112</prism:startingPage>
		<prism:doi>10.3390/M2112</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2112</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2111">

	<title>Molbank, Vol. 2025, Article M2111: (1S,4R)-4,7,7-Trimethyl-1-(1H-perimidin-2-yl)-2-oxabicyclo[2.2.1]heptan-3-one</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2111</link>
	<description>Perimidine derivatives are versatile heterocycles with growing significance in medicinal chemistry and materials sciences. However, their structural variety remains limited. This study focused on the synthesis and crystal structure characterization of a new perimidine-based molecule. A bicyclic perimidine lactone, (1S,4R)-4,7,7-trimethyl-1-(1H-perimidin-2-yl)-2-oxabicyclo[2.2.1]heptan-3-one (1), was synthesized through an intramolecular dehydration of a monoamide intermediate formed from 1,8-diaminonaphthalene and (1S)-(&amp;amp;ndash;)-camphanic chloride under basic conditions. The product was purified and crystallized from acetone, giving single crystals suitable for X-ray diffraction. Structural analysis revealed two stereogenic centers and crystallization in the chiral tetragonal P43212 space group, with stabilization through N&amp;amp;mdash;H&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;O and C&amp;amp;mdash;H&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;N hydrogen bonds as well as C&amp;amp;mdash;H&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;&amp;amp;pi; interactions.</description>
	<pubDate>2025-12-16</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2111: (1S,4R)-4,7,7-Trimethyl-1-(1H-perimidin-2-yl)-2-oxabicyclo[2.2.1]heptan-3-one</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2111">doi: 10.3390/M2111</a></p>
	<p>Authors:
		Elżbieta Speina
		Krzysztof Łyczko
		Adam Mieczkowski
		</p>
	<p>Perimidine derivatives are versatile heterocycles with growing significance in medicinal chemistry and materials sciences. However, their structural variety remains limited. This study focused on the synthesis and crystal structure characterization of a new perimidine-based molecule. A bicyclic perimidine lactone, (1S,4R)-4,7,7-trimethyl-1-(1H-perimidin-2-yl)-2-oxabicyclo[2.2.1]heptan-3-one (1), was synthesized through an intramolecular dehydration of a monoamide intermediate formed from 1,8-diaminonaphthalene and (1S)-(&amp;amp;ndash;)-camphanic chloride under basic conditions. The product was purified and crystallized from acetone, giving single crystals suitable for X-ray diffraction. Structural analysis revealed two stereogenic centers and crystallization in the chiral tetragonal P43212 space group, with stabilization through N&amp;amp;mdash;H&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;O and C&amp;amp;mdash;H&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;N hydrogen bonds as well as C&amp;amp;mdash;H&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;&amp;amp;pi; interactions.</p>
	]]></content:encoded>

	<dc:title>(1S,4R)-4,7,7-Trimethyl-1-(1H-perimidin-2-yl)-2-oxabicyclo[2.2.1]heptan-3-one</dc:title>
			<dc:creator>Elżbieta Speina</dc:creator>
			<dc:creator>Krzysztof Łyczko</dc:creator>
			<dc:creator>Adam Mieczkowski</dc:creator>
		<dc:identifier>doi: 10.3390/M2111</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-12-16</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-12-16</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2111</prism:startingPage>
		<prism:doi>10.3390/M2111</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2111</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2110">

	<title>Molbank, Vol. 2025, Article M2110: (4R,4aS,6bR,8aR,12bS,14aS)-2-((E)-2-Bromo-4-chlorobenzylidene)-4,4a,6b,8a,11,11,12b,14a-octamethylicosahydropicen-3(2H)-one</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2110</link>
	<description>Friedelin, a pentacyclic triterpene, has been reported to inhibit potential reactive oxygen species (ROS)-scavenging activity. Accordingly, we modified the structure of this compound with the aim of obtaining derivatives. A new derivative (compound 4), with an &amp;amp;alpha;,&amp;amp;beta;-unsaturated ketone moiety, was synthesized via an aldol condensation. Structural characterization of this compound was performed using nuclear magnetic resonance (NMR) spectroscopy and high-resolution electrospray ionization mass spectrometry.</description>
	<pubDate>2025-12-15</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2110: (4R,4aS,6bR,8aR,12bS,14aS)-2-((E)-2-Bromo-4-chlorobenzylidene)-4,4a,6b,8a,11,11,12b,14a-octamethylicosahydropicen-3(2H)-one</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2110">doi: 10.3390/M2110</a></p>
	<p>Authors:
		Kaichen Guan
		Jinzheng Yu
		Yangzhonghui Chen
		Jianqin Chen
		Qian Zhao
		Xiaojiang Hao
		Juan Xu
		Xiao Ding
		</p>
	<p>Friedelin, a pentacyclic triterpene, has been reported to inhibit potential reactive oxygen species (ROS)-scavenging activity. Accordingly, we modified the structure of this compound with the aim of obtaining derivatives. A new derivative (compound 4), with an &amp;amp;alpha;,&amp;amp;beta;-unsaturated ketone moiety, was synthesized via an aldol condensation. Structural characterization of this compound was performed using nuclear magnetic resonance (NMR) spectroscopy and high-resolution electrospray ionization mass spectrometry.</p>
	]]></content:encoded>

	<dc:title>(4R,4aS,6bR,8aR,12bS,14aS)-2-((E)-2-Bromo-4-chlorobenzylidene)-4,4a,6b,8a,11,11,12b,14a-octamethylicosahydropicen-3(2H)-one</dc:title>
			<dc:creator>Kaichen Guan</dc:creator>
			<dc:creator>Jinzheng Yu</dc:creator>
			<dc:creator>Yangzhonghui Chen</dc:creator>
			<dc:creator>Jianqin Chen</dc:creator>
			<dc:creator>Qian Zhao</dc:creator>
			<dc:creator>Xiaojiang Hao</dc:creator>
			<dc:creator>Juan Xu</dc:creator>
			<dc:creator>Xiao Ding</dc:creator>
		<dc:identifier>doi: 10.3390/M2110</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-12-15</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-12-15</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2110</prism:startingPage>
		<prism:doi>10.3390/M2110</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2110</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2109">

	<title>Molbank, Vol. 2025, Article M2109: Synthesis of 3,5-Diamino-Substituted Dithieno[3,2-b:2&amp;prime;,3&amp;prime;-d]thiophene Derivatives</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2109</link>
	<description>We report the first synthesis of 3,5-diamino-substituted dithieno[3,2-b:2&amp;amp;prime;,3&amp;amp;prime;-d]thiophene derivatives, bearing alkoxycarbonyl or acetyl groups at C-2 and C-6 positions. The target compounds were prepared via the reaction of 3,4-dibromothiophene-2,5-dicarbonitrile with alkyl thioglycolates or mercaptoacetone in the presence of DBU and isolated in 67&amp;amp;ndash;87% yield. The key dinitrile was synthesized in 76% yield from 3,4-dibromothiophene-2,5-dicarbaldehyde. In turn, this dialdehyde was prepared on a multigram scale from commercially available 2,5-dimethylthiophene in three steps. The resulting dithieno[3,2-b:2&amp;amp;prime;,3&amp;amp;prime;-d]thiophenes serve as valuable building blocks for materials chemistry, offering multiple reactive sites for further structural elaboration and property tuning.</description>
	<pubDate>2025-12-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2109: Synthesis of 3,5-Diamino-Substituted Dithieno[3,2-b:2&amp;prime;,3&amp;prime;-d]thiophene Derivatives</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2109">doi: 10.3390/M2109</a></p>
	<p>Authors:
		Roman A. Irgashev
		Nikita A. Kazin
		</p>
	<p>We report the first synthesis of 3,5-diamino-substituted dithieno[3,2-b:2&amp;amp;prime;,3&amp;amp;prime;-d]thiophene derivatives, bearing alkoxycarbonyl or acetyl groups at C-2 and C-6 positions. The target compounds were prepared via the reaction of 3,4-dibromothiophene-2,5-dicarbonitrile with alkyl thioglycolates or mercaptoacetone in the presence of DBU and isolated in 67&amp;amp;ndash;87% yield. The key dinitrile was synthesized in 76% yield from 3,4-dibromothiophene-2,5-dicarbaldehyde. In turn, this dialdehyde was prepared on a multigram scale from commercially available 2,5-dimethylthiophene in three steps. The resulting dithieno[3,2-b:2&amp;amp;prime;,3&amp;amp;prime;-d]thiophenes serve as valuable building blocks for materials chemistry, offering multiple reactive sites for further structural elaboration and property tuning.</p>
	]]></content:encoded>

	<dc:title>Synthesis of 3,5-Diamino-Substituted Dithieno[3,2-b:2&amp;amp;prime;,3&amp;amp;prime;-d]thiophene Derivatives</dc:title>
			<dc:creator>Roman A. Irgashev</dc:creator>
			<dc:creator>Nikita A. Kazin</dc:creator>
		<dc:identifier>doi: 10.3390/M2109</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-12-10</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-12-10</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2109</prism:startingPage>
		<prism:doi>10.3390/M2109</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2109</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2108">

	<title>Molbank, Vol. 2025, Article M2108: (S)-2-((E)-2-((S)-2-Methyl-5-(prop-1-en-2-yl)cyclopent-1-en-1-yl)vinyl)-5-(prop-1-en-2-yl)cyclopent-1-ene-1-carbaldehyde</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2108</link>
	<description>(S)-2-methyl-5-(prop-1-en-2-yl)cyclopent-1-ene-1-carbaldehyde (2) is a component of the essential oils of several plants and has also been used in many syntheses, usually of terpenes. Although the preparation of compound 2 has been reported several times, no side products have been reported previously. In this Short Note, we present the identification of one such side product. This new compound (3) arises from a vinylogous aldol autocondensation, occurring after the formation of 2, even when the reaction runs for a short time. However, it can diminish the yield of 2 when the reaction is allowed to continue for a longer time.</description>
	<pubDate>2025-12-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2108: (S)-2-((E)-2-((S)-2-Methyl-5-(prop-1-en-2-yl)cyclopent-1-en-1-yl)vinyl)-5-(prop-1-en-2-yl)cyclopent-1-ene-1-carbaldehyde</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2108">doi: 10.3390/M2108</a></p>
	<p>Authors:
		Andrea Marrero-González
		Juan F. Rodríguez-Caro
		María M. Afonso
		José Antonio Palenzuela
		</p>
	<p>(S)-2-methyl-5-(prop-1-en-2-yl)cyclopent-1-ene-1-carbaldehyde (2) is a component of the essential oils of several plants and has also been used in many syntheses, usually of terpenes. Although the preparation of compound 2 has been reported several times, no side products have been reported previously. In this Short Note, we present the identification of one such side product. This new compound (3) arises from a vinylogous aldol autocondensation, occurring after the formation of 2, even when the reaction runs for a short time. However, it can diminish the yield of 2 when the reaction is allowed to continue for a longer time.</p>
	]]></content:encoded>

	<dc:title>(S)-2-((E)-2-((S)-2-Methyl-5-(prop-1-en-2-yl)cyclopent-1-en-1-yl)vinyl)-5-(prop-1-en-2-yl)cyclopent-1-ene-1-carbaldehyde</dc:title>
			<dc:creator>Andrea Marrero-González</dc:creator>
			<dc:creator>Juan F. Rodríguez-Caro</dc:creator>
			<dc:creator>María M. Afonso</dc:creator>
			<dc:creator>José Antonio Palenzuela</dc:creator>
		<dc:identifier>doi: 10.3390/M2108</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-12-10</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-12-10</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2108</prism:startingPage>
		<prism:doi>10.3390/M2108</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2108</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2107">

	<title>Molbank, Vol. 2025, Article M2107: 1&amp;beta;, 6&amp;alpha;-Dihydroxy-5&amp;alpha;H-eudesma-3(4), 11(13)-dien-12, 8&amp;beta;-olide</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2107</link>
	<description>1&amp;amp;beta;, 6&amp;amp;alpha;-dihydroxy-5&amp;amp;alpha;H-eudesma-3(4), 11(13)-dien-12, 8&amp;amp;beta;-olide is a natural eudesmane sesquiterpene lactone isolated from the aerial parts of Inula nervosa Wall. In this paper, we report the X-ray crystallography of the compound 1 for the first time, along with the 1D/2D NMR spectra.</description>
	<pubDate>2025-12-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2107: 1&amp;beta;, 6&amp;alpha;-Dihydroxy-5&amp;alpha;H-eudesma-3(4), 11(13)-dien-12, 8&amp;beta;-olide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2107">doi: 10.3390/M2107</a></p>
	<p>Authors:
		Dan-Dan Xu
		Jie-Yi Ren
		Zhen-Ning Wu
		Yi-Yu Qi
		Jiang-Jiang Tang
		</p>
	<p>1&amp;amp;beta;, 6&amp;amp;alpha;-dihydroxy-5&amp;amp;alpha;H-eudesma-3(4), 11(13)-dien-12, 8&amp;amp;beta;-olide is a natural eudesmane sesquiterpene lactone isolated from the aerial parts of Inula nervosa Wall. In this paper, we report the X-ray crystallography of the compound 1 for the first time, along with the 1D/2D NMR spectra.</p>
	]]></content:encoded>

	<dc:title>1&amp;amp;beta;, 6&amp;amp;alpha;-Dihydroxy-5&amp;amp;alpha;H-eudesma-3(4), 11(13)-dien-12, 8&amp;amp;beta;-olide</dc:title>
			<dc:creator>Dan-Dan Xu</dc:creator>
			<dc:creator>Jie-Yi Ren</dc:creator>
			<dc:creator>Zhen-Ning Wu</dc:creator>
			<dc:creator>Yi-Yu Qi</dc:creator>
			<dc:creator>Jiang-Jiang Tang</dc:creator>
		<dc:identifier>doi: 10.3390/M2107</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-12-10</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-12-10</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2107</prism:startingPage>
		<prism:doi>10.3390/M2107</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2107</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2106">

	<title>Molbank, Vol. 2025, Article M2106: 7,7&amp;prime;-(1,4-Phenylene)bis(2-benzyl-3-(3,4-dihydroisoquinolin-2(1H)-yl)-6-(4-methoxybenzyl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-5-one)</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2106</link>
	<description>The multicomponent synthesis of a novel and highly symmetric polyheterocycle based on the pyrrolo[3,4-b]pyridin-5-one core incorporating the privileged tetrahydroisoquinoline moiety is described. The target compound was synthesized as an inseparable mixture of stereoisomers through a pseudo-repetitive Ugi&amp;amp;ndash;Zhu five-component reaction (PR-UZ-5CR) coupled to a double post-transformation sequence involving an intermolecular aza Diels&amp;amp;ndash;Alder cycloaddition, an intramolecular N-acylation, and a final tandem aromatization step. The product was prepared in 63% overall yield, and with an excellent atom economy of 85%, within a total reaction time of 85 min, and a temperature range from 25 to 65 &amp;amp;deg;C. Structural elucidation and molecular mass confirmation were successfully achieved through NMR and FT-IR spectroscopy, and high-resolution mass spectrometry (HRMS), respectively.</description>
	<pubDate>2025-12-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2106: 7,7&amp;prime;-(1,4-Phenylene)bis(2-benzyl-3-(3,4-dihydroisoquinolin-2(1H)-yl)-6-(4-methoxybenzyl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-5-one)</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2106">doi: 10.3390/M2106</a></p>
	<p>Authors:
		Roberto E. Blanco-Carapia
		Alejandro Islas-Jácome
		Eduardo González-Zamora
		</p>
	<p>The multicomponent synthesis of a novel and highly symmetric polyheterocycle based on the pyrrolo[3,4-b]pyridin-5-one core incorporating the privileged tetrahydroisoquinoline moiety is described. The target compound was synthesized as an inseparable mixture of stereoisomers through a pseudo-repetitive Ugi&amp;amp;ndash;Zhu five-component reaction (PR-UZ-5CR) coupled to a double post-transformation sequence involving an intermolecular aza Diels&amp;amp;ndash;Alder cycloaddition, an intramolecular N-acylation, and a final tandem aromatization step. The product was prepared in 63% overall yield, and with an excellent atom economy of 85%, within a total reaction time of 85 min, and a temperature range from 25 to 65 &amp;amp;deg;C. Structural elucidation and molecular mass confirmation were successfully achieved through NMR and FT-IR spectroscopy, and high-resolution mass spectrometry (HRMS), respectively.</p>
	]]></content:encoded>

	<dc:title>7,7&amp;amp;prime;-(1,4-Phenylene)bis(2-benzyl-3-(3,4-dihydroisoquinolin-2(1H)-yl)-6-(4-methoxybenzyl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-5-one)</dc:title>
			<dc:creator>Roberto E. Blanco-Carapia</dc:creator>
			<dc:creator>Alejandro Islas-Jácome</dc:creator>
			<dc:creator>Eduardo González-Zamora</dc:creator>
		<dc:identifier>doi: 10.3390/M2106</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-12-10</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-12-10</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2106</prism:startingPage>
		<prism:doi>10.3390/M2106</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2106</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2105">

	<title>Molbank, Vol. 2025, Article M2105: 9-Oxo-2-(p-tolyl)-4,9-dihydropyrazolo[5,1-b]quinazoline-3a(3H)-carboxylic Acid</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2105</link>
	<description>Compounds based on the pyrazoloquinazoline scaffold are of significant interest in synthetic organic chemistry owing to their potential biological activity. In this work, we describe the synthesis of a new derivative with this scaffold, 9-oxo-2-(p-tolyl)-4,9-dihydropyrazolo[5,1-b]quinazoline-3a(3H)-carboxylic acid, obtained by reacting 2,4-dioxo-4-(p-tolyl)butanoic acid with 2-aminobenzohydrazide in a 1:1 ratio when mixed in ethanol. The compound was characterized by 1H/13C NMR, IR, and X-ray diffraction analysis.</description>
	<pubDate>2025-12-08</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2105: 9-Oxo-2-(p-tolyl)-4,9-dihydropyrazolo[5,1-b]quinazoline-3a(3H)-carboxylic Acid</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2105">doi: 10.3390/M2105</a></p>
	<p>Authors:
		Anastasia A. Andreeva
		Yurii V. Shklyaev
		Andrey N. Maslivets
		</p>
	<p>Compounds based on the pyrazoloquinazoline scaffold are of significant interest in synthetic organic chemistry owing to their potential biological activity. In this work, we describe the synthesis of a new derivative with this scaffold, 9-oxo-2-(p-tolyl)-4,9-dihydropyrazolo[5,1-b]quinazoline-3a(3H)-carboxylic acid, obtained by reacting 2,4-dioxo-4-(p-tolyl)butanoic acid with 2-aminobenzohydrazide in a 1:1 ratio when mixed in ethanol. The compound was characterized by 1H/13C NMR, IR, and X-ray diffraction analysis.</p>
	]]></content:encoded>

	<dc:title>9-Oxo-2-(p-tolyl)-4,9-dihydropyrazolo[5,1-b]quinazoline-3a(3H)-carboxylic Acid</dc:title>
			<dc:creator>Anastasia A. Andreeva</dc:creator>
			<dc:creator>Yurii V. Shklyaev</dc:creator>
			<dc:creator>Andrey N. Maslivets</dc:creator>
		<dc:identifier>doi: 10.3390/M2105</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-12-08</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-12-08</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2105</prism:startingPage>
		<prism:doi>10.3390/M2105</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2105</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2104">

	<title>Molbank, Vol. 2025, Article M2104: P,P,P&amp;prime;,P&amp;prime;-Tetraisopropyl(1,4-phenylenebis(hydroxymethylene))bis(phosphonate)</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2104</link>
	<description>We report the synthesis and molecular structure as determined by single-crystal X-ray diffraction of P,P,P&amp;amp;prime;,P&amp;amp;prime;-tetraisopropyl(1,4-phenylenebis(hydroxymethylene))bis(phosphonate). The compound was fully characterized by 1H, 13C, and 31P NMR spectroscopy, IR spectroscopy, and Mass Spectrometry.</description>
	<pubDate>2025-12-08</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2104: P,P,P&amp;prime;,P&amp;prime;-Tetraisopropyl(1,4-phenylenebis(hydroxymethylene))bis(phosphonate)</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2104">doi: 10.3390/M2104</a></p>
	<p>Authors:
		Jaden K. Jones
		Aidan P. McKay
		David B. Cordes
		Brian A. Chalmers
		</p>
	<p>We report the synthesis and molecular structure as determined by single-crystal X-ray diffraction of P,P,P&amp;amp;prime;,P&amp;amp;prime;-tetraisopropyl(1,4-phenylenebis(hydroxymethylene))bis(phosphonate). The compound was fully characterized by 1H, 13C, and 31P NMR spectroscopy, IR spectroscopy, and Mass Spectrometry.</p>
	]]></content:encoded>

	<dc:title>P,P,P&amp;amp;prime;,P&amp;amp;prime;-Tetraisopropyl(1,4-phenylenebis(hydroxymethylene))bis(phosphonate)</dc:title>
			<dc:creator>Jaden K. Jones</dc:creator>
			<dc:creator>Aidan P. McKay</dc:creator>
			<dc:creator>David B. Cordes</dc:creator>
			<dc:creator>Brian A. Chalmers</dc:creator>
		<dc:identifier>doi: 10.3390/M2104</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-12-08</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-12-08</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2104</prism:startingPage>
		<prism:doi>10.3390/M2104</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2104</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2103">

	<title>Molbank, Vol. 2025, Article M2103: N-(9-Ethyl-9H-carbazol-2-yl)-N&amp;prime;-(1-phenylethyl)thiourea</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2103</link>
	<description>Substituted thiourea derivatives represent a structurally diverse group of compounds with high biological activity. In this paper, we present the synthesis of N-(9-ethyl-9H-carbazol-2-yl)-N&amp;amp;prime;-(1-phenylethyl)thiourea by condensation reaction. The structure of the title compound was confirmed by 1H and 13C nuclear magnetic resonance (NMR), Fourier-transform infrared spectroscopy (FT-IR), and high-resolution mass spectrometry (HRMS).</description>
	<pubDate>2025-12-05</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2103: N-(9-Ethyl-9H-carbazol-2-yl)-N&amp;prime;-(1-phenylethyl)thiourea</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2103">doi: 10.3390/M2103</a></p>
	<p>Authors:
		Agnieszka Maksymiuk-Kłos
		Rafał Słapa
		Marek Bartkowiak
		Radosław Michalik
		Monika Pazura-Turowska
		Dorota Szubińska-Lelonkiewicz
		Anna Bielenica
		</p>
	<p>Substituted thiourea derivatives represent a structurally diverse group of compounds with high biological activity. In this paper, we present the synthesis of N-(9-ethyl-9H-carbazol-2-yl)-N&amp;amp;prime;-(1-phenylethyl)thiourea by condensation reaction. The structure of the title compound was confirmed by 1H and 13C nuclear magnetic resonance (NMR), Fourier-transform infrared spectroscopy (FT-IR), and high-resolution mass spectrometry (HRMS).</p>
	]]></content:encoded>

	<dc:title>N-(9-Ethyl-9H-carbazol-2-yl)-N&amp;amp;prime;-(1-phenylethyl)thiourea</dc:title>
			<dc:creator>Agnieszka Maksymiuk-Kłos</dc:creator>
			<dc:creator>Rafał Słapa</dc:creator>
			<dc:creator>Marek Bartkowiak</dc:creator>
			<dc:creator>Radosław Michalik</dc:creator>
			<dc:creator>Monika Pazura-Turowska</dc:creator>
			<dc:creator>Dorota Szubińska-Lelonkiewicz</dc:creator>
			<dc:creator>Anna Bielenica</dc:creator>
		<dc:identifier>doi: 10.3390/M2103</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-12-05</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-12-05</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2103</prism:startingPage>
		<prism:doi>10.3390/M2103</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2103</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2102">

	<title>Molbank, Vol. 2025, Article M2102: Bis(1,2,4-triphenylcyclopentadienyl) Terbium 4,4,4-trifluoro-1-phenylbutane-1,3-dionate</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2102</link>
	<description>A new bis(cyclopentadienyl) terbium(III) complex with 1,2,4-triphenylcyclopentadienyl and 4,4,4-trifluoro-1-phenylbutane-1,3-dionate ligands was synthesized. Single-crystal X-ray analysis revealed a mononuclear bis(cyclopentadienyl) complex with a diketonate ligand in the bisector plane. The compound under study exhibits a ligand ligand charge transfer state (LLCT), according to optical spectroscopy and crystallographic data.</description>
	<pubDate>2025-12-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2102: Bis(1,2,4-triphenylcyclopentadienyl) Terbium 4,4,4-trifluoro-1-phenylbutane-1,3-dionate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2102">doi: 10.3390/M2102</a></p>
	<p>Authors:
		Daniil A. Bardonov
		Mikhail E. Minyaev
		Lada N. Puntus
		Ilya E. Nifant’ev
		Dmitrii M. Roitershtein
		</p>
	<p>A new bis(cyclopentadienyl) terbium(III) complex with 1,2,4-triphenylcyclopentadienyl and 4,4,4-trifluoro-1-phenylbutane-1,3-dionate ligands was synthesized. Single-crystal X-ray analysis revealed a mononuclear bis(cyclopentadienyl) complex with a diketonate ligand in the bisector plane. The compound under study exhibits a ligand ligand charge transfer state (LLCT), according to optical spectroscopy and crystallographic data.</p>
	]]></content:encoded>

	<dc:title>Bis(1,2,4-triphenylcyclopentadienyl) Terbium 4,4,4-trifluoro-1-phenylbutane-1,3-dionate</dc:title>
			<dc:creator>Daniil A. Bardonov</dc:creator>
			<dc:creator>Mikhail E. Minyaev</dc:creator>
			<dc:creator>Lada N. Puntus</dc:creator>
			<dc:creator>Ilya E. Nifant’ev</dc:creator>
			<dc:creator>Dmitrii M. Roitershtein</dc:creator>
		<dc:identifier>doi: 10.3390/M2102</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-12-04</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-12-04</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2102</prism:startingPage>
		<prism:doi>10.3390/M2102</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2102</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2101">

	<title>Molbank, Vol. 2025, Article M2101: Methyl (1aRS,7aSR)-7-formyl-1a-phenyl-1,1a-dihydroazirino[2,3-b]benzo[e][1,4]thiazine-7a(7H)-carboxylate</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2101</link>
	<description>The first representative of the aziridine-fused benzo[e][1,4]thiazine series was synthesized from methyl 2-bromo-2-phenyl-2H-azirine-2-carboxylate and benzo[d]thiazole in 74% yield. The reaction proceeds via the SN2&amp;amp;prime;-SN2&amp;amp;prime;-cascade to form the azirinylthiazolium salt followed by a water-induced thiazole ring expansion. The structure of the title compound was established based on 1H, 13C, 2D NMR spectroscopy and high-resolution mass spectrometry, and unambiguously confirmed by X-ray diffraction analysis.</description>
	<pubDate>2025-12-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2101: Methyl (1aRS,7aSR)-7-formyl-1a-phenyl-1,1a-dihydroazirino[2,3-b]benzo[e][1,4]thiazine-7a(7H)-carboxylate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2101">doi: 10.3390/M2101</a></p>
	<p>Authors:
		Ilya P. Filippov
		Anastasiya V. Agafonova
		Nikolai V. Rostovskii
		Mikhail S. Novikov
		</p>
	<p>The first representative of the aziridine-fused benzo[e][1,4]thiazine series was synthesized from methyl 2-bromo-2-phenyl-2H-azirine-2-carboxylate and benzo[d]thiazole in 74% yield. The reaction proceeds via the SN2&amp;amp;prime;-SN2&amp;amp;prime;-cascade to form the azirinylthiazolium salt followed by a water-induced thiazole ring expansion. The structure of the title compound was established based on 1H, 13C, 2D NMR spectroscopy and high-resolution mass spectrometry, and unambiguously confirmed by X-ray diffraction analysis.</p>
	]]></content:encoded>

	<dc:title>Methyl (1aRS,7aSR)-7-formyl-1a-phenyl-1,1a-dihydroazirino[2,3-b]benzo[e][1,4]thiazine-7a(7H)-carboxylate</dc:title>
			<dc:creator>Ilya P. Filippov</dc:creator>
			<dc:creator>Anastasiya V. Agafonova</dc:creator>
			<dc:creator>Nikolai V. Rostovskii</dc:creator>
			<dc:creator>Mikhail S. Novikov</dc:creator>
		<dc:identifier>doi: 10.3390/M2101</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-12-04</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-12-04</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2101</prism:startingPage>
		<prism:doi>10.3390/M2101</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2101</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2100">

	<title>Molbank, Vol. 2025, Article M2100: (E)-8-(4-(4-(Diphenylamino)styryl)phenoxy)-N,N,N-trimethyloctan-1-aminium Bromide</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2100</link>
	<description>Structural optimization integrating triphenylamine and quaternary ammonium salt-based antimicrobial peptide mimics has yielded novel theranostic hybrid molecules. These compounds exhibit fluorescence imaging, photodynamic antibacterial activity, and membrane-disruption capabilities, demonstrating broad-spectrum efficacy with low resistance induction. In this study, we successfully developed a novel triphenylamine-quaternary ammonium derivative (TPQ), ultimately obtaining the target compound (E)-8-(4-(4-(diphenylamino)styryl)phenoxy)-N,N,N-trimethyloctan-1-aminium bromide (Compound 5). This achievement provides a potent strategy against growing bacterial drug resistance.</description>
	<pubDate>2025-12-03</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2100: (E)-8-(4-(4-(Diphenylamino)styryl)phenoxy)-N,N,N-trimethyloctan-1-aminium Bromide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2100">doi: 10.3390/M2100</a></p>
	<p>Authors:
		Saiya Yang
		Ya-Na Wang
		Yuyang Ma
		Ruirui Li
		Maxwell Ampomah-Wireko
		Cedric Dzidzor Kodjo Amengor
		En Zhang
		Yi-Hong Zhao
		</p>
	<p>Structural optimization integrating triphenylamine and quaternary ammonium salt-based antimicrobial peptide mimics has yielded novel theranostic hybrid molecules. These compounds exhibit fluorescence imaging, photodynamic antibacterial activity, and membrane-disruption capabilities, demonstrating broad-spectrum efficacy with low resistance induction. In this study, we successfully developed a novel triphenylamine-quaternary ammonium derivative (TPQ), ultimately obtaining the target compound (E)-8-(4-(4-(diphenylamino)styryl)phenoxy)-N,N,N-trimethyloctan-1-aminium bromide (Compound 5). This achievement provides a potent strategy against growing bacterial drug resistance.</p>
	]]></content:encoded>

	<dc:title>(E)-8-(4-(4-(Diphenylamino)styryl)phenoxy)-N,N,N-trimethyloctan-1-aminium Bromide</dc:title>
			<dc:creator>Saiya Yang</dc:creator>
			<dc:creator>Ya-Na Wang</dc:creator>
			<dc:creator>Yuyang Ma</dc:creator>
			<dc:creator>Ruirui Li</dc:creator>
			<dc:creator>Maxwell Ampomah-Wireko</dc:creator>
			<dc:creator>Cedric Dzidzor Kodjo Amengor</dc:creator>
			<dc:creator>En Zhang</dc:creator>
			<dc:creator>Yi-Hong Zhao</dc:creator>
		<dc:identifier>doi: 10.3390/M2100</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-12-03</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-12-03</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2100</prism:startingPage>
		<prism:doi>10.3390/M2100</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2100</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2099">

	<title>Molbank, Vol. 2025, Article M2099: (Z)-N-Carbamothioyl-4-hydroxy-2-oxo-4-(p-tolyl)but-3-enamide</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2099</link>
	<description>The reaction of 5-(p-tolyl)furan-2,3-dione with thiourea in a 1:1 ratio when refluxed in 1,4-dioxane gives (Z)-N-carbamothioyl-4-hydroxy-2-oxo-4-(p-tolyl)but-3-enamide with a good yield. This compound was fully characterized.</description>
	<pubDate>2025-12-02</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2099: (Z)-N-Carbamothioyl-4-hydroxy-2-oxo-4-(p-tolyl)but-3-enamide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2099">doi: 10.3390/M2099</a></p>
	<p>Authors:
		Alexandra O. Derevnina
		Yurii V. Shklyaev
		Andrey N. Maslivets
		</p>
	<p>The reaction of 5-(p-tolyl)furan-2,3-dione with thiourea in a 1:1 ratio when refluxed in 1,4-dioxane gives (Z)-N-carbamothioyl-4-hydroxy-2-oxo-4-(p-tolyl)but-3-enamide with a good yield. This compound was fully characterized.</p>
	]]></content:encoded>

	<dc:title>(Z)-N-Carbamothioyl-4-hydroxy-2-oxo-4-(p-tolyl)but-3-enamide</dc:title>
			<dc:creator>Alexandra O. Derevnina</dc:creator>
			<dc:creator>Yurii V. Shklyaev</dc:creator>
			<dc:creator>Andrey N. Maslivets</dc:creator>
		<dc:identifier>doi: 10.3390/M2099</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-12-02</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-12-02</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2099</prism:startingPage>
		<prism:doi>10.3390/M2099</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2099</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2098">

	<title>Molbank, Vol. 2025, Article M2098: Synthesis and Characterization of Three New Furan-Containing Terpyridine Derivatives</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2098</link>
	<description>Three new terpyridine derivatives which contain a pendant furan heterocycle have been prepared and characterized. The first two, 4&amp;amp;prime;-(4,5-dimethylfuran-2-yl)-2,2&amp;amp;prime;:6&amp;amp;prime;,2&amp;amp;Prime;-terpyridine (1) and 4&amp;amp;prime;-((1,3-dioxolan-2-yl)furan-2-yl)-2,2&amp;amp;prime;:6&amp;amp;prime;,2&amp;amp;Prime;-terpyridine (2), are obtained through the reaction of 2-acetylpyridine and suitable furaldehydes using the Kr&amp;amp;ouml;hnke reaction. The last one, 4&amp;amp;prime;-(5-formylfuran-2-yl)-2,2&amp;amp;prime;:6&amp;amp;prime;,2&amp;amp;prime;&amp;amp;rsquo;-terpyridine (3) is obtained via acidic hydrolysis of the acetal onto terpyridine (2). The structures of these new compounds are confirmed using different analytical techniques such as NMR and infrared spectroscopy (ATR-IR) as well as by High Resolution Mass Spectrometry (HRMS).</description>
	<pubDate>2025-12-02</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2098: Synthesis and Characterization of Three New Furan-Containing Terpyridine Derivatives</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2098">doi: 10.3390/M2098</a></p>
	<p>Authors:
		Jérôme Husson
		</p>
	<p>Three new terpyridine derivatives which contain a pendant furan heterocycle have been prepared and characterized. The first two, 4&amp;amp;prime;-(4,5-dimethylfuran-2-yl)-2,2&amp;amp;prime;:6&amp;amp;prime;,2&amp;amp;Prime;-terpyridine (1) and 4&amp;amp;prime;-((1,3-dioxolan-2-yl)furan-2-yl)-2,2&amp;amp;prime;:6&amp;amp;prime;,2&amp;amp;Prime;-terpyridine (2), are obtained through the reaction of 2-acetylpyridine and suitable furaldehydes using the Kr&amp;amp;ouml;hnke reaction. The last one, 4&amp;amp;prime;-(5-formylfuran-2-yl)-2,2&amp;amp;prime;:6&amp;amp;prime;,2&amp;amp;prime;&amp;amp;rsquo;-terpyridine (3) is obtained via acidic hydrolysis of the acetal onto terpyridine (2). The structures of these new compounds are confirmed using different analytical techniques such as NMR and infrared spectroscopy (ATR-IR) as well as by High Resolution Mass Spectrometry (HRMS).</p>
	]]></content:encoded>

	<dc:title>Synthesis and Characterization of Three New Furan-Containing Terpyridine Derivatives</dc:title>
			<dc:creator>Jérôme Husson</dc:creator>
		<dc:identifier>doi: 10.3390/M2098</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-12-02</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-12-02</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2098</prism:startingPage>
		<prism:doi>10.3390/M2098</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2098</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2097">

	<title>Molbank, Vol. 2025, Article M2097: 1-[4-(4-Chlorophenyl)piperazin-1-yl]-2-[(4-phenyl-4H-1,2,4-triazol-3-yl)sulfanyl]ethan-1-one</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2097</link>
	<description>Heterocyclic systems such as 1,2,4-triazoles and piperazines play an important role in modern medicinal chemistry due to their structural diversity and broad spectrum of biological activities. In this Short Note, we report the synthesis and spectroscopic characterization of a new hybrid molecule combining both pharmacophoric fragments: 1-[4-(4-chlorophenyl)piperazin-1-yl]-2-[(4-phenyl-4H-1,2,4-triazol-3-yl)sulfanyl]ethan-1-one (compound 3). The compound was obtained in 70% yield via S-alkylation of 4-phenyl-1,2,4-triazole-3-thione with a chloroacetyl derivative of 4-chlorophenylpiperazine under alkaline conditions. The structure of 3 was confirmed by 1H and 13C NMR spectroscopy, DEPT-135, 2D NMR (COSY, NOESY, HSQC, HMBC), FT-IR, and elemental analysis. These results support the utility of combining triazole and piperazine fragments in the design of new heterocyclic frameworks with potential biological relevance.</description>
	<pubDate>2025-12-02</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2097: 1-[4-(4-Chlorophenyl)piperazin-1-yl]-2-[(4-phenyl-4H-1,2,4-triazol-3-yl)sulfanyl]ethan-1-one</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2097">doi: 10.3390/M2097</a></p>
	<p>Authors:
		Wiktoria Drzał
		Jarosław Sobstyl
		Nazar Trotsko
		</p>
	<p>Heterocyclic systems such as 1,2,4-triazoles and piperazines play an important role in modern medicinal chemistry due to their structural diversity and broad spectrum of biological activities. In this Short Note, we report the synthesis and spectroscopic characterization of a new hybrid molecule combining both pharmacophoric fragments: 1-[4-(4-chlorophenyl)piperazin-1-yl]-2-[(4-phenyl-4H-1,2,4-triazol-3-yl)sulfanyl]ethan-1-one (compound 3). The compound was obtained in 70% yield via S-alkylation of 4-phenyl-1,2,4-triazole-3-thione with a chloroacetyl derivative of 4-chlorophenylpiperazine under alkaline conditions. The structure of 3 was confirmed by 1H and 13C NMR spectroscopy, DEPT-135, 2D NMR (COSY, NOESY, HSQC, HMBC), FT-IR, and elemental analysis. These results support the utility of combining triazole and piperazine fragments in the design of new heterocyclic frameworks with potential biological relevance.</p>
	]]></content:encoded>

	<dc:title>1-[4-(4-Chlorophenyl)piperazin-1-yl]-2-[(4-phenyl-4H-1,2,4-triazol-3-yl)sulfanyl]ethan-1-one</dc:title>
			<dc:creator>Wiktoria Drzał</dc:creator>
			<dc:creator>Jarosław Sobstyl</dc:creator>
			<dc:creator>Nazar Trotsko</dc:creator>
		<dc:identifier>doi: 10.3390/M2097</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-12-02</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-12-02</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2097</prism:startingPage>
		<prism:doi>10.3390/M2097</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2097</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2096">

	<title>Molbank, Vol. 2025, Article M2096: (7aR*,7bR*)-7a,7b-Dihydro-15H-dibenzo[f,f&amp;prime;]cyclopenta[1,2-b:5,4-b&amp;prime;]dichromene</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2096</link>
	<description>The reaction of a 2-naphthol-derived Mannich base with the push-pull 5-morpholinopenta-2,4-dienal under acidic conditions unexpectedly afforded (7aR*,7bR*)-7a,7b-dihydro-15H-dibenzo[f,f&amp;amp;prime;]cyclopenta[1,2-b:5,4-b&amp;amp;prime;]dichromene. The structure of this product was unambiguously confirmed by NMR spectroscopy and X-ray diffraction analysis. A plausible mechanism involves the in situ generation of 1,2-naphthoquinone-1-methide, followed by a [4 + 2] cycloaddition and a subsequent interrupted iso-Nazarov cyclization. In this process, the enol tautomer of the resulting fused cyclopentenone is trapped by a second equivalent of the 1,2-naphthoquinone-1-methide, leading to the observed polycyclic framework.</description>
	<pubDate>2025-11-27</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2096: (7aR*,7bR*)-7a,7b-Dihydro-15H-dibenzo[f,f&amp;prime;]cyclopenta[1,2-b:5,4-b&amp;prime;]dichromene</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2096">doi: 10.3390/M2096</a></p>
	<p>Authors:
		Dmitry V. Osipov
		Oleg P. Demidov
		Vitaly A. Osyanin
		</p>
	<p>The reaction of a 2-naphthol-derived Mannich base with the push-pull 5-morpholinopenta-2,4-dienal under acidic conditions unexpectedly afforded (7aR*,7bR*)-7a,7b-dihydro-15H-dibenzo[f,f&amp;amp;prime;]cyclopenta[1,2-b:5,4-b&amp;amp;prime;]dichromene. The structure of this product was unambiguously confirmed by NMR spectroscopy and X-ray diffraction analysis. A plausible mechanism involves the in situ generation of 1,2-naphthoquinone-1-methide, followed by a [4 + 2] cycloaddition and a subsequent interrupted iso-Nazarov cyclization. In this process, the enol tautomer of the resulting fused cyclopentenone is trapped by a second equivalent of the 1,2-naphthoquinone-1-methide, leading to the observed polycyclic framework.</p>
	]]></content:encoded>

	<dc:title>(7aR*,7bR*)-7a,7b-Dihydro-15H-dibenzo[f,f&amp;amp;prime;]cyclopenta[1,2-b:5,4-b&amp;amp;prime;]dichromene</dc:title>
			<dc:creator>Dmitry V. Osipov</dc:creator>
			<dc:creator>Oleg P. Demidov</dc:creator>
			<dc:creator>Vitaly A. Osyanin</dc:creator>
		<dc:identifier>doi: 10.3390/M2096</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-11-27</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-11-27</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2096</prism:startingPage>
		<prism:doi>10.3390/M2096</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2096</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2095">

	<title>Molbank, Vol. 2025, Article M2095: Three-Step Synthesis of (E)-1-(2-(Pyridin-2-yl)benzo[d]thiazol-6-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one as a Potential Ligand for Transition Metals</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2095</link>
	<description>In the present study, (E)-1-(2-(pyridin-2-yl)benzo[d]thiazol-6-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one (4) was designed and synthesized via a three-step reaction sequence. Initially, 6-acetylbenzo[d]thiazol-2(3H)-one (1) was hydrolyzed to the corresponding 5-acetyl-2-aminothiophenol 2 and then cyclized with pyridine-2-carbaldehyde. The final product was synthesized by a base-catalyzed aldol condensation of 1-(2-(pyridin-2-yl)benzo[d]thiazol-6-yl)ethan-1-one (3) and 3,4,5-trimethoxybenzaldehyde and was comprehensively characterized.</description>
	<pubDate>2025-11-21</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2095: Three-Step Synthesis of (E)-1-(2-(Pyridin-2-yl)benzo[d]thiazol-6-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one as a Potential Ligand for Transition Metals</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2095">doi: 10.3390/M2095</a></p>
	<p>Authors:
		Yordanka B. Ivanova
		Ognyan I. Petrov
		</p>
	<p>In the present study, (E)-1-(2-(pyridin-2-yl)benzo[d]thiazol-6-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one (4) was designed and synthesized via a three-step reaction sequence. Initially, 6-acetylbenzo[d]thiazol-2(3H)-one (1) was hydrolyzed to the corresponding 5-acetyl-2-aminothiophenol 2 and then cyclized with pyridine-2-carbaldehyde. The final product was synthesized by a base-catalyzed aldol condensation of 1-(2-(pyridin-2-yl)benzo[d]thiazol-6-yl)ethan-1-one (3) and 3,4,5-trimethoxybenzaldehyde and was comprehensively characterized.</p>
	]]></content:encoded>

	<dc:title>Three-Step Synthesis of (E)-1-(2-(Pyridin-2-yl)benzo[d]thiazol-6-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one as a Potential Ligand for Transition Metals</dc:title>
			<dc:creator>Yordanka B. Ivanova</dc:creator>
			<dc:creator>Ognyan I. Petrov</dc:creator>
		<dc:identifier>doi: 10.3390/M2095</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-11-21</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-11-21</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2095</prism:startingPage>
		<prism:doi>10.3390/M2095</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2095</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2094">

	<title>Molbank, Vol. 2025, Article M2094: Mixed-Ligand Copper(II) Complex with Ethyl (2-(Methylcarbamoyl)phenyl)carbamate and 3-Methylquinazoline-2,4(1H,3H)-dione</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2094</link>
	<description>(This paper presents the synthesis of a novel copper(II) metal complex with ethyl (2-(methylcarbamoyl)phenyl)carbamate and 3-methylquinazoline-2,4(1H,3H)-dione. The characterization of the compound was conducted through various techniques, including melting point determination, microwave plasma atomic emission spectrometry (MP-AES) for Cu, attenuated total reflection (ATR), IR, 1H NMR, and 13C NMR spectroscopy. The coordination compound was obtained after mixing water solutions of the metal salt and the ligand dissolved in DMSO and water solutions of NaOH, in a metal-to-ligand-to-base ratio of 1:2:2. The ligand and the metal chloride were brought into the reaction at room temperature in DMSO and H2O as solvents, respectively. The results indicate the successful formation of a stable mixed-ligand Cu(II) coordination compound involving N,O-donor ligands. Based on the obtained data, we assumed that the ligands are coordinated through N- and O-donor atoms. Spectroscopic data suggested that the ligand (3-methylquinazoline-2,4(1H,3H)-dione), by using (NaOH), coordinated to a metal ion as a monodentate ligand through the nitrogen atom of the NH group and ethyl (2-(methylcarbamoyl)phenyl)carbamate coordinated in a bidentate fashion through the N- and O-donor atoms of ester group. Additionally, two hydroxyl groups were bridged for two metal ions into the formed dimer structure.</description>
	<pubDate>2025-11-21</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2094: Mixed-Ligand Copper(II) Complex with Ethyl (2-(Methylcarbamoyl)phenyl)carbamate and 3-Methylquinazoline-2,4(1H,3H)-dione</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2094">doi: 10.3390/M2094</a></p>
	<p>Authors:
		Petya Emilova Marinova
		Nikola Burdzhiev
		Evelina Varbanova
		Slava Tsoneva
		Stoyanka Nikolova
		</p>
	<p>(This paper presents the synthesis of a novel copper(II) metal complex with ethyl (2-(methylcarbamoyl)phenyl)carbamate and 3-methylquinazoline-2,4(1H,3H)-dione. The characterization of the compound was conducted through various techniques, including melting point determination, microwave plasma atomic emission spectrometry (MP-AES) for Cu, attenuated total reflection (ATR), IR, 1H NMR, and 13C NMR spectroscopy. The coordination compound was obtained after mixing water solutions of the metal salt and the ligand dissolved in DMSO and water solutions of NaOH, in a metal-to-ligand-to-base ratio of 1:2:2. The ligand and the metal chloride were brought into the reaction at room temperature in DMSO and H2O as solvents, respectively. The results indicate the successful formation of a stable mixed-ligand Cu(II) coordination compound involving N,O-donor ligands. Based on the obtained data, we assumed that the ligands are coordinated through N- and O-donor atoms. Spectroscopic data suggested that the ligand (3-methylquinazoline-2,4(1H,3H)-dione), by using (NaOH), coordinated to a metal ion as a monodentate ligand through the nitrogen atom of the NH group and ethyl (2-(methylcarbamoyl)phenyl)carbamate coordinated in a bidentate fashion through the N- and O-donor atoms of ester group. Additionally, two hydroxyl groups were bridged for two metal ions into the formed dimer structure.</p>
	]]></content:encoded>

	<dc:title>Mixed-Ligand Copper(II) Complex with Ethyl (2-(Methylcarbamoyl)phenyl)carbamate and 3-Methylquinazoline-2,4(1H,3H)-dione</dc:title>
			<dc:creator>Petya Emilova Marinova</dc:creator>
			<dc:creator>Nikola Burdzhiev</dc:creator>
			<dc:creator>Evelina Varbanova</dc:creator>
			<dc:creator>Slava Tsoneva</dc:creator>
			<dc:creator>Stoyanka Nikolova</dc:creator>
		<dc:identifier>doi: 10.3390/M2094</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-11-21</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-11-21</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2094</prism:startingPage>
		<prism:doi>10.3390/M2094</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2094</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2093">

	<title>Molbank, Vol. 2025, Article M2093: 2-(Difluoroboryloxy)benzamide</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2093</link>
	<description>The title compound has been fully characterised by NMR for the first time. Fully assigned 1H and 13C NMR spectra, and the X-ray structure of two different polymorphs are presented. The polymorphs show similar molecular geometries but exhibit significantly different patterns of intermolecular interactions.</description>
	<pubDate>2025-11-20</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2093: 2-(Difluoroboryloxy)benzamide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2093">doi: 10.3390/M2093</a></p>
	<p>Authors:
		R. Alan Aitken
		Hibet E. M. Akkache
		David B. Cordes
		Aidan P. McKay
		Dorian Moreau
		</p>
	<p>The title compound has been fully characterised by NMR for the first time. Fully assigned 1H and 13C NMR spectra, and the X-ray structure of two different polymorphs are presented. The polymorphs show similar molecular geometries but exhibit significantly different patterns of intermolecular interactions.</p>
	]]></content:encoded>

	<dc:title>2-(Difluoroboryloxy)benzamide</dc:title>
			<dc:creator>R. Alan Aitken</dc:creator>
			<dc:creator>Hibet E. M. Akkache</dc:creator>
			<dc:creator>David B. Cordes</dc:creator>
			<dc:creator>Aidan P. McKay</dc:creator>
			<dc:creator>Dorian Moreau</dc:creator>
		<dc:identifier>doi: 10.3390/M2093</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-11-20</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-11-20</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2093</prism:startingPage>
		<prism:doi>10.3390/M2093</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2093</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2092">

	<title>Molbank, Vol. 2025, Article M2092: Schiff Base Heterobimetallic Complex as Single-Source Precursor</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2092</link>
	<description>A bimetallic complex based on a salophen-type ligand was synthesized. The compound was characterized by ESI-MS, single-crystal, and powder X-ray diffraction. The heterobimetallic complex was thermally treated to investigate its capacity as a single-source precursor for the formation of mixed metal oxides.</description>
	<pubDate>2025-11-20</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2092: Schiff Base Heterobimetallic Complex as Single-Source Precursor</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2092">doi: 10.3390/M2092</a></p>
	<p>Authors:
		Jocelyn Pradegan
		Aurélien Crochet
		Katharina M. Fromm
		</p>
	<p>A bimetallic complex based on a salophen-type ligand was synthesized. The compound was characterized by ESI-MS, single-crystal, and powder X-ray diffraction. The heterobimetallic complex was thermally treated to investigate its capacity as a single-source precursor for the formation of mixed metal oxides.</p>
	]]></content:encoded>

	<dc:title>Schiff Base Heterobimetallic Complex as Single-Source Precursor</dc:title>
			<dc:creator>Jocelyn Pradegan</dc:creator>
			<dc:creator>Aurélien Crochet</dc:creator>
			<dc:creator>Katharina M. Fromm</dc:creator>
		<dc:identifier>doi: 10.3390/M2092</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-11-20</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-11-20</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2092</prism:startingPage>
		<prism:doi>10.3390/M2092</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2092</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2091">

	<title>Molbank, Vol. 2025, Article M2091: 2,5-Dimethylbenzyl 2-{(4,6-diaminopyrimidin-2-yl)thio}acetate</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2091</link>
	<description>2,5-Dimethylbenzyl 2-{(4,6-diaminopyrimidin-2-yl)thio}acetate was prepared by an alkylation reaction between the sodium salt of 4,6-diamino-2-mercaptopyrimidine and chloroacetic acid. The structure was unambiguously elucidated based on high-resolution mass spectrometry (HRMS) as well as spectroscopies such as infrared (IR) and nuclear magnetic resonance (NMR).</description>
	<pubDate>2025-11-19</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2091: 2,5-Dimethylbenzyl 2-{(4,6-diaminopyrimidin-2-yl)thio}acetate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2091">doi: 10.3390/M2091</a></p>
	<p>Authors:
		Gulrukh Salieva
		Malokhat Uktamova
		Sardorbek Otajonov
		Kohei Torikai
		Tursunali Kholikov
		</p>
	<p>2,5-Dimethylbenzyl 2-{(4,6-diaminopyrimidin-2-yl)thio}acetate was prepared by an alkylation reaction between the sodium salt of 4,6-diamino-2-mercaptopyrimidine and chloroacetic acid. The structure was unambiguously elucidated based on high-resolution mass spectrometry (HRMS) as well as spectroscopies such as infrared (IR) and nuclear magnetic resonance (NMR).</p>
	]]></content:encoded>

	<dc:title>2,5-Dimethylbenzyl 2-{(4,6-diaminopyrimidin-2-yl)thio}acetate</dc:title>
			<dc:creator>Gulrukh Salieva</dc:creator>
			<dc:creator>Malokhat Uktamova</dc:creator>
			<dc:creator>Sardorbek Otajonov</dc:creator>
			<dc:creator>Kohei Torikai</dc:creator>
			<dc:creator>Tursunali Kholikov</dc:creator>
		<dc:identifier>doi: 10.3390/M2091</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-11-19</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-11-19</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2091</prism:startingPage>
		<prism:doi>10.3390/M2091</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2091</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2090">

	<title>Molbank, Vol. 2025, Article M2090: Trichloro[2,5-bis[N-(4-isopropylphenyl)-P,P-diisopropylphosphorimidoyl-&amp;kappa;N]pyrrole-&amp;kappa;N]zirconium(IV)&amp;middot;Benzene</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2090</link>
	<description>A new zirconium trichloride complex, supported by a monoanionic, pyrrole-based bisphosphinimine NNN-pincer ligand, [LZrCl3] (L = 2,5-[iPr2P=N(4-iPrC6H4)]2NH(C6H2) (1), is reported. Comparison with a related iminopincer complex reveals significant differences in bond lengths and angles between the atoms around the metal centre, largely due to the more electron donating phosphinimine (R3P=NR (R = alkyl, aryl)) functionality. The P=N bonds in complex (1&amp;amp;bull;benzene) are longer than in the proteo ligand HL (L = 2,5-[Ph2P=N(4-iPrC6H4)]2NH(C6H2)), which is consistent with phosphinimine coordination to a metal. This is the only reported zirconium complex with this specific ligand scaffold; no analogous complexes have been reported for other group 4 metals. This structure expands the library of Zr pincer complexes that bear tridentate ligand frameworks and sets the stage for the preparation of related complexes.</description>
	<pubDate>2025-11-14</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2090: Trichloro[2,5-bis[N-(4-isopropylphenyl)-P,P-diisopropylphosphorimidoyl-&amp;kappa;N]pyrrole-&amp;kappa;N]zirconium(IV)&amp;middot;Benzene</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2090">doi: 10.3390/M2090</a></p>
	<p>Authors:
		Thamara V. Salazar-Barrientos
		Christopher P. Forfar
		Paul G. Hayes
		</p>
	<p>A new zirconium trichloride complex, supported by a monoanionic, pyrrole-based bisphosphinimine NNN-pincer ligand, [LZrCl3] (L = 2,5-[iPr2P=N(4-iPrC6H4)]2NH(C6H2) (1), is reported. Comparison with a related iminopincer complex reveals significant differences in bond lengths and angles between the atoms around the metal centre, largely due to the more electron donating phosphinimine (R3P=NR (R = alkyl, aryl)) functionality. The P=N bonds in complex (1&amp;amp;bull;benzene) are longer than in the proteo ligand HL (L = 2,5-[Ph2P=N(4-iPrC6H4)]2NH(C6H2)), which is consistent with phosphinimine coordination to a metal. This is the only reported zirconium complex with this specific ligand scaffold; no analogous complexes have been reported for other group 4 metals. This structure expands the library of Zr pincer complexes that bear tridentate ligand frameworks and sets the stage for the preparation of related complexes.</p>
	]]></content:encoded>

	<dc:title>Trichloro[2,5-bis[N-(4-isopropylphenyl)-P,P-diisopropylphosphorimidoyl-&amp;amp;kappa;N]pyrrole-&amp;amp;kappa;N]zirconium(IV)&amp;amp;middot;Benzene</dc:title>
			<dc:creator>Thamara V. Salazar-Barrientos</dc:creator>
			<dc:creator>Christopher P. Forfar</dc:creator>
			<dc:creator>Paul G. Hayes</dc:creator>
		<dc:identifier>doi: 10.3390/M2090</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-11-14</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-11-14</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2090</prism:startingPage>
		<prism:doi>10.3390/M2090</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2090</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2089">

	<title>Molbank, Vol. 2025, Article M2089: N,N&amp;prime;-Di(p-tolyl)-1,4-benzoquinonediimine (N,N&amp;prime;-Di-p-tolylcyclohexa-2,5-diene-1,4-diimine)</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2089</link>
	<description>The title compound has been fully characterised using 1H and 13C NMR spectroscopy, which reveals (E) to (Z) isomerisation upon dissolution. In the solid state, X-ray diffraction shows exclusively the (E)-isomer with two geometrically near-identical independent molecules each with the outer rings tilted with respect to the central ring.</description>
	<pubDate>2025-11-13</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2089: N,N&amp;prime;-Di(p-tolyl)-1,4-benzoquinonediimine (N,N&amp;prime;-Di-p-tolylcyclohexa-2,5-diene-1,4-diimine)</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2089">doi: 10.3390/M2089</a></p>
	<p>Authors:
		R. Alan Aitken
		Rebecca Bascombe
		Alexandra M. Z. Slawin
		</p>
	<p>The title compound has been fully characterised using 1H and 13C NMR spectroscopy, which reveals (E) to (Z) isomerisation upon dissolution. In the solid state, X-ray diffraction shows exclusively the (E)-isomer with two geometrically near-identical independent molecules each with the outer rings tilted with respect to the central ring.</p>
	]]></content:encoded>

	<dc:title>N,N&amp;amp;prime;-Di(p-tolyl)-1,4-benzoquinonediimine (N,N&amp;amp;prime;-Di-p-tolylcyclohexa-2,5-diene-1,4-diimine)</dc:title>
			<dc:creator>R. Alan Aitken</dc:creator>
			<dc:creator>Rebecca Bascombe</dc:creator>
			<dc:creator>Alexandra M. Z. Slawin</dc:creator>
		<dc:identifier>doi: 10.3390/M2089</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-11-13</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-11-13</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2089</prism:startingPage>
		<prism:doi>10.3390/M2089</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2089</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2088">

	<title>Molbank, Vol. 2025, Article M2088: (1R,2R,6S)-3-Methyl-6-(3-(4-phenylpiperidin-1-yl)prop-1-en-2-yl)cyclohex-3-ene-1,2-diol</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2088</link>
	<description>Parkinson&amp;amp;rsquo;s disease (PD) is a progressive neurodegenerative disorder whose primary manifestation is motor dysfunction. Previous research showed that (1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol (Prottremine) exhibits potent antiparkinsonian activity in animal models of PD, with an efficacy comparable to levodopa. Herein, we report the synthesis of a new Prottremine derivative, (1R,2R,6S)-3-methyl-6-(3-(4-phenylpiperidin-1-yl)prop-1-en-2-yl)cyclohex-3-ene-1,2-diol. The compound was fully characterized and its structure was confirmed through single-crystal X-ray diffraction analysis.</description>
	<pubDate>2025-11-12</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2088: (1R,2R,6S)-3-Methyl-6-(3-(4-phenylpiperidin-1-yl)prop-1-en-2-yl)cyclohex-3-ene-1,2-diol</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2088">doi: 10.3390/M2088</a></p>
	<p>Authors:
		Alexandra V. Podturkina
		Nikolai S. Li-Zhulanov
		Tatyana V. Rybalova
		Konstantin P. Volcho
		Nariman F. Salakhutdinov
		</p>
	<p>Parkinson&amp;amp;rsquo;s disease (PD) is a progressive neurodegenerative disorder whose primary manifestation is motor dysfunction. Previous research showed that (1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol (Prottremine) exhibits potent antiparkinsonian activity in animal models of PD, with an efficacy comparable to levodopa. Herein, we report the synthesis of a new Prottremine derivative, (1R,2R,6S)-3-methyl-6-(3-(4-phenylpiperidin-1-yl)prop-1-en-2-yl)cyclohex-3-ene-1,2-diol. The compound was fully characterized and its structure was confirmed through single-crystal X-ray diffraction analysis.</p>
	]]></content:encoded>

	<dc:title>(1R,2R,6S)-3-Methyl-6-(3-(4-phenylpiperidin-1-yl)prop-1-en-2-yl)cyclohex-3-ene-1,2-diol</dc:title>
			<dc:creator>Alexandra V. Podturkina</dc:creator>
			<dc:creator>Nikolai S. Li-Zhulanov</dc:creator>
			<dc:creator>Tatyana V. Rybalova</dc:creator>
			<dc:creator>Konstantin P. Volcho</dc:creator>
			<dc:creator>Nariman F. Salakhutdinov</dc:creator>
		<dc:identifier>doi: 10.3390/M2088</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-11-12</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-11-12</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2088</prism:startingPage>
		<prism:doi>10.3390/M2088</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2088</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2087">

	<title>Molbank, Vol. 2025, Article M2087: (E)-4-(4-((8-Bromooctyl)oxy)styryl)-N,N-diphenylaniline</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2087</link>
	<description>Triphenylamine and phenol derivatives are two types of antimicrobial molecules with broad application prospects. Through functional modification, these compounds integrate fluorescence imaging and photodynamic antibacterial therapy, thereby achieving theranostic capabilities. They exert broad-spectrum and highly efficient antimicrobial activity via a membrane-disrupting mechanism, which consequently reduces the propensity for inducing drug resistance. In this work, triphenylamine-phenol derivatives (TPO) were designed and synthesized through three consecutive reactions: Wittig reaction, Heck reaction, and substitution reaction. Double bonds, hydroxyl groups, and brominated alkyl chains were gradually introduced to finally obtain the target product (E)-4-(4-((8-bromooctyl)oxy)styryl)-N,N-diphenylaniline (5). This study provides new insights into the development of novel and highly efficient antibacterial agents.</description>
	<pubDate>2025-11-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2087: (E)-4-(4-((8-Bromooctyl)oxy)styryl)-N,N-diphenylaniline</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2087">doi: 10.3390/M2087</a></p>
	<p>Authors:
		Yi-Qiong Sun
		Ya-Na Wang
		Kai-Wei Zhu
		Ruirui Li
		Maxwell Ampomah-Wireko
		Cedric Dzidzor Kodjo Amengor
		En Zhang
		Yi-Hong Zhao
		</p>
	<p>Triphenylamine and phenol derivatives are two types of antimicrobial molecules with broad application prospects. Through functional modification, these compounds integrate fluorescence imaging and photodynamic antibacterial therapy, thereby achieving theranostic capabilities. They exert broad-spectrum and highly efficient antimicrobial activity via a membrane-disrupting mechanism, which consequently reduces the propensity for inducing drug resistance. In this work, triphenylamine-phenol derivatives (TPO) were designed and synthesized through three consecutive reactions: Wittig reaction, Heck reaction, and substitution reaction. Double bonds, hydroxyl groups, and brominated alkyl chains were gradually introduced to finally obtain the target product (E)-4-(4-((8-bromooctyl)oxy)styryl)-N,N-diphenylaniline (5). This study provides new insights into the development of novel and highly efficient antibacterial agents.</p>
	]]></content:encoded>

	<dc:title>(E)-4-(4-((8-Bromooctyl)oxy)styryl)-N,N-diphenylaniline</dc:title>
			<dc:creator>Yi-Qiong Sun</dc:creator>
			<dc:creator>Ya-Na Wang</dc:creator>
			<dc:creator>Kai-Wei Zhu</dc:creator>
			<dc:creator>Ruirui Li</dc:creator>
			<dc:creator>Maxwell Ampomah-Wireko</dc:creator>
			<dc:creator>Cedric Dzidzor Kodjo Amengor</dc:creator>
			<dc:creator>En Zhang</dc:creator>
			<dc:creator>Yi-Hong Zhao</dc:creator>
		<dc:identifier>doi: 10.3390/M2087</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-11-10</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-11-10</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2087</prism:startingPage>
		<prism:doi>10.3390/M2087</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2087</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2086">

	<title>Molbank, Vol. 2025, Article M2086: Bromo(5-cyclohexyl-1-methyl-1H-1,2,4-triazol-4-ium-3-yl)bis(triphenylphosphane)palladium Tetrafluoroborate</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2086</link>
	<description>Transition metal complexes bearing protic N-heterocyclic carbene (pNHC) ligands are promising precatalysts for organic reactions due to their capacity for unique hydrogen-bonding interactions. Herein, we report the synthesis and structural characterization of the first Pd(II) complex featuring a pNHC derived from 1,2,4-triazole&amp;amp;mdash;a heterocyclic system previously unexplored for the preparation of metal/pNHC complexes. The complex was synthesized via oxidative addition of 3-bromo-5-cyclohexyl-1-methyl-1H-1,2,4-triazole to Pd(PPh3)4 in the presence of NH4BF4. Its molecular structure was characterized by NMR spectroscopy and X-ray diffraction analysis.</description>
	<pubDate>2025-11-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2086: Bromo(5-cyclohexyl-1-methyl-1H-1,2,4-triazol-4-ium-3-yl)bis(triphenylphosphane)palladium Tetrafluoroborate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2086">doi: 10.3390/M2086</a></p>
	<p>Authors:
		Andrey Y. Chernenko
		Igor V. Lavrentev
		Maxim A. Shevchenko
		Mikhail E. Minyaev
		Konstantin E. Shepelenko
		Victor M. Chernyshev
		</p>
	<p>Transition metal complexes bearing protic N-heterocyclic carbene (pNHC) ligands are promising precatalysts for organic reactions due to their capacity for unique hydrogen-bonding interactions. Herein, we report the synthesis and structural characterization of the first Pd(II) complex featuring a pNHC derived from 1,2,4-triazole&amp;amp;mdash;a heterocyclic system previously unexplored for the preparation of metal/pNHC complexes. The complex was synthesized via oxidative addition of 3-bromo-5-cyclohexyl-1-methyl-1H-1,2,4-triazole to Pd(PPh3)4 in the presence of NH4BF4. Its molecular structure was characterized by NMR spectroscopy and X-ray diffraction analysis.</p>
	]]></content:encoded>

	<dc:title>Bromo(5-cyclohexyl-1-methyl-1H-1,2,4-triazol-4-ium-3-yl)bis(triphenylphosphane)palladium Tetrafluoroborate</dc:title>
			<dc:creator>Andrey Y. Chernenko</dc:creator>
			<dc:creator>Igor V. Lavrentev</dc:creator>
			<dc:creator>Maxim A. Shevchenko</dc:creator>
			<dc:creator>Mikhail E. Minyaev</dc:creator>
			<dc:creator>Konstantin E. Shepelenko</dc:creator>
			<dc:creator>Victor M. Chernyshev</dc:creator>
		<dc:identifier>doi: 10.3390/M2086</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-11-10</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-11-10</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2086</prism:startingPage>
		<prism:doi>10.3390/M2086</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2086</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2085">

	<title>Molbank, Vol. 2025, Article M2085: Synthesis of a Stable Long-Wavelength Fluorescent BODIPY FL-NAADP Conjugate</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2085</link>
	<description>Nicotinic acid adenine dinucleotide phosphate (NAADP) is a second messenger that stimulates intracellular Ca2+ release in both mammalian cells and echinoderm egg homogenates. A NAADP linked covalently to a stable long-wavelength fluorescent dye would be a useful probe with which to characterize NAADP&amp;amp;ndash;receptor interactions in solution and potentially to determine intracellular-binding localization. We report the synthesis of a BODIPY-NAADP covalent conjugate made through linking the carboxyl group of BODIPY FL to the primary amino group of 5-(3-aminopropyl)-NAADP through amide bond formation. The starting pyridine dinucleotide analog, 5-(3-aminopropyl)-NAADP was available through enzyme-catalyzed base exchange between NADP and a substituted nicotinic acid analog. The resulting 5-BODIPY-NAADP conjugate was purified to homogeneity using ion-exchange chromatography, was produced in milligram quantities, and its spectroscopic properties were characterized.</description>
	<pubDate>2025-11-05</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2085: Synthesis of a Stable Long-Wavelength Fluorescent BODIPY FL-NAADP Conjugate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2085">doi: 10.3390/M2085</a></p>
	<p>Authors:
		Zhong Guan
		James T. Slama
		</p>
	<p>Nicotinic acid adenine dinucleotide phosphate (NAADP) is a second messenger that stimulates intracellular Ca2+ release in both mammalian cells and echinoderm egg homogenates. A NAADP linked covalently to a stable long-wavelength fluorescent dye would be a useful probe with which to characterize NAADP&amp;amp;ndash;receptor interactions in solution and potentially to determine intracellular-binding localization. We report the synthesis of a BODIPY-NAADP covalent conjugate made through linking the carboxyl group of BODIPY FL to the primary amino group of 5-(3-aminopropyl)-NAADP through amide bond formation. The starting pyridine dinucleotide analog, 5-(3-aminopropyl)-NAADP was available through enzyme-catalyzed base exchange between NADP and a substituted nicotinic acid analog. The resulting 5-BODIPY-NAADP conjugate was purified to homogeneity using ion-exchange chromatography, was produced in milligram quantities, and its spectroscopic properties were characterized.</p>
	]]></content:encoded>

	<dc:title>Synthesis of a Stable Long-Wavelength Fluorescent BODIPY FL-NAADP Conjugate</dc:title>
			<dc:creator>Zhong Guan</dc:creator>
			<dc:creator>James T. Slama</dc:creator>
		<dc:identifier>doi: 10.3390/M2085</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-11-05</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-11-05</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2085</prism:startingPage>
		<prism:doi>10.3390/M2085</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2085</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2083">

	<title>Molbank, Vol. 2025, Article M2083: 8,8&amp;prime;-Dichloro-2,2,2&amp;prime;,2&amp;prime;-tetraethyl-4,4&amp;prime;-bibenzo[1,3,6,2]dioxazastannocinylidene</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2083</link>
	<description>Upon the reaction of glyoxal-bis(2-hydroxy-5-chlorophenyl)imine LH2 with diethyltin dichloride in the presence of a base (Et3N) in DMSO, the 1D-coordination polymer 1 was obtained, in which formally the L&amp;amp;rsquo;(SnEt2)2 fragment acts as a monomeric unit. It was found that during the reaction, the initial ligand L undergoes transformation in the tin atom&amp;amp;rsquo;s coordination sphere. This transformation results in the formation of a new ditopic 1,4-bis((5-chloro-2-oxidophenyl)imino)but-2-ene-2,3-bis(olate) ligand L&amp;amp;rsquo;. The structure of the resulting complex 1 was examined by single-crystal X-ray diffraction analysis, elemental analysis, IR, and UV spectroscopy.</description>
	<pubDate>2025-11-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2083: 8,8&amp;prime;-Dichloro-2,2,2&amp;prime;,2&amp;prime;-tetraethyl-4,4&amp;prime;-bibenzo[1,3,6,2]dioxazastannocinylidene</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2083">doi: 10.3390/M2083</a></p>
	<p>Authors:
		Irina N. Meshcheryakova
		Ilya A. Yakushev
		Anton V. Cherkasov
		Maxim V. Arsenyev
		Anastasiya V. Klimashevskaya
		Dmitriy S. Kolevatov
		Alexandr V. Piskunov
		</p>
	<p>Upon the reaction of glyoxal-bis(2-hydroxy-5-chlorophenyl)imine LH2 with diethyltin dichloride in the presence of a base (Et3N) in DMSO, the 1D-coordination polymer 1 was obtained, in which formally the L&amp;amp;rsquo;(SnEt2)2 fragment acts as a monomeric unit. It was found that during the reaction, the initial ligand L undergoes transformation in the tin atom&amp;amp;rsquo;s coordination sphere. This transformation results in the formation of a new ditopic 1,4-bis((5-chloro-2-oxidophenyl)imino)but-2-ene-2,3-bis(olate) ligand L&amp;amp;rsquo;. The structure of the resulting complex 1 was examined by single-crystal X-ray diffraction analysis, elemental analysis, IR, and UV spectroscopy.</p>
	]]></content:encoded>

	<dc:title>8,8&amp;amp;prime;-Dichloro-2,2,2&amp;amp;prime;,2&amp;amp;prime;-tetraethyl-4,4&amp;amp;prime;-bibenzo[1,3,6,2]dioxazastannocinylidene</dc:title>
			<dc:creator>Irina N. Meshcheryakova</dc:creator>
			<dc:creator>Ilya A. Yakushev</dc:creator>
			<dc:creator>Anton V. Cherkasov</dc:creator>
			<dc:creator>Maxim V. Arsenyev</dc:creator>
			<dc:creator>Anastasiya V. Klimashevskaya</dc:creator>
			<dc:creator>Dmitriy S. Kolevatov</dc:creator>
			<dc:creator>Alexandr V. Piskunov</dc:creator>
		<dc:identifier>doi: 10.3390/M2083</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-11-04</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-11-04</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2083</prism:startingPage>
		<prism:doi>10.3390/M2083</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2083</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2084">

	<title>Molbank, Vol. 2025, Article M2084: Straightforward Synthesis of Thiophene Bioisosteres of the Pyrrolo[3,2-c]quinoline Framework from Martinelline Alkaloids</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2084</link>
	<description>We report the first green and diastereoselective synthesis of novel thiophene bioisosteres designed to mimic the privileged pyrrolo[3,2-c]quinoline core of martinelline alkaloids. The key step features an intramolecular 1,3-dipolar cycloaddition of in situ generated non-stabilized azomethine ylides from sarcosine, which proceeds with excellent yield and diastereoselectivity. This sustainable protocol, leveraging ultrasonic irradiation, recyclable hydrotalcite catalysts, and the green solvent cyclopentyl methyl ether (CPME), efficiently constructs the complex tricyclic framework. The structure and stereochemistry of the novel bioisostere were unambiguously confirmed by X-ray crystallography. This method offers a valuable, eco-friendly approach for diversifying natural product-inspired libraries in medicinal chemistry.</description>
	<pubDate>2025-11-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2084: Straightforward Synthesis of Thiophene Bioisosteres of the Pyrrolo[3,2-c]quinoline Framework from Martinelline Alkaloids</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2084">doi: 10.3390/M2084</a></p>
	<p>Authors:
		Tamer S. Saleh
		Abdullah S. Al-Bogami
		</p>
	<p>We report the first green and diastereoselective synthesis of novel thiophene bioisosteres designed to mimic the privileged pyrrolo[3,2-c]quinoline core of martinelline alkaloids. The key step features an intramolecular 1,3-dipolar cycloaddition of in situ generated non-stabilized azomethine ylides from sarcosine, which proceeds with excellent yield and diastereoselectivity. This sustainable protocol, leveraging ultrasonic irradiation, recyclable hydrotalcite catalysts, and the green solvent cyclopentyl methyl ether (CPME), efficiently constructs the complex tricyclic framework. The structure and stereochemistry of the novel bioisostere were unambiguously confirmed by X-ray crystallography. This method offers a valuable, eco-friendly approach for diversifying natural product-inspired libraries in medicinal chemistry.</p>
	]]></content:encoded>

	<dc:title>Straightforward Synthesis of Thiophene Bioisosteres of the Pyrrolo[3,2-c]quinoline Framework from Martinelline Alkaloids</dc:title>
			<dc:creator>Tamer S. Saleh</dc:creator>
			<dc:creator>Abdullah S. Al-Bogami</dc:creator>
		<dc:identifier>doi: 10.3390/M2084</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-11-04</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-11-04</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2084</prism:startingPage>
		<prism:doi>10.3390/M2084</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2084</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2082">

	<title>Molbank, Vol. 2025, Article M2082: 2-Methyl-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol]-2-ium Iodide</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2082</link>
	<description>The synthesis of the first 2-alkyl-1,2,3-selenadiazol-2-ium salt is reported. Extensive spectroscopic characterization including Se-NMR was performed and the results are compared with those of the known 3-ium isomer. The yellow compound crystallizes in blocks as well as in columns. The crystal structures of both types are solved by X-ray diffraction and give final proof of the molecular structure.</description>
	<pubDate>2025-11-03</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2082: 2-Methyl-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol]-2-ium Iodide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2082">doi: 10.3390/M2082</a></p>
	<p>Authors:
		Dieter Schollmeyer
		Heiner Detert
		</p>
	<p>The synthesis of the first 2-alkyl-1,2,3-selenadiazol-2-ium salt is reported. Extensive spectroscopic characterization including Se-NMR was performed and the results are compared with those of the known 3-ium isomer. The yellow compound crystallizes in blocks as well as in columns. The crystal structures of both types are solved by X-ray diffraction and give final proof of the molecular structure.</p>
	]]></content:encoded>

	<dc:title>2-Methyl-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol]-2-ium Iodide</dc:title>
			<dc:creator>Dieter Schollmeyer</dc:creator>
			<dc:creator>Heiner Detert</dc:creator>
		<dc:identifier>doi: 10.3390/M2082</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-11-03</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-11-03</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2082</prism:startingPage>
		<prism:doi>10.3390/M2082</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2082</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2081">

	<title>Molbank, Vol. 2025, Article M2081: (Z)-6-((Dimethylamino)methylene)-2-methyl-2,3-dihydroimidazo[2,1-b]thiazol-5(6H)-one</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2081</link>
	<description>Imidazothiazoles are important and attractive scaffolds for the design of potential biologically active small molecules. Dialkylenamines are convenient building blocks and are often used as intermediate reagents for the synthesis of various heterocyclic systems such as pyrimidine, pyridine, pyrazole, etc. In the present paper, the simple and effective synthesis of (Z)-6-((dimethylamino)methylene)-2-methyl-2,3-dihydroimidazo[2,1-b]thiazol-5(6H)-one (2) is reported. The proposed method, based on the reflux of 2-methyl-2,3-dihydroimidazo[2,1-b]thiazol-5(6H)-one with N,N-dimethylformamide dimethyl acetal, leads to an 80% yield of title compound 2. The structure of the synthesized compound 2 was confirmed using 1H, 13C NMR, and LC-MS spectra. The applied protocol demonstrates practical advantages such as the absence of a solvent, a simple work-up, and the possibility of scale-up.</description>
	<pubDate>2025-11-01</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2081: (Z)-6-((Dimethylamino)methylene)-2-methyl-2,3-dihydroimidazo[2,1-b]thiazol-5(6H)-one</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2081">doi: 10.3390/M2081</a></p>
	<p>Authors:
		Lesya Saliyeva
		Serhii Holota
		Nataliia Slyvka
		Mykhailo Vovk
		</p>
	<p>Imidazothiazoles are important and attractive scaffolds for the design of potential biologically active small molecules. Dialkylenamines are convenient building blocks and are often used as intermediate reagents for the synthesis of various heterocyclic systems such as pyrimidine, pyridine, pyrazole, etc. In the present paper, the simple and effective synthesis of (Z)-6-((dimethylamino)methylene)-2-methyl-2,3-dihydroimidazo[2,1-b]thiazol-5(6H)-one (2) is reported. The proposed method, based on the reflux of 2-methyl-2,3-dihydroimidazo[2,1-b]thiazol-5(6H)-one with N,N-dimethylformamide dimethyl acetal, leads to an 80% yield of title compound 2. The structure of the synthesized compound 2 was confirmed using 1H, 13C NMR, and LC-MS spectra. The applied protocol demonstrates practical advantages such as the absence of a solvent, a simple work-up, and the possibility of scale-up.</p>
	]]></content:encoded>

	<dc:title>(Z)-6-((Dimethylamino)methylene)-2-methyl-2,3-dihydroimidazo[2,1-b]thiazol-5(6H)-one</dc:title>
			<dc:creator>Lesya Saliyeva</dc:creator>
			<dc:creator>Serhii Holota</dc:creator>
			<dc:creator>Nataliia Slyvka</dc:creator>
			<dc:creator>Mykhailo Vovk</dc:creator>
		<dc:identifier>doi: 10.3390/M2081</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-11-01</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-11-01</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2081</prism:startingPage>
		<prism:doi>10.3390/M2081</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2081</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2080">

	<title>Molbank, Vol. 2025, Article M2080: Missing Crystal Structure and DFT Study of Calcium Complex Based on 4-(3-Hydroxy-2-methyl-4-oxopyridin-1(4H)-yl) Acetic Acid</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2080</link>
	<description>Recently, 3-hydroxy-4-pyridinones have been extensively studied as chelating bidentate agents of metal ions for various biomedical applications. This study reports the structural characterization and density functional theory (DFT) analysis of centrosymmetric calcium complex based on 4-(3-hydroxy-2-methyl-4-oxopyridin-1(4H)-yl) acetic acid (1). The structure of complex 1 was determined by X-ray crystallography. The 3-hydroxy-4-pyridinone ligand in the studied complex is bound to the calcium ion in the desired monodentate, non-bridging manner. The calcium ion has a coordination number of six and adopts a distorted octahedral geometry. Analyzed geometric characteristics corresponding to hydrogen bonds in the crystal. The theoretical study of intra- and intermolecular interactions utilized DFT with the PBE0-D3/def2-TZVP (Gaussian Inc., Wallingford, CT, USA) level of theory. The charge redistribution in the ligand was studied in comparison with the free acid molecule.</description>
	<pubDate>2025-10-24</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2080: Missing Crystal Structure and DFT Study of Calcium Complex Based on 4-(3-Hydroxy-2-methyl-4-oxopyridin-1(4H)-yl) Acetic Acid</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2080">doi: 10.3390/M2080</a></p>
	<p>Authors:
		Roman V. Rumyantcev
		Marina A. Katkova
		Galina S. Zabrodina
		Georgy K. Fukin
		Sergey Yu. Ketkov
		</p>
	<p>Recently, 3-hydroxy-4-pyridinones have been extensively studied as chelating bidentate agents of metal ions for various biomedical applications. This study reports the structural characterization and density functional theory (DFT) analysis of centrosymmetric calcium complex based on 4-(3-hydroxy-2-methyl-4-oxopyridin-1(4H)-yl) acetic acid (1). The structure of complex 1 was determined by X-ray crystallography. The 3-hydroxy-4-pyridinone ligand in the studied complex is bound to the calcium ion in the desired monodentate, non-bridging manner. The calcium ion has a coordination number of six and adopts a distorted octahedral geometry. Analyzed geometric characteristics corresponding to hydrogen bonds in the crystal. The theoretical study of intra- and intermolecular interactions utilized DFT with the PBE0-D3/def2-TZVP (Gaussian Inc., Wallingford, CT, USA) level of theory. The charge redistribution in the ligand was studied in comparison with the free acid molecule.</p>
	]]></content:encoded>

	<dc:title>Missing Crystal Structure and DFT Study of Calcium Complex Based on 4-(3-Hydroxy-2-methyl-4-oxopyridin-1(4H)-yl) Acetic Acid</dc:title>
			<dc:creator>Roman V. Rumyantcev</dc:creator>
			<dc:creator>Marina A. Katkova</dc:creator>
			<dc:creator>Galina S. Zabrodina</dc:creator>
			<dc:creator>Georgy K. Fukin</dc:creator>
			<dc:creator>Sergey Yu. Ketkov</dc:creator>
		<dc:identifier>doi: 10.3390/M2080</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-10-24</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-10-24</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2080</prism:startingPage>
		<prism:doi>10.3390/M2080</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2080</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2079">

	<title>Molbank, Vol. 2025, Article M2079: Revisiting the Coordination Chemistry of Molybdenum(V): Novel Complexes with Pyrazinoate and Picolinate Ligands</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2079</link>
	<description>Reactions of (pyH)5[MoOCl4(H2O)]3Cl2 with picolinic and pyrazinoic acids yielded three new dinuclear molybdenum(V) complexes: (pyH)2[Mo2O4Cl2(pic)2]&amp;amp;middot;CH3CN (1), (pyH)2[Mo2O4Cl2(pic)2]&amp;amp;middot;CH3CH2CN (2) and (pyH)2[Mo2O4Cl2(pyraz)2]&amp;amp;middot;CH3CN (3) (pic&amp;amp;minus; = picolinate, pyraz&amp;amp;minus; = pyrazinoate and pyH+ = protonated pyridine). The compounds were characterized by single-crystal X-ray diffraction, infrared and 1H NMR spectroscopy, elemental analysis, and TG/DSC measurements. All display a robust {MoV2O4}2+ core with the heteroaromatic ligands bound in a N,O-bidentate chelating manner.</description>
	<pubDate>2025-10-24</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2079: Revisiting the Coordination Chemistry of Molybdenum(V): Novel Complexes with Pyrazinoate and Picolinate Ligands</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2079">doi: 10.3390/M2079</a></p>
	<p>Authors:
		Barbara Modec
		Nina Podjed Rihtaršič
		</p>
	<p>Reactions of (pyH)5[MoOCl4(H2O)]3Cl2 with picolinic and pyrazinoic acids yielded three new dinuclear molybdenum(V) complexes: (pyH)2[Mo2O4Cl2(pic)2]&amp;amp;middot;CH3CN (1), (pyH)2[Mo2O4Cl2(pic)2]&amp;amp;middot;CH3CH2CN (2) and (pyH)2[Mo2O4Cl2(pyraz)2]&amp;amp;middot;CH3CN (3) (pic&amp;amp;minus; = picolinate, pyraz&amp;amp;minus; = pyrazinoate and pyH+ = protonated pyridine). The compounds were characterized by single-crystal X-ray diffraction, infrared and 1H NMR spectroscopy, elemental analysis, and TG/DSC measurements. All display a robust {MoV2O4}2+ core with the heteroaromatic ligands bound in a N,O-bidentate chelating manner.</p>
	]]></content:encoded>

	<dc:title>Revisiting the Coordination Chemistry of Molybdenum(V): Novel Complexes with Pyrazinoate and Picolinate Ligands</dc:title>
			<dc:creator>Barbara Modec</dc:creator>
			<dc:creator>Nina Podjed Rihtaršič</dc:creator>
		<dc:identifier>doi: 10.3390/M2079</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-10-24</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-10-24</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2079</prism:startingPage>
		<prism:doi>10.3390/M2079</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2079</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2078">

	<title>Molbank, Vol. 2025, Article M2078: N-(2-Fluoro-2-propen-1-yl)-5-(trifluoromethyl)-2-pyridinecarboxamide</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2078</link>
	<description>Herein, the synthesis and crystallization of the unreported compound N-(2-fluoro-2-propen-1-yl)-5-(trifluoromethyl)-2-pyridinecarboxamide is achieved via amide coupling with a (2-fluoroallyl)ammonium salt. The structural properties are analyzed via single-crystal X-ray crystallography. Hydrogen bonding interactions between the amide groups and pyridine nitrogen atoms create a unique linear array of molecules in the crystal packing diagram. Furthermore, to validate the crystallographic data, the structural features of the compound are evaluated and compared to values reported in the literature.</description>
	<pubDate>2025-10-21</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2078: N-(2-Fluoro-2-propen-1-yl)-5-(trifluoromethyl)-2-pyridinecarboxamide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2078">doi: 10.3390/M2078</a></p>
	<p>Authors:
		Taylor Semeniuk
		Jean-Denys Hamel
		</p>
	<p>Herein, the synthesis and crystallization of the unreported compound N-(2-fluoro-2-propen-1-yl)-5-(trifluoromethyl)-2-pyridinecarboxamide is achieved via amide coupling with a (2-fluoroallyl)ammonium salt. The structural properties are analyzed via single-crystal X-ray crystallography. Hydrogen bonding interactions between the amide groups and pyridine nitrogen atoms create a unique linear array of molecules in the crystal packing diagram. Furthermore, to validate the crystallographic data, the structural features of the compound are evaluated and compared to values reported in the literature.</p>
	]]></content:encoded>

	<dc:title>N-(2-Fluoro-2-propen-1-yl)-5-(trifluoromethyl)-2-pyridinecarboxamide</dc:title>
			<dc:creator>Taylor Semeniuk</dc:creator>
			<dc:creator>Jean-Denys Hamel</dc:creator>
		<dc:identifier>doi: 10.3390/M2078</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-10-21</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-10-21</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2078</prism:startingPage>
		<prism:doi>10.3390/M2078</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2078</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2077">

	<title>Molbank, Vol. 2025, Article M2077: 2-Benzyl-6-carboxy-5,6,7,8-tetrahydroimidazo[1,2-a]pyrimidin-1-ium 2,2,2-trifluoroacetate</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2077</link>
	<description>Cyclic guanidines are valuable scaffolds for the design of compounds acting on GABAergic neurotransmission, owing to their ability to mimic the amino functionality of GABA as bioisosteres. With the aim to obtain a more potent and selective betaine/GABA transporter (BGT1) inhibitor, a basic hydrolysis of ethyl (E)-2-(acetylimino)-1-(3-phenylprop-2-yn-1-yl)hexahydropyrimidine-5-carboxylate was attempted. However, we isolated a byproduct, which was identified as the trifluoroacetate salt of 2-benzyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyrimidine-6-carboxylic acid. The structure was confirmed by NMR spectroscopy and LC-MS. Herein we report the preparation, characterization, and spectral data of this fused heterocyclic compound.</description>
	<pubDate>2025-10-20</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2077: 2-Benzyl-6-carboxy-5,6,7,8-tetrahydroimidazo[1,2-a]pyrimidin-1-ium 2,2,2-trifluoroacetate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2077">doi: 10.3390/M2077</a></p>
	<p>Authors:
		Francesco Bavo
		Christos Avgerinos
		Elena Martino
		Bente Frølund
		</p>
	<p>Cyclic guanidines are valuable scaffolds for the design of compounds acting on GABAergic neurotransmission, owing to their ability to mimic the amino functionality of GABA as bioisosteres. With the aim to obtain a more potent and selective betaine/GABA transporter (BGT1) inhibitor, a basic hydrolysis of ethyl (E)-2-(acetylimino)-1-(3-phenylprop-2-yn-1-yl)hexahydropyrimidine-5-carboxylate was attempted. However, we isolated a byproduct, which was identified as the trifluoroacetate salt of 2-benzyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyrimidine-6-carboxylic acid. The structure was confirmed by NMR spectroscopy and LC-MS. Herein we report the preparation, characterization, and spectral data of this fused heterocyclic compound.</p>
	]]></content:encoded>

	<dc:title>2-Benzyl-6-carboxy-5,6,7,8-tetrahydroimidazo[1,2-a]pyrimidin-1-ium 2,2,2-trifluoroacetate</dc:title>
			<dc:creator>Francesco Bavo</dc:creator>
			<dc:creator>Christos Avgerinos</dc:creator>
			<dc:creator>Elena Martino</dc:creator>
			<dc:creator>Bente Frølund</dc:creator>
		<dc:identifier>doi: 10.3390/M2077</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-10-20</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-10-20</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2077</prism:startingPage>
		<prism:doi>10.3390/M2077</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2077</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2076">

	<title>Molbank, Vol. 2025, Article M2076: 1,1-Bis(4-ethylphenyl)-propan-1,2-diol</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2076</link>
	<description>Diols represent a structurally diverse class of compounds with considerable biological and functional significance. Herein, we describe the synthesis of 1,1-bis(4-ethylphenyl)propan-1,2-diol (BEPP) via a Grignard reaction. The structure of BEPP was unambiguously elucidated by 1H and 13C nuclear magnetic resonance (NMR), heteronuclear multiple-bond correlation (HMBC), high-resolution mass spectrometry (HRMS), and infrared (IR) spectroscopy.</description>
	<pubDate>2025-10-16</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2076: 1,1-Bis(4-ethylphenyl)-propan-1,2-diol</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2076">doi: 10.3390/M2076</a></p>
	<p>Authors:
		Ichika Hayashida
		Malokhat Uktamova
		Sarvinoz Tirkasheva
		Kohei Torikai
		</p>
	<p>Diols represent a structurally diverse class of compounds with considerable biological and functional significance. Herein, we describe the synthesis of 1,1-bis(4-ethylphenyl)propan-1,2-diol (BEPP) via a Grignard reaction. The structure of BEPP was unambiguously elucidated by 1H and 13C nuclear magnetic resonance (NMR), heteronuclear multiple-bond correlation (HMBC), high-resolution mass spectrometry (HRMS), and infrared (IR) spectroscopy.</p>
	]]></content:encoded>

	<dc:title>1,1-Bis(4-ethylphenyl)-propan-1,2-diol</dc:title>
			<dc:creator>Ichika Hayashida</dc:creator>
			<dc:creator>Malokhat Uktamova</dc:creator>
			<dc:creator>Sarvinoz Tirkasheva</dc:creator>
			<dc:creator>Kohei Torikai</dc:creator>
		<dc:identifier>doi: 10.3390/M2076</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-10-16</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-10-16</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2076</prism:startingPage>
		<prism:doi>10.3390/M2076</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2076</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2075">

	<title>Molbank, Vol. 2025, Article M2075: 3-((Benzyloxy)carbonyl)bicyclo[1.1.1]pentane-1-carboxylic Acid</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2075</link>
	<description>The compound 3-((benzyloxy)carbonyl)bicyclo[1.1.1]pentane-1-carboxylic acid was successfully synthesized. High-quality crystals were obtained, and its X-ray structure was solved and refined by Hirshfeld atom refinement using custom aspherical scattering factors with the Olex2/NoSphereA2 package. Hydrogen bonding interactions lead to head-to-head carboxylic acid dimer formation. A positional disorder for the bridging H-atom was detected and modeled to two parts in a 0.85:0.15 ratio. Detailed comparison with a neutron diffraction study of benzoic acid at the same temperature (100 K) demonstrates that the E&amp;amp;ndash;H-bond distances in the title compound are in excellent agreement (differing less than 1%) and the displacement ellipsoids volumes to the model are also in excellent agreement to the neutron diffraction structure. Moreover, both the variation in refined disorder occupancy and differences in C=O and C&amp;amp;ndash;O lengths of the disordered carboxylic acids in the two structures track well with their dimer O&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;O separations. This is longer by 0.023 &amp;amp;Aring; in the structure of the title compound than in that of benzoic acid. A database search was conducted and used for comparison of the title compound to other high-quality structures of bicyclo[1.1.1]pentane-containing species.</description>
	<pubDate>2025-10-16</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2075: 3-((Benzyloxy)carbonyl)bicyclo[1.1.1]pentane-1-carboxylic Acid</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2075">doi: 10.3390/M2075</a></p>
	<p>Authors:
		Dennis D. Toporkov
		Stacie K. Nelson
		Jean-Denys Hamel
		René T. Boeré
		</p>
	<p>The compound 3-((benzyloxy)carbonyl)bicyclo[1.1.1]pentane-1-carboxylic acid was successfully synthesized. High-quality crystals were obtained, and its X-ray structure was solved and refined by Hirshfeld atom refinement using custom aspherical scattering factors with the Olex2/NoSphereA2 package. Hydrogen bonding interactions lead to head-to-head carboxylic acid dimer formation. A positional disorder for the bridging H-atom was detected and modeled to two parts in a 0.85:0.15 ratio. Detailed comparison with a neutron diffraction study of benzoic acid at the same temperature (100 K) demonstrates that the E&amp;amp;ndash;H-bond distances in the title compound are in excellent agreement (differing less than 1%) and the displacement ellipsoids volumes to the model are also in excellent agreement to the neutron diffraction structure. Moreover, both the variation in refined disorder occupancy and differences in C=O and C&amp;amp;ndash;O lengths of the disordered carboxylic acids in the two structures track well with their dimer O&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;O separations. This is longer by 0.023 &amp;amp;Aring; in the structure of the title compound than in that of benzoic acid. A database search was conducted and used for comparison of the title compound to other high-quality structures of bicyclo[1.1.1]pentane-containing species.</p>
	]]></content:encoded>

	<dc:title>3-((Benzyloxy)carbonyl)bicyclo[1.1.1]pentane-1-carboxylic Acid</dc:title>
			<dc:creator>Dennis D. Toporkov</dc:creator>
			<dc:creator>Stacie K. Nelson</dc:creator>
			<dc:creator>Jean-Denys Hamel</dc:creator>
			<dc:creator>René T. Boeré</dc:creator>
		<dc:identifier>doi: 10.3390/M2075</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-10-16</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-10-16</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2075</prism:startingPage>
		<prism:doi>10.3390/M2075</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2075</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2074">

	<title>Molbank, Vol. 2025, Article M2074: Efficient Synthesis of Unsymmetrical 7,7&amp;prime;-Biindolizines</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2074</link>
	<description>Six new unsymmetrical 7,7&amp;amp;prime;-biindolizines were synthesized through an efficient metal-free [2+2+1] cycloaddition of ethyl 3-benzoyl-7-(pyridin-4-yl)indolizine-1-carboxylate with two equivalents of dimethyl acetylenedicarboxylate in methanol. The transformation involves one C&amp;amp;equiv;C triple bond cleavage and provides access to previously unexplored unsymmetrical functionalized 7,7&amp;amp;prime;-biindolizines.</description>
	<pubDate>2025-10-15</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2074: Efficient Synthesis of Unsymmetrical 7,7&amp;prime;-Biindolizines</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2074">doi: 10.3390/M2074</a></p>
	<p>Authors:
		Roxana Ciorteanu
		Andreea Danila
		Catalina Ionica Ciobanu
		Ioana Radu
		Ionel I. Mangalagiu
		Ramona Danac
		</p>
	<p>Six new unsymmetrical 7,7&amp;amp;prime;-biindolizines were synthesized through an efficient metal-free [2+2+1] cycloaddition of ethyl 3-benzoyl-7-(pyridin-4-yl)indolizine-1-carboxylate with two equivalents of dimethyl acetylenedicarboxylate in methanol. The transformation involves one C&amp;amp;equiv;C triple bond cleavage and provides access to previously unexplored unsymmetrical functionalized 7,7&amp;amp;prime;-biindolizines.</p>
	]]></content:encoded>

	<dc:title>Efficient Synthesis of Unsymmetrical 7,7&amp;amp;prime;-Biindolizines</dc:title>
			<dc:creator>Roxana Ciorteanu</dc:creator>
			<dc:creator>Andreea Danila</dc:creator>
			<dc:creator>Catalina Ionica Ciobanu</dc:creator>
			<dc:creator>Ioana Radu</dc:creator>
			<dc:creator>Ionel I. Mangalagiu</dc:creator>
			<dc:creator>Ramona Danac</dc:creator>
		<dc:identifier>doi: 10.3390/M2074</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-10-15</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-10-15</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2074</prism:startingPage>
		<prism:doi>10.3390/M2074</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2074</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2073">

	<title>Molbank, Vol. 2025, Article M2073: (5R*,6R*) 11-Benzoyl-4,10-dimethyl-2,8-diphenyl-2,3,8,9-tetraazadispiro [4.0.46.15]undeca-3,9-diene-1,7-dione</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2073</link>
	<description>Cyclopropanes are important in drug discovery because their unique structure, including inherent three-dimensionality, can enhance a drug&amp;amp;rsquo;s properties, such as metabolic stability, target binding, and membrane permeability. In this communication, (5R*,6R*) 11-benzoyl-4,10-dimethyl-2,8-diphenyl-2,3,8,9-tetraazadispiro[4.0.46.15]undeca-3,9-diene-1,7-dione was prepared via a stereoselective one-pot reaction of phenylglyoxal hydrate with two equivalents of 5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one in EtOH in the presence of sodium acetate and N-bromosuccinimide. The structure of the newly synthesized compound was established by 1H and 13C NMR, IR spectroscopy, high-resolution mass spectrometry, and elemental analysis.</description>
	<pubDate>2025-10-15</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2073: (5R*,6R*) 11-Benzoyl-4,10-dimethyl-2,8-diphenyl-2,3,8,9-tetraazadispiro [4.0.46.15]undeca-3,9-diene-1,7-dione</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2073">doi: 10.3390/M2073</a></p>
	<p>Authors:
		Michail N. Elinson
		Varvara M. Kalashnikova
		Yuliya E. Ryzhkova
		Oleg A. Rakitin
		</p>
	<p>Cyclopropanes are important in drug discovery because their unique structure, including inherent three-dimensionality, can enhance a drug&amp;amp;rsquo;s properties, such as metabolic stability, target binding, and membrane permeability. In this communication, (5R*,6R*) 11-benzoyl-4,10-dimethyl-2,8-diphenyl-2,3,8,9-tetraazadispiro[4.0.46.15]undeca-3,9-diene-1,7-dione was prepared via a stereoselective one-pot reaction of phenylglyoxal hydrate with two equivalents of 5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one in EtOH in the presence of sodium acetate and N-bromosuccinimide. The structure of the newly synthesized compound was established by 1H and 13C NMR, IR spectroscopy, high-resolution mass spectrometry, and elemental analysis.</p>
	]]></content:encoded>

	<dc:title>(5R*,6R*) 11-Benzoyl-4,10-dimethyl-2,8-diphenyl-2,3,8,9-tetraazadispiro [4.0.46.15]undeca-3,9-diene-1,7-dione</dc:title>
			<dc:creator>Michail N. Elinson</dc:creator>
			<dc:creator>Varvara M. Kalashnikova</dc:creator>
			<dc:creator>Yuliya E. Ryzhkova</dc:creator>
			<dc:creator>Oleg A. Rakitin</dc:creator>
		<dc:identifier>doi: 10.3390/M2073</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-10-15</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-10-15</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2073</prism:startingPage>
		<prism:doi>10.3390/M2073</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2073</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2072">

	<title>Molbank, Vol. 2025, Article M2072: Development of New Amide Derivatives of Betulinic Acid: Synthetic Approaches and Structural Characterization</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2072</link>
	<description>In this study, we report the synthesis of three new derivatives of betulinic acid, a pentacyclic triterpenoid known for its antitumor activity. These derivatives were synthesized via amide bond formation at the C-28 position using 3-[(Ethylimino)methylidene]amino-N,N-dimethylpropan-1-amine (EDC)/Hydroxybenzotriazole (HOBt) activation and various amines as nucleophiles. The synthesized compounds were characterized by nuclear magnetic resonance (NMR) techniques, including proton (1H), carbon-13 (13C), COSY, HSQC, and DEPT, as well as ultraviolet&amp;amp;ndash;visible (UV-VIS) spectroscopy, Fourier-transform infrared (IR) and elemental analysis. This work highlights the potential of semi-synthetic modification of betulinic acid to enhance anticancer properties while addressing challenges in solubility and bioavailability. Further structural optimization and formulation studies are warranted to improve drug-like properties and therapeutic applicability.</description>
	<pubDate>2025-10-13</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2072: Development of New Amide Derivatives of Betulinic Acid: Synthetic Approaches and Structural Characterization</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2072">doi: 10.3390/M2072</a></p>
	<p>Authors:
		Qinwei Xu
		Yuhan Xie
		Jin Qi
		Zimo Ren
		Carmine Coluccini
		Paolo Coghi
		</p>
	<p>In this study, we report the synthesis of three new derivatives of betulinic acid, a pentacyclic triterpenoid known for its antitumor activity. These derivatives were synthesized via amide bond formation at the C-28 position using 3-[(Ethylimino)methylidene]amino-N,N-dimethylpropan-1-amine (EDC)/Hydroxybenzotriazole (HOBt) activation and various amines as nucleophiles. The synthesized compounds were characterized by nuclear magnetic resonance (NMR) techniques, including proton (1H), carbon-13 (13C), COSY, HSQC, and DEPT, as well as ultraviolet&amp;amp;ndash;visible (UV-VIS) spectroscopy, Fourier-transform infrared (IR) and elemental analysis. This work highlights the potential of semi-synthetic modification of betulinic acid to enhance anticancer properties while addressing challenges in solubility and bioavailability. Further structural optimization and formulation studies are warranted to improve drug-like properties and therapeutic applicability.</p>
	]]></content:encoded>

	<dc:title>Development of New Amide Derivatives of Betulinic Acid: Synthetic Approaches and Structural Characterization</dc:title>
			<dc:creator>Qinwei Xu</dc:creator>
			<dc:creator>Yuhan Xie</dc:creator>
			<dc:creator>Jin Qi</dc:creator>
			<dc:creator>Zimo Ren</dc:creator>
			<dc:creator>Carmine Coluccini</dc:creator>
			<dc:creator>Paolo Coghi</dc:creator>
		<dc:identifier>doi: 10.3390/M2072</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-10-13</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-10-13</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2072</prism:startingPage>
		<prism:doi>10.3390/M2072</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2072</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2025/4/M2071">

	<title>Molbank, Vol. 2025, Article M2071: Crystal Structure of 3-(Anthracen-2&amp;prime;-yl)-ortho-carborane</title>
	<link>https://www.mdpi.com/1422-8599/2025/4/M2071</link>
	<description>Crystal molecular structure of 3-(anthracen-2&amp;amp;prime;-yl)-ortho-carborane was determined by single crystal X-ray diffraction study at 100 K. The asymmetric cell unit contains two enantiomeric pairs of molecules, in one of which the intramolecular dihydrogen bond CH...HB is formed with the participation of the C(1)H hydrogen of the anthracene substituent, and in the other with the participation of the C(3)H hydrogen. In all molecules, the polycyclic aromatic and carborane fragments are rotated relative to each other in such a way that the C-C bond of the ortho-carborane cage is approximately parallel to the plane of the aromatic substituent. According to quantum chemical calculations, the minimum energy corresponds to the formation of an intramolecular dihydrogen bond C(1)H...HB(4/7), whereas the C(3)H...HB(4/7) bond is formed rather as a result of intermolecular interactions in the crystal lattice.</description>
	<pubDate>2025-10-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2025, Article M2071: Crystal Structure of 3-(Anthracen-2&amp;prime;-yl)-ortho-carborane</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2025/4/M2071">doi: 10.3390/M2071</a></p>
	<p>Authors:
		Kyrill Yu. Suponitsky
		Akim V. Shmal’ko
		Sergey A. Anufriev
		Igor B. Sivaev
		</p>
	<p>Crystal molecular structure of 3-(anthracen-2&amp;amp;prime;-yl)-ortho-carborane was determined by single crystal X-ray diffraction study at 100 K. The asymmetric cell unit contains two enantiomeric pairs of molecules, in one of which the intramolecular dihydrogen bond CH...HB is formed with the participation of the C(1)H hydrogen of the anthracene substituent, and in the other with the participation of the C(3)H hydrogen. In all molecules, the polycyclic aromatic and carborane fragments are rotated relative to each other in such a way that the C-C bond of the ortho-carborane cage is approximately parallel to the plane of the aromatic substituent. According to quantum chemical calculations, the minimum energy corresponds to the formation of an intramolecular dihydrogen bond C(1)H...HB(4/7), whereas the C(3)H...HB(4/7) bond is formed rather as a result of intermolecular interactions in the crystal lattice.</p>
	]]></content:encoded>

	<dc:title>Crystal Structure of 3-(Anthracen-2&amp;amp;prime;-yl)-ortho-carborane</dc:title>
			<dc:creator>Kyrill Yu. Suponitsky</dc:creator>
			<dc:creator>Akim V. Shmal’ko</dc:creator>
			<dc:creator>Sergey A. Anufriev</dc:creator>
			<dc:creator>Igor B. Sivaev</dc:creator>
		<dc:identifier>doi: 10.3390/M2071</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-10-10</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-10-10</prism:publicationDate>
	<prism:volume>2025</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2071</prism:startingPage>
		<prism:doi>10.3390/M2071</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2025/4/M2071</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
    
<cc:License rdf:about="https://creativecommons.org/licenses/by/4.0/">
	<cc:permits rdf:resource="https://creativecommons.org/ns#Reproduction" />
	<cc:permits rdf:resource="https://creativecommons.org/ns#Distribution" />
	<cc:permits rdf:resource="https://creativecommons.org/ns#DerivativeWorks" />
</cc:License>

</rdf:RDF>
